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1.1 Discovery of cochleates:  
The transition of negatively charged lipids from the liquid-crystalline to the gel state due to ionic 
interaction has been intensively investigated in past decades (Papahadjopoulos et al., 1973; Träuble 
and Eibl, 1974). This interaction leads to major morphological transformation into a rolled up 
cylindrical structure that were noted by Verkleij and coworkers during morphological evaluations in 
1974 (Verkleij et al., 1974; Ververgaert et al., 1975). These cylindrical structures were also observed 
by Dr. D. Papahadjopoulos and co‐workers while developing method for formulation of large vesicles 
(Papahadjopoulos and Kimelberg, 1974; Papahadjopoulos et al., 1975), at an intermediate stage, who 
named them 'cochleates' in 1975 (Papahadjopoulos, 1978). The term cochleate originates from Greek 
term for 'snail with spiral shell' which corresponds to the folding pattern of cylinders (Figure 1.1).  
Cochleates are formed due to self-assembly of negatively charged lipid bilayers and cations. Self-
assembly at molecular level can be described as a process in which spontaneous arrangement of 
molecular subunits results into formation of ordered structures with properties unlike their 
precursors (Zhang, 2003). During cochleate formation positively charged binding agent and lipid head 
group interacts in order to form hierarchical superstructures (Poste et al., 1976). The interactions 
involved in this process are usually of non-covalent nature (e.g. electrostatic interactions, Van der 
Waals forces, hydrogen bonds, hydrophobic interactions etc.). This process finally results in formation 
of highly ordered cochleates from structures with less ordered states.  
 
 
Figure 1.1: Cryo scanning electron micrograph of calcium cochleates of a) DMPS displaying folding 
pattern (figure from unpublished data) and b) DOPS showing cylindrical morphology (figure reported 
in article 1 of this thesis).   
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1.2 Materials for cochleate formation 
Lipids: Naturally occurring phospholipids have often been used for preparation of cochleates. Most 
commonly used classes are anionic phospholipids e.g. Phosphatidic acid (Kouaouci et al., 1985), 
Phosphatidylethanolamine (Sarig et al., 2011), Phosphatidylinositol and Phosphatidylglycerol (Garidel 
et al., 2001), phosphatidylserines (PS) etc. Until the last two decades cochleate systems were mainly 
synthesized from mixtures of lipids viz bovine brain PS (Papahadjopoulos, 1978), Porcine brain PS, 
Soya PS (Zarif and Tan, 2003) etc. More recently pure synthetic lipids like 1,2-dioleoyl-sn-glycero-3-
phospho-L-serine (DOPS) have been used in studies to incorporate drugs (Zarif et al., 2000). There are 
also reports regarding formation of cochleates from neutral lipids. Galactosylceramides (Kulkarni et 
al., 1999), sphingosines (Archibald and Mann, 1993) have been evaluated in past for their ability to 
produce cochleates. In 2010 cholesterol cochleates were synthesized by Harris et al. using ethanol 
injection method (Harris et al., 2011). 
Binding Agents: Metal cations are commonly used as binding agents for cochleate formation. Divalent 
cations like Ca+2, Mg+2, Ba+2 and Zn+2 have been used in the past as binding agents with negatively 
charged phospholipids (Loomba and Scarabelli, 2013). Amongst these calcium is reported as most 
potent cation for cochleate formation (Papahadjopoulos et al., 1978). Monovalent ions like Na+ have 
also served as binding agents for cochleate formation from phosphatidylglycerols (Garidel et al., 
2001). Organic cations like drugs or antimicrobial agents e.g. Oligo-acyl-lycyls (Sarig et al., 2011), 
2,3,5,6-tetraaminopyrimidine, tobramycin, and polylysine have been employed for cochleate 
formation from anionic phospholipids (Jin, 2004). Cochleate formation from lipids like 
galactocerebroside in absence of binding agents has also been reported. In these cases the 
conversion of acyl chains to gel state and cochleation were initiated due to use of non-aqueous 
solvents and temperature fluctuations (Archibald and Yager, 1992). 
 
1.3 Basic structure of cochleates: 
Cochleates have a peculiar multilamellar structure (Figure 1.2) which imparts them extraordinary 
stability. Interaction of negatively charged bilayers with cations result in substantial structural 
rearrangement that causes aggregation and fusion of bilayers. This interaction triggers conversion of 
aliphatic acyl chains in lipid bilayer into gel state (Jacobson and Papahadjopoulos, 1975). The resulting 
planar bilayer sheets consist of lipid and binding agent in molar ratio of 2:1 (Bangham and 
Papahadjopoulos, 1966). These crystallized planar sheets further tightly fold upon to form cylindrical 
carpet roll like structure. Hence a typical cochleate is made up of sheets consisting alternating layers 







Figure 1.2: Diagrammatic representation of structure of cochleates, with close view of organization 
of lipid molecules before and after interaction with of calcium ions (binding agent) 
 
Molecules with different properties viz. hydrophobic, hydrophilic, charged etc. are known to 
associate with cochleates and their incorporation into cochleates has been explained theoretically by 
Zarif et al. (2005). The schematic diagram in Figure 1.3 explains the possible embedding of molecules 
with different properties. As per this theory the hydrophobic molecules will get entrapped in lipid 
chains to minimize interaction with water (Figure 1.3a). Amphiphilic molecules may have higher 
probability to fit perfectly between bilayer with their hydrophobic and hydrophilic regions aligned 
with lipid molecules (Figure 1.3b). Whereas the charged molecules can partition into interbilayer 
domains (Figure 1.3c and d) since charged interactions with lipids and binding agent can promote the 
encapsulation.  
Although entrapment of the molecule is highly defined by its nature the shape of molecule is also an 
important parameter. It has been observed that hydrophobic and linear molecules are best 
candidates to get incorporated in cochleates. Whereas small neutral hydrophilic molecules have 





Figure 1.3: Diagrammatic representation of organization of A) hydrophobic B) amphiphilic C) 
negatively charged and D) positively charged drug molecules in cochleates based on their nature 
(reproduced from (Zarif, 2005)). 
1.4 Advantages of cochleates 
Cochleates are comprised of well tolerated and non-immunogenic excipients which are of natural 
origin (Ramasamy et al., 2009). The building blocks of cochleates such as phosphatidylserines impart 
additional benefits such as improved cognitive functions, better immune function and antiaging 
benefits (Sankar and Reddy, 2010). Repeated oral and intra-peritoneal doses of cochleates to mice 
have shown that cochleates are well tolerated, not toxic and non-inflammatory (Gibson et al., 2004; 
Zarif and Mannino, 2002). Condensed framework of cochleates can facilitate in protection of 
associated molecules from harsh conditions such as extreme pH, proteolytic enzymes etc. The 
extremely hydrophobic nature of cochleate surface and resistance to oxygen penetration protects 
the internalized moieties from oxidation. Multilamellar structure of cochleates imparts them 
potential for slow release of drugs. All these advantages are mainly favorable for establishing oral 
efficacy of drugs which are prone to degradation in gastric environment. Cochleates can easily be 
produced on large scale. They are very stable formulations with long shelf life. They can remain stable 
over a year at room temperature in absence of aqueous medium, or over 2 years when refrigerated 
at 4 °C (Rao et al., 2007). They can retain their structure, shape, and function even after being 
subjected to processes such as lyophilization. Hence solid structure of cochleates can provide 
chemical as well as mechanical stability (Bozo et al., 2015) and increase the shelf life of fragile 
susceptible molecules (Rao et al., 2007).  
 
1.5 Theoretical aspects of mechanism of drug release from cochleates 
Mechanism of action of cochleates is not completely understood at cellular or tissue level in biological 
systems. When administered in body, supramolecular and crystalline structure of the cochleates may 
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provide protection to the encochleated molecules from the hostile environments. This could facilitate 
the components within the interior of the cochleate to remain intact, even though the outer layers 
of the cochleate are exposed to degradation (Mannino and Gould-Fogerite, 1995). Hence, gradual 
digestion of cochleate may take place leading to slow release and enhanced absorption. In results of 
cell line studies, cochleates containing fluorescent probes have been shown to bind to the plasma 
membrane (Gibson et al., 2004). One of theories put forth for explanation of uptake studies considers 
phagocytic processes for cell internalization. Cochleates with smaller dimensions or their fragments 
may be taken up by endocytosis in active phagocytic cells and release the contents gradually in cell 
cytoplasm. In course of time concentration gradient between cochleate and endocytic vesicle may 
cause calcium to leach out facilitating release of the contents within the endocytic vesicle. Another 
theory for mechanism of action is based on the fact that calcium ions and phospholipids play pivotal 
roles in naturally occurring membrane fusion events. This probably increases chances of interaction 
between cell surface and calcium rich cochleates. During close encounter the outer layer, edge or end 
of the cochleate and the cell membrane might undergo fusion. As a result encochleated material may 
be transferred onto cell membranes and eventually be released into the cytoplasm of the cell. The 
cochleate could then separate from the cell and undergo another fusion event, with the same or 
another cell. Hence the contact of the cochleate system with the mucous membrane may facilitate 
in drug absorption (Rao et al., 2007).  
 
1.6 Methods for preparation of cochleates: 
1.6.1 Trapping method:  
Papahadjopoulos reported preparation of PS-Ca cochleates by trapping method (Papahadjopoulos et 
al., 1975) i.e. simple mixing of aqueous suspension of lipid and binding agent in molar ratio of 2:1. 
Trapping method involves the formation of lipid dispersion viz liposomes, micelles etc. as initial step. 
This is followed by dropwise addition of a solution of binding agent like metal cations into lipid 
dispersion. Although it is a straight forward procedure it seldom offers narrow size distribution of the 
final product (Mannino et al., 2005; Zarif and Mannino, 2002). Some modifications such as solvent 
drip method have been used to improve the loading of active ingredients in cochleates. Briefly, in this 
modification the active ingredient is dissolved in solvents such as ethanol and added to liposomal 
suspension. This triggers transfer of active ingredient in higher concentration on liposomal bilayer 
and hence in cochleates precipitated from them (Mannino et al., 2014). In other modification, 
liposomes were prepared at higher pH by simple mixing of excipients and drug or by film hydration 
method in order to attain increase in entrapment. These liposomes were further subjected to 
cochleate formation by the trapping method (Zarif, 2005).  
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1.6.2 Dialysis method: 
In this method cochleates are prepared by a process involving dialysis. First approach is called 'LC 
dialysis method'. In this approach, small unilamellar vesicles are prepared from mixture of lipid and 
detergents using dialysis. These vesicles are then further subjected to a second dialysis step in 
presence of binding agent. The second approach is called ′DC dialysis method'. In this approach, a 
mixture of detergent and lipids is directly dialyzed in the solution of binding agent. Both approaches 
necessitates use of detergent (e.g. Octyl β D glucopyranoside 2% w/v solution). Dialysis method forms 
cochleates with large dimensions (Gould-Fogerite and Mannino, 2000; Gould-Fogerite and Mannino, 
1992; Papahadjopoulos, 1978; Zarif, 2002). 
1.6.3 Hydrogel isolation method 
Hydrogel isolation method utilizes a binary aqueous–aqueous emulsion system for producing small-
sized cochleates from unilamellar vesicles. Liposomes are suspended in dispersed phase of an 
aqueous emulsion formed by immiscible polymer solution (e.g. Dextran-500000/PEG-8000). Further 
the solution of positively charged binding agent such as Ca2+ or Zn2+ is added to this emulsion. Slow 
diffusion of binding agent through polymer solution results in formation of cochleates with particle 
size in nano-range. The precipitate is then subjected to washing to get rid of polymers. This process 
can be used to produce cochleates containing drugs or biologically relevant molecules (Jin et al., 
2001). 
1.6.4 Emulsification-lyophilization method 
This process involves formation of multiple emulsion. Briefly, lipid is dissolved in a solvent (viz. 
chloroform, cyclohexane) which is considered as the oil phase (O). A solution containing binding agent 
and cryoprotectant are used as the inner water phase (W1), and the buffer as the outer water phase 
(W2). At initial stage, a primary emulsion with submicron particle size is prepared with aid of probe 
sonicator using phase O: phase W1 in 3:1 ratio. This emulsion is further added as dispersed phase to 
five parts of aqueous phase (W2) and gently emulsified to form double emulsion of W1/O/W2. The 
resultant double emulsion is lyophilized and cochleates are formed on rehydration from lyophilized 
powder (Wang et al., 2014). 
1.6.5 Solvent injection method: 
Harris et al. and coworkers reported a method of preparation for cholesterol cochleates in 2011. In 
this study, ethanoic solution of cholesterol was rapidly injected and mixed with distilled water in ratio 
1:9. Mixing was performed above room temperature (40°-75°C). Cochleates obtained by this 
procedure were hollow cylindrical structures of varying length. They were made up of tightly coiled 
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multi-bilayer cholesterol helices sometimes with one end closed. Some characteristic planar 
hexagonal microcrystals were also observed along with cylinders (Harris et al., 2011). 
 
1.7 Characterization of cochleates: 
1.7.1 Evaluation of morphology and dimensions of cochleates 
Morphology of cochleates have often been evaluated by simple visualization (Miclea et al., 2007; 
Ramani and Balasubramanian, 2003; Zarif, 2005). Optical microscopy was used to evaluate success of 
cochleation by several working groups. This could be achieved by addition of EDTA solution to the 
cochleate suspension and observing formation of large vesicles arising from aggregated cochleates 
under optical microscope. Electron microscopy techniques such as TEM, SEM, AFM etc. have been 
mainly employed to study structural details of cochleates (Bozo et al., 2015). Amongst these freeze 
fracture TEM technique is argued to be most favorable to evaluate the morphology of cochleates 
(Papahadjopoulos-Sternberg, 2012; Zarif, 2005). 
The dimensions of cochleates depend upon size of lipid particles (Liposomes, micelles etc. ), final lipid 
concentration and rate of calcium addition (Zarif, 2005). Cochleates prepared by trapping method or 
dialysis method are in micron size. Images of cochleates in micron range acquired by electron 
microscopy (e.g. SEM) have been utilized for particle size determination (Zarif and Mannino, 2002). 
Such large cochleates have also been evaluated for particle size by incorporation of fluorescent probe 
and visualization using fluorescence microscope (Miclea et al., 2007). Particle size measurement of 
nanocochleate formulations prepared by techniques such as hydrogel isolation or emulsification-
lyophilization have been reported based on photon correlation spectroscopy data (Pham et al., 2014; 
Wang et al., 2014).  
1.7.2 Differential scanning calorimetry (DSC) 
Differential scanning calorimetry has been used to measure a number of characteristic properties of 
cochleate samples especially in order to observe crystallization events during complexation of lipid 
and binding agent. The addition of binding agent to lipid dispersions induces the appearance of peak 
at higher temperature away from original transition peak of pure lipid (Portis et al., 1979; Silvius and 
Gagne, 1984; Takahashi et al., 1995). The ability of DSC to record transitions in heat capacity has been 
exploited in monitoring the effect of incorporation of various drugs in cochleate systems and the 
physicochemical properties of drug after incorporation (e.g. Ketoconazole cochleates)(Landge et al., 





1.7.3 Fourier transform infrared (FT-IR) spectroscopy 
Fourier transform infrared spectroscopy was reported as effective technique to investigate the 
conformational changes that occur in lipid after conversion to cochleate phase by studying methylene 
vibrational bands. Methylene vibrational bands in spectral region 2919 and 2850 cm-1 correspond to 
antisymmetric and symmetric stretching CH2 modes respectively. Cochleate phase showed symmetric 
stretching of CH2 in acyl chains. Monitoring the frequencies in scissoring vibrations of the methylene 
and methyl groups can also shed some light on acyl chain packing. In this region cochleate phase with 
an orthorhombic subcell lattice (with molecules ordered all-trans acyl chains being arranged 
perpendicular to each other) gives rise to a splitting of band into two components at 1462 cm−1 and 
1472 cm−1 (Garidel et al., 2000; Snyder, 1967). A marked narrowing of the band arising due to C=O 
ester stretching with band maximum to 1732 cm-1 is observed. Such narrow shape results from a 
reduced head group mobility, changes in the polarity or possible interfacial hydrogen bonding 
interactions (Garidel et al., 2000; Zhang et al., 1997). FT-IR studies of PS-Ca complex suggested that 
Ca2+ binds to the phosphate in head group and causes a dehydration of the phosphate ester (Dluhy 
et al., 1983; Flach and Mendelsohn, 1993). The data obtained from FT-IR supports observation that 
crystallization of the hydrocarbon chains takes place after complex formation (of lipid and binding 
agent) as explained in thermal analysis. The possibility of hydrogen bonding between the drug 
molecules and phospholipids in cochleate formulations have also been determined based on FT-IR 
studies (Chellampillai et al., 2014; Landge et al., 2013). 
1.7.4 X-ray analysis: 
X-ray analysis of cochleates revealed supporting data for DSC and FT-IR studies (Garidel et al., 2001; 
Hauser et al., 1977). The repeat distance obtained by small angle x ray scattering (SAXS) and wide 
angle x ray scattering (WAXS) indicate formation of a tight, anhydrous Ca-lipid chelate with crystalline 
hydrocarbon chains (Garidel et al., 2001; Hauser et al., 1977). The SAXS patterns of cochleates show 
multiple reflections suggesting the lamellar phase. The repeat distance of the cochleates can be 
calculated from the first reflection of highest intensity. This SAXS pattern remains constant below 
transition temperature of cochleate phase. When cochleates are heated above its transition 
temperature a hydrated lamellar phase is formed which exhibits completely different SAXS pattern 
with an increased lamellar repeat distance and broad diffraction peaks with almost similar intensities. 
Hydrated gel phase can also be differentiated from reflection pattern of cochleates. WAXS data 
reveals information about the packing of the acyl chains. The cochleate phase shows appearance of 
multiple sharp reflections in the wide angle scattering region which is indicative of the formation of 
a highly ordered chain lattice (Blaurock and McIntosh, 1986; Ruocco and Graham Shipley, 1982). 
Above transition of cochleate phases a very broad peak is observed, which is characteristic for the 
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liquid-crystalline phase with fluid acyl chains.(Blaurock, 1982; Tardieu et al., 1973). Hydrated gel state 
also shows a single broad WAXS band at lower repeat distance, indicating bilayer with tilted 
hydrocarbon chains (Ranck et al., 1974; Tardieu et al., 1973). Hence diffraction patterns of crystalline 
cochleate phase and other phases are characteristic and can be easily identified using x-ray analysis. 
1.7.5 Nuclear magnetic resonance (NMR)  
NMR studies on phosphatidylserine calcium cochleates were reported by Hauser et al. (1977). The 
2H-NMR spectra of aqueous lipid suspension in absence of binding agent consisted of a broad singlet. 
This can be explained by presence of excess free water giving rise to fast exchange between free and 
bound water of the hydration shells in bilayer lipids. In contrast, the complex of binding agent and 
lipid gave rise to sharper singlet in the 2H-NMR spectra. This can be regarded to interaction of binding 
agent with lipid head group which can displace water molecules. The spectra remained constant even 
after freeze-drying. 31P-NMR studies showed that the signal of lipid dispersion is completely 
broadened to the baseline on complex formation. This can be correlated with interaction of binding 
agent which leads to higher order and reduced segmental motion of the polar head group (Butler et 
al., 1970; Tocanne et al., 1974; Verkleij et al., 1974). 
 
1.8 Applications of cochleates 
1.8.1 Pharmaceutical industry 
In last few decades considerable research has been devoted towards study of lipid based drug 
delivery systems amongst which cochleates are one of potential drug delivery system owing unique 
advantages. Cochleates have been investigated for the safe and effective delivery of number of 
therapeutically active molecules. Although hydrophobic or amphipathic molecules are usually 
preferred drug candidates, cochleates have been used as vehicles for different kinds of drugs (Zarif, 
2005) as discussed below; 
Cochleates showed potential to encapsulate number of antifungal agents. Many studies on oral 
delivery of cochleate-mediated amphotericin B (Amb), a potent antifungal drug have been reported. 
Amb cochleates proved efficient when orally administered in a murine model of systemic candidiasis 
(Santangelo et al., 2000). Delmas et al. investigated Amb cochleates in murine model of systemic 
aspergillosis which showed improved safety profile by oral route (Delmas et al., 2002). Other 
antifungal agents such as nystatin have also been incorporated into cochleate formulations (Mannino 
and Lu, 2014). Ketoconazole cochleates were characterized and evaluated for topical delivery (Landge 
et al., 2013).  
Nanocochleates of Amb and miltefosine were developed for oral administration against visceral 
leishmaniasis (Pham et al., 2014). Efficacy of orally administered Amb cochleates against 
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leishmaniasis was confirmed by Wasan et al in hamster model (2009). Cochleates of aminoglycoside 
antibiotic amikacin have also shown positive results on oral and intra peritoneal administration in 
black mice infected by Mycobacterium avium complex (Lu and Mannino, 2014). Cochleate 
formulations of other antibiotics such as gentamicin, paromomycin have been evaluated to enhance 
their oral bioavailability. Clofazimine cochleates showed lower toxicity and improved bactericidal 
action during in vitro evaluation in anti-tubercular model (Popescu et al., 2001). Cochleates can be 
used to deliver antiviral drugs, such as acyclovir and nelfinavir(Gould-Fogerite and Mannino, 1999; 
Zarif et al., 2003). Bio Delivery Sciences Inc.(Morrisville, NC) has investigated the potential of 
cochleates to deliver anti-inflammatory agents (e.g. aspirin, ibuprofen, naproxen, 
acetaminophen)(Rao et al., 2007). Aspirin and acetaminophen cochleate formulations were found 
more effective than free drugs in inhibition of nitric oxide synthase in cell-culture studies. In vivo 
studies also showed cochleates to be beneficial in protecting the gastrointestinal tract from side 
effects such as gastric irritation, ulceration and bleeding (Delmarre et al., 2004b). Cochleates have 
been employed to deliver anticancer drugs such as paclitaxel, fisetin etc. (Chellampillai et al., 2014). 
Apart from this, cochleates can be used as a safe, non-viral approach in vaccine therapy. Cochleate 
have been proved efficacious mediators for induction of antigen-specific immune responses in vivo 
following intranasal (Del Campo et al., 2010), oral (Gould-Fogerite and Mannino, 1996) and 
intramuscular (Gould-Fogerite et al., 1998) administration. Evaluation of cochleate formulations 
containing antigens showed generation of strong, long-lasting, mucosal and circulating antibody 
responses in rodent models. Cochleates were also reported to be useful for delivery of plasmid DNA, 
gene and proteins (Rao et al., 2007).  
1.8.2 Food industry 
Cochleates can stabilize and protect an extended range of micronutrients. Hence nutraceutical 
cochleate formulations can be employed to increase the nutritional value of processed foods, baked 
goods, natural or artificial dairy products and ready to make products (Delmarre et al., 2004a). 
Domesticated animal chow, fish food, poultry feed can also be improved by using this approach. It 
has been evaluated as a strategy to deliver fragile nutrients which can be destroyed during food 
manufacturing or storage, e.g. quercetin, silibin, vitamins and lycopene. Using cochleates as vehicle 
such molecules could be efficiently added without affecting the color or taste of both nutraceutical 
and food (Jin et al., 2007). Cochleates of omega‐3 fatty acids, beta carotene have been used in 
products such as cakes, muffins, pasta, soups and cookies without altering their taste or odor (Sankar 
and Reddy, 2010). Cochleates can be employed to incorporate one or more additional agents such as 
coloring agents, flavoring agents, edible acids, preservatives etc. 
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1.8.3 Cosmetic industry 
Phospholipids are known to exhibit beneficial effects on the visual appearance of humans. The topical 
application of phospholipid lamellar systems offer a wide range of advantages such as increased 
moisturization, restoring action, biodegradability, biocompatibility and extended release. Their 
similarity with biological membranes allows better penetration into skin, compared with other 
delivery systems. Therefore, cochleates can be a favorable strategy to improve the topical delivery of 
cosmeceuticals (Lasic, 1997; Rahimpour and Hamishehkar, 2012). 
1.8.4 Perfume industry 
Perfumes are mixtures of fragrances which are chemicals with low molecular weight, lipophilic 
character and high vapor pressure. Their reactive functional groups (viz. ketones, aldehydes) make 
them susceptible to degradation by oxidation or hydrolysis (Cortial et al., 2015). For most perfumes 
as well as the essential oils used for insect repellants prolonged release of fragrance is more desirable 
than burst release (Nasir, 2010). Therefore, in order to improve the stability of fragrance, prevent 
evaporation and sustain hydrophilic environment the encapsulation in solid lipid delivery systems 




1.9 Aim of the study 
 
Cochleates offer a high potential for several biomedical applications. Considering the advances of this 
system towards pharmaceutical industry many studies have focused on the feasibility of employing 
cochleates as drug delivery vehicles. However, further research is needed on relatively unexplored 
areas such as thermodynamic stability, formation pathway or structural features of cochleates as 
detailed understanding of this system may prove vital for formulation development. Another 
noteworthy challenge is polydispersity of cochleate formulations. Cochleate formation follows a 
continuous self-assembly process which includes unrestrained growth of particles (Kulkarni et al., 
1999; Zarif, 2002). Hence controlling the morphology and the dimensions of individual particles in 
cochleate formulations is a difficult task. Also the coexistence of intermediate structures makes the 
purification of formulation a demanding affair. Traditional strategies for preparation of cochleates, 
such as simple mixing, dialysis etc. lack precise control over morphology of final product. Such 
structural diversity of formulation may cause unpredictable, non-reproducible and erratic drug 
release resulting in highly variable bio-availability of incorporated drugs. Therefore, there is a growing 
need for a strategy to address this issue. Although in past few decades improvements were made in 
cochleate formation protocols, these methods have limitations for large scale production. In view of 
all the above mentioned aspects our study was aimed at following goals: 
 
 To study formation mechanism of cochleates through detailed electron microscopy in order 
to understand different intermediate and metastable structures. Motivation of this study arises 
from the fact that although formation of cochleate cylinders has been explained, specific 
aspects of formation process are not known. 
 
 To develop a theoretical model for estimation of dimensions of cochleates and validate the 
model by comparing experimentally observed dimensions. 
 
 To develop simple, reproducible and economic procedure for formation of cochleates which 
could be easily transformed to large scale production, reduce random particle aggregation and 
thereby decrease the size dispersity in cochleate systems. 
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2.1 Publication 1:  
Understanding cochleate formation: Insights into structural evolution 
Kalpa Nagarsekar, Mukul Ashtikar, Frank Steiniger, Jana Thamm, Felix Schacher, Alfred Fahr 
Soft Matter, submitted on 12th June 2015, manuscript resubmitted after peer review 
 
Abstract 
Phosphatidylserines of different chain lengths (Viz. C8:0, C10:0, C14:0, C16:0, C18:1, C18:0) were 
evaluated for cochleate formation using calcium as binding agent. The chosen lipids in the present 
study exhibited transition temperatures in range of -11 to 68˚C. During cochleate formation, process 
temperature was decreased to decelerate the self-assembly. Detailed electron microscopy study of 
these samples was carried out to investigate formation of array of structures during self-assembly of 
cochleates. Our observations suggested that variation in phosphatidylserine chain length did not have 
remarkable influence on the type of structures that evolved during formation process. During 
progression of cochleate formation structures such as ribbons, stacks and networks were identified 
in all lipid samples. Based on these findings from microscopy studies we have proposed revision in 
probable pathway for cochleate formation. 
 
Own contribution to manuscript: 
1. Experimental design 
2. Preparation and evaluation of cochleates except for FFTEM, SEM and SAXS. 
3. Data evaluation, interpretation and presentation of the results. 







2.2 Publication 2:  
Electron microscopy and theoretical modeling of cochleates 
Kalpa Nagarsekar, Mukul Ashtikar, Frank Steiniger, Jana Thamm, Felix Schacher, Alfred Fahr and 
Sylvio May 
Langmuir, 2014, 30 (44), pp 13143–13151 Published on October 28, 2014 
 
Abstract 
Cochleates of phosphatidylserine C18:0 and C18:1 were prepared using calcium ions as binding agent 
under identical conditions. Detailed structural analysis of cochleates from both lipids was carried out 
using different microscopy techniques. Our investigations confirmed presence of a continuous hollow 
channel in rolled-up bilayers stating that most of the cochleate particles formed from lipids under 
investigation are not like cigars as explained in past. The structure of cochleate was found to be 
variant along its long axis and tend to exhibit a pattern like an involute in most of the cases. Also the 
estimated dimensions of the internal channels appeared to be characteristic for building blocks. This 
knowledge was used for building a thermodynamic model based on minimizing phenomenological 
free energy for estimating optimal dimensions of a cochleate. Our calculations suggest that 
membrane bending and calcium induced bilayer−bilayer adhesion alone are insufficient to reproduce 
the observed experimental dimensions.  
 
Own contribution to manuscript: 
1. Experimental design 
2. Preparation and evaluation of cochleates except for SAXS, SEM and cryo-electron tomography. 
3. Data evaluation, interpretation and presentation of the results except for the theoretical 
model. 







2.3 Publication 3:  
Micro-spherical cochleate composites: method development for monodisperse system 
Kalpa Nagarsekar, Mukul Ashtikar, Frank Steiniger, Jana Thamm, Felix Schacher, Alfred Fahr  
Journal of Liposome Research, submitted on 8th September 2015, manuscript under review. 
 
Abstract 
A new method was developed to fabricate cochleate composites with a simple microfluidic setup, by 
employing solvent effect. Product obtained from the proposed method was characterized using 
electron microscopy, small angle X-ray scattering and compared with those obtained by other 
established methodologies. These microspheres (3−5 μm in diameter) made of nanocochleates retain 
the basic advantages of cochleates. Our simple strategy eliminates elaborate preparation methods, 
is convenient and could easily be programmed to transform for large scale production. The results of 
current investigation illustrate this approach to be promising for preparing monodisperse cochleate 
system with analogous quality.  
 
Own contribution to manuscript: 
1. Experiment design 
2. Preparation and evaluation of cochleate formulations except for SEM and SAXS. 
3. Data evaluation, interpretation and presentation of the results. 
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,ĞŶĐĞ͕ ŝƚ ŝƐ ŝŵƉŽƌƚĂŶƚ ƚŽ ƐƚƵĚǇ ĨŽƌŵĂƚŝŽŶ ŽĨ ĐŽĐŚůĞĂƚĞƐ ĐůŽƐĞůǇ ŝŶ ŽƌĚĞƌ ƚŽ ŐĂŝŶ ƵŶĚĞƌƐƚĂŶĚŝŶŐ ŽĨ ƚŚŝƐ ĚƌƵŐϱϴ
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ĐŚĂƌĂĐƚĞƌŝǌĂƚŝŽŶƚĞĐŚŶŝƋƵĞ͘/ŶƚŚĞƉĂƐƚŵŽƐƚŽĨƚŚĞŝŶǀĞƐƚŝŐĂƚŝŽŶƐƌĞůĂƚĞĚƚŽƐƚƌƵĐƚƵƌĂůĨĞĂƚƵƌĞƐŽƌĨŽƌŵĂƚŝŽŶŽĨϵϲ
ĐŽĐŚůĞĂƚĞƐŚĂǀĞƌĞůŝĞĚƐƚƌŽŶŐůǇŽŶĨƌĞĞǌĞĨƌĂĐƚƵƌĞƚĞĐŚŶŝƋƵĞƐϮϵ͘/ŶƚŚĞĐƵƌƌĞŶƚƐƚƵĚǇĂůŽŶŐǁŝƚŚ&ƌĞĞǌĞ&ƌĂĐƚƵƌĞϵϳ
dƌĂŶƐŵŝƐƐŝŽŶ ůĞĐƚƌŽŶ DŝĐƌŽƐĐŽƉǇ ;&&dDͿ ǁĞ ĞŵƉůŽǇĞĚ ŽƚŚĞƌ D ƚĞĐŚŶŝƋƵĞƐ ůŝŬĞ ĐƌǇŽͲ^D ;^ĐĂŶŶŝŶŐϵϴ




ƚŚĞŝƌ ĨŽƌŵĂƚŝŽŶ ĂƐ ĂůƚĞƌŶĂƚŝǀĞ ĨŝƌƐƚ ƐƚĂŐĞ͕ ǁŚŝĐŚ ŝƐ ĂŶ ƵŶƌĞĐŽŐŶŝǌĞĚ ĨĂĐĞƚ ŝŶ ƉŚŽƐƉŚĂƚŝĚǇůƐĞƌŝŶĞ ĐŽĐŚůĞĂƚĞϭϬϯ
ĨŽƌŵĂƚŝŽŶ͘KƵƌƌĞƐƵůƚƐŝŶĚŝĐĂƚĞƚŚĂƚĂůůƐĞůĞĐƚĞĚW^ĚŝƐƉůĂǇĞĚƉƌĞƐĞŶĐĞŽĨƐŝŵŝůĂƌŝŶƚĞƌŵĞĚŝĂƚĞƐƚƌƵĐƚƵƌĞƐƐŽŵĞϭϬϰ










ϭ͕ϮͲĚŝŽĐƚĂŶŽǇůͲƐŶͲŐůǇĐĞƌŽͲϯͲƉŚŽƐƉŚŽͲ>ͲƐĞƌŝŶĞ ΀ƐŽĚŝƵŵ ƐĂůƚ΁ ;KĐƚW^Ϳ͖ ϭ͕ϮͲĚŝĚĞĐĂŶŽǇůͲƐŶͲŐůǇĐĞƌŽͲϯͲƉŚŽƐƉŚŽͲ>Ͳϭϭϭ
ƐĞƌŝŶĞ ΀ƐŽĚŝƵŵ ƐĂůƚ΁ ;W^Ϳ͖ ϭ͕ϮͲŝŵǇƌŝƐƚŽǇůͲƐŶͲŐůǇĐĞƌŽͲϯͲ ƉŚŽƐƉŚŽͲ>ͲƐĞƌŝŶĞ ΀ƐŽĚŝƵŵ ƐĂůƚ΁ ;DW^Ϳ͖ ϭ͕ϮͲϭϭϮ
ĚŝƉĂůŵŝƚŽǇůͲƐŶͲŐůǇĐĞƌŽͲϯͲƉŚŽƐƉŚŽͲ>ͲƐĞƌŝŶĞ ΀ƐŽĚŝƵŵ ƐĂůƚ΁ ;WW^Ϳ͖ ϭ͕ϮͲĚŝŽůĞŽǇůͲƐŶͲŐůǇĐĞƌŽͲϯͲƉŚŽƐƉŚŽͲ>ͲƐĞƌŝŶĞϭϭϯ


















































dƌĂŶƐŵŝƐƐŝŽŶ ĞůĞĐƚƌŽŶŵŝĐƌŽƐĐŽƉǇ͗ Ŷ ĂůŝƋƵŽƚ ŽĨ ϱ ʅ> ŽĨ ƚŚĞ ĚŝƐƉĞƌƐŝŽŶǁĂƐ ƉůĂĐĞĚ ŽŶƚŽ Ă &ŽƌŵǀĂƌͲĐŽĂƚĞĚϭϱϯ
ĐŽƉƉĞƌ ŐƌŝĚ ;ϯϬϬŵĞƐŚ͕ WůĂŶŽ͕ 'ĞƌŵĂŶǇͿ ĨŽƌ ϰŵŝŶƵƚĞƐ͘ ǆĐĞƐƐ ŽĨ ůŝƋƵŝĚǁĂƐ ƌĞŵŽǀĞĚǁŝƚŚ Ă ůŝŶƚͲĨƌĞĞ ĨŝůƚĞƌϭϱϰ
ƉĂƉĞƌ ĂŶĚ ƚŚĞ ŐƌŝĚ ǁĂƐ Ăŝƌ ĚƌŝĞĚ͘ dD ŐƌŝĚƐ ǁĞƌĞ ŝŶǀĞƐƚŝŐĂƚĞĚ ƵƐŝŶŐ ĞŝƐƐ D ϵϬϮ ;Ăƌů ĞŝƐƐ͕ 'ĞƌŵĂŶǇͿϭϱϱ
ŽƉĞƌĂƚĞĚĂƚϴϬ<s͘/ŵĂŐĞƐǁĞƌĞƚĂŬĞŶǁŝƚŚĂϭŬǆϭŬ&ĂƐƚ^ĐĂŶͲ&ϭϭϰĂŵĞƌĂ;ds/W^'ŵď,͕'ĞƌŵĂŶǇͿ͘dŽϭϱϲ





ĂŶĚ ŝŶƐĞƌƚĞĚ ŝŶƚŽ WŚŝůŝƉƐ D ϭϮϬ ĐƌǇŽͲdD ;WŚŝůŝƉƐ D ϭϮϬ͕ EĞƚŚĞƌůĂŶĚƐͿ ĨŽƌ ĞǀĂůƵĂƚŝŽŶ͘ dŚĞ ŝŵĂŐĞƐǁĞƌĞϭϲϮ
ƌĞĐŽƌĚĞĚǁŝƚŚϭŬĐĂŵĞƌĂ;&ĂƐƚ^ĐĂŶ&ϭϭϰds/W^͕'ĞƌŵĂŶǇͿ͘ϭϲϯ
/ŶǀĞƐƚŝŐĂƚŝŽŶŽĨƌŽƐƐ^ĞĐƚŝŽŶŽĨZĞƐŝŶͲŵďĞĚĚĞĚƐƚĂĐŬƐ͗ŵďĞĚĚŝŶŐǁĂƐĐĂƌƌŝĞĚŽƵƚƵƐŝŶŐƐĂŵĞƉƌŽĐĞĚƵƌĞĂƐϭϲϰ
ĚĞƐĐƌŝďĞĚ ďǇ EĂŐĂƌƐĞŬĂƌ Ğƚ Ăů͘Ϯ͘ ƌŝĞĨůǇ͕ ƐĂŵƉůĞ ǁĂƐ ƌĞĚŝƐƉĞƌƐĞĚ ŝŶ ϭϬϬ ŵD ĐĂĐŽĚǇůĂƚĞ ďƵĨĨĞƌ ;Ɖ, ϳ͘ϮͿϭϲϱ
ĐŽŶƚĂŝŶŝŶŐϭйKƐKϰĨŽƌϮŚ͘^ĂŵƉůĞǁĂƐĐĞŶƚƌŝĨƵŐĞĚĂŐĂŝŶĂŶĚƌŝŶƐĞĚŝŶďƵĨĨĞƌďĞĨŽƌĞĚĞŚǇĚƌĂƚŝŽŶŝŶĞƚŚĂŶŽůϭϲϲ
;ϱϬйǀͬǀͿĨŽƌϭϱŵŝŶ͘/ƚǁĂƐĨƵƌƚŚĞƌƐƵďũĞĐƚĞĚĨŽƌϭŚƚŽϭйƵƌĂŶǇůĂĐĞƚĂƚĞƐŽůƵƚŝŽŶƚŽŝŵƉƌŽǀĞĐŽŶƚƌĂƐƚ͘dŚĞϭϲϳ
ƉĞůůĞƚǁĂƐ ƚŚĞŶ ƌĞĚŝƐƉĞƌƐĞĚ ŝŶĂŶĞƉŽǆǇ ƌĞƐŝŶƌĂůĚŝƚĞ ;ŐĂƌ ^ĐŝĞŶƚŝĨŝĐ͕hŶŝƚĞĚ<ŝŶŐĚŽŵͿƵƐĞĚĂƐĞŵďĞĚĚŝŶŐϭϲϴ
ŵĞĚŝƵŵ͘dŚĞŵŝǆƚƵƌĞǁĂƐƉŽůǇŵĞƌŝǌĞĚĂŶĚƚŚĞƉŽůǇŵĞƌďůŽĐŬƐǁĞƌĞƵůƚƌĂŵŝĐƌŽƚŽŵĞĚŝŶƚŽƚŚŝŶ;ϳϬоϭϬϬŶŵͿϭϲϵ
ƐůŝĐĞƐ͕ ƵƐŝŶŐ Ă ĚŝĂŵŽŶĚ ŬŶŝĨĞ ŵŽƵŶƚĞĚ ŽŶ ĂŶ hůƚƌĂĐƵƚ  ĚĞǀŝĐĞ ;ZĞŝĐŚĞƌƚ >ĂďƚĞĐ͕ 'ĞƌŵĂŶǇͿ Ăƚ ƌŽŽŵϭϳϬ
ƚĞŵƉĞƌĂƚƵƌĞ͘dŚĞƐůŝĐĞƐǁĞƌĞƚŚĞŶƚƌĂŶƐĨĞƌƌĞĚƚŽĐŽƉƉĞƌŐƌŝĚƐ;YƵĂŶƚŝĨŽŝů͕'ĞƌŵĂŶǇͿĂŶĚĞǆĂŵŝŶĞĚďǇdD͘ϭϳϭ
^ŵĂůůĂŶŐůĞyͲZĂǇƐĐĂƚƚĞƌŝŶŐϭϳϮ
ůů ƐĂŵƉůĞƐ ǁĞƌĞ ĚŝĂůǇǌĞĚ ĂŶĚ ĨƌĞĞǌĞ ĚƌŝĞĚ ďĞĨŽƌĞ ĞǀĂůƵĂƚŝŽŶ͘ ^y^ ŵĞĂƐƵƌĞŵĞŶƚƐ ǁĞƌĞ ƉĞƌĨŽƌŵĞĚ ŽŶ Ăϭϳϯ
ƌƵŬĞƌ EĂŶŽƐƚĂƌ ;ƌƵŬĞƌ͕ 'ĞƌŵĂŶǇͿ ĞƋƵŝƉƉĞĚ ǁŝƚŚ Ă /ђ^ ;/ŶĐŽĂdĞĐ͕ 'ĞƌŵĂŶǇͿ yͲƌĂǇ ƐŽƵƌĐĞ͕ ŽƉĞƌĂƚŝŶŐ Ăƚϭϳϰ
ʄсϭ͘ϱϰ͘dŚĞƐĂŵƉůĞͲƚŽͲĚĞƚĞĐƚŽƌĚŝƐƚĂŶĐĞǁĂƐϭϬϳĐŵ͘^ĂŵƉůĞƐǁĞƌĞŵŽƵŶƚĞĚŽŶĂŵĞƚĂůƌĂĐŬĂŶĚĨŝǆĞĚƵƐŝŶŐϭϳϱ
ƚĂƉĞ͘ůůŵĞĂƐƵƌĞŵĞŶƚƐǁĞƌĞĐĂƌƌŝĞĚŽƵƚĂƚƌŽŽŵƚĞŵƉĞƌĂƚƵƌĞĨŽƌϭϮϬŵŝŶƵƚĞƐ͕ǁŝƚŚĂϮƉŽƐŝƚŝŽŶƐĞŶƐŝƚŝǀĞϭϳϲ
ĚĞƚĞĐƚŽƌsĂŶƚĞĐϮϬϬϬ;ƌƵŬĞƌ'ŵď,͕'ĞƌŵĂŶǇͿ͘ dŚĞƐĐĂƚƚĞƌŝŶŐƉĂƚƚĞƌŶƐǁĞƌĞ ĐŽƌƌĞĐƚĞĚ ĨŽƌ ƚŚĞďĂĐŬŐƌŽƵŶĚϭϳϳ









dŽĚĞĐƌĞĂƐĞ ƚŚĞƉŽůǇĚŝƐƉĞƌƐŝƚǇ͕ Ăůů ůŝƉŝĚĚŝƐƉĞƌƐŝŽŶƐǁĞƌĞƐƵďũĞĐƚĞĚƚŽĞǆƚƌƵƐŝŽŶďĞĨŽƌĞĐŽĐŚůĞĂƚĞĨŽƌŵĂƚŝŽŶ͘ϭϴϯ
ŵŽŶŐƐƚĐŚŽƐĞŶůŝƉŝĚƐ͕KW^ĨŽƌŵĞĚůŝƉŽƐŽŵĞƐ͘KĐƚW^ĂŶĚW^ŚĂǀŝŶŐƐƚƌŽŶŐƐƵƌĨĂĐƚĂŶƚƉƌŽƉĞƌƚŝĞƐĨŽƌŵĞĚϭϴϰ
ŵŝĐĞůůĞƐ ĂůŽŶŐ ǁŝƚŚ ƐŵĂůů ǀĞƐŝĐůĞƐ͘ ,ŝŐŚ dŵ ůŝƉŝĚƐ ůŝŬĞ ^W^͕ WW^ ĂŶĚ DW^ ĨŽƌŵĞĚ ďŝůĂǇĞƌ ĚŝƐĐƐ ;&ŝŐ ϭͿ͘ϭϴϱ
ŽĐŚůĞĂƚĞƐǁĞƌĞ ĨŽƌŵƵůĂƚĞĚ ƵƐŝŶŐ ƐŝŵƉůĞ ƚƌĂƉƉŝŶŐŵĞƚŚŽĚ ĐŽŶƚĞŵƉůĂƚŝŶŐ ƚŚĞ ĞĂƐĞ ŽĨ ĐŽŶƚƌŽů ŽǀĞƌ ƉƌŽĐĞƐƐϭϴϲ
ĐŽŶĚŝƚŝŽŶƐ͘ŽŶƐŝĚĞƌŝŶŐƚŚĞƐƚƌŽŶŐŝŶĨůƵĞŶĐĞŽĨƉƌŽĐĞƐƐƉĂƌĂŵĞƚĞƌƐŽŶŵŽƌƉŚŽůŽŐǇŽĨƚŚĞĨŝŶĂůƉƌŽĚƵĐƚƐ͕ŝƚǁĂƐϭϴϳ
ĂƐƐƵƌĞĚ ƚŚĂƚ ĚƵƌŝŶŐ ƉƌĞƉĂƌĂƚŝŽŶ Ăůů ĐŽŶĚŝƚŝŽŶƐ ǁĞƌĞ ŬĞƉƚ ĐŽŶƐƚĂŶƚ ĞǆĐĞƉƚ ƚŚĞ ǀĂƌŝĂďůĞ ŽĨ ŝŶƚĞƌĞƐƚ ŝ͘Ğ͘ϭϴϴ
ƚĞŵƉĞƌĂƚƵƌĞ͘&ŽƌŵƵůĂƚŝŽŶƐǁĞƌĞƉƌĞƉĂƌĞĚĂƚĚŝĨĨĞƌĞŶƚƚĞŵƉĞƌĂƚƵƌĞƐƚŽŝĚĞŶƚŝĨǇŝŶƚĞƌŵĞĚŝĂƚĞƐĂŶĚĚĞƚĞƌŵŝŶĞϭϴϵ
ƚŚĞƉĂƚŚǁĂǇŽĨĐŽĐŚůĞĂƚĞĨŽƌŵĂƚŝŽŶ͘sŝƐƵĂůůǇ͕ĚƵƌŝŶŐĨŽƌŵƵůĂƚŝŽŶĂůůƚƌĂŶƐůƵĐĞŶƚůŝƉŝĚĚŝƐƉĞƌƐŝŽŶƐǁĞŶƚƚƵƌďŝĚϭϵϬ
ĨŽůůŽǁŝŶŐ ƉƌĞĐŝƉŝƚĂƚŝŽŶ ƵƉŽŶ ĂĚĚŝƚŝŽŶ ŽĨ ĂůϮ ƐŽůƵƚŝŽŶ͘ dŚŝƐ ŽďƐĞƌǀĂƚŝŽŶ ǁĂƐ ĐŽŶƐŝƐƚĞŶƚ ĨŽƌ Ăůů ƉƌŽĐĞƐƐϭϵϭ
ƚĞŵƉĞƌĂƚƵƌĞƐ͘ tŚŝƚĞ ĨůƵĨĨǇ ƉƌĞĐŝƉŝƚĂƚĞ ĂŶĚ Ă ĐůĞĂƌ ƐƵƉĞƌŶĂƚĂŶƚ ǁĞƌĞ ĨŽƌŵĞĚ ŝŶ ƚŚĞ ƐĂŵƉůĞƐ ǁŚŝĐŚ ǁĞƌĞϭϵϮ
ƉƌĞƉĂƌĞĚďĞůŽǁƚŚĞdŵŽĨƚŚĞƌĞƐƉĞĐƚŝǀĞ ůŝƉŝĚ͘,ŽǁĞǀĞƌ͕ƚŚĞƐĂŵƉůĞƐƉƌĞƉĂƌĞĚĂďŽǀĞdŵƐŚŽǁĞĚĂĚĞŶƐĞůǇϭϵϯ
ĂŐŐƌĞŐĂƚĞĚ ƐƵƐƉĞŶƐŝŽŶ͘ dŚĞ ĐŚĂŶŐĞ ĨƌŽŵ ŽƉĂůĞƐĐĞŶƚ ƚŽ ƚƵƌďŝĚ ƐƵƐƉĞŶƐŝŽŶ ĂĨƚĞƌ ĂĚĚŝƚŝŽŶ ŽĨ ĐĂůĐŝƵŵ ǁĂƐϭϵϰ
ĐŽŶƐŝĚĞƌĞĚ ĂƐ ĂŶ ŝŶĚŝĐĂƚŝŽŶ ĨŽƌ ďŝŶĚŝŶŐ ƉƌŽĐĞƐƐĞƐ ƚĂŬŝŶŐ ƉůĂĐĞ͘ dŚĞ ǀŝƐƵĂů ĂƉƉĞĂƌĂŶĐĞ ŽĨ ƐĂŵƉůĞƐ ĚŝĚ ŶŽƚϭϵϱ






ďĞƚƚĞƌ ĐŽŶƚƌĂƐƚ ĂŐŐƌĞŐĂƚĞĚ ďŝůĂǇĞƌƐ ĂŶĚ ƌŝďďŽŶƐǁĞƌĞ ǀŝƐƵĂůŝǌĞĚ ďǇ ŶĞŐĂƚŝǀĞ ƐƚĂŝŶŝŶŐ ǁŝƚŚ ƵƌĂŶǇů ĂĐĞƚĂƚĞ ŝŶϮϬϮ
dD͘dŚĞĚƌǇŝŶŐŽĨĐŽĐŚůĞĂƚĞƐĂŵƉůĞƐĚƵƌŝŶŐĞůĞĐƚƌŽŶŵŝĐƌŽƐĐŽƉǇĚŝĚŶŽƚĂĨĨĞĐƚƚŚĞƚƵďƵůĞƐƚƌƵĐƚƵƌĞ͕ŽƌĐĂƵƐĞϮϬϯ
ĐŽůůĂƉƐŝŶŐŽĨƚŚĞŝŶƚĞƌŶĂůŚŽůůŽǁƐƉĂĐĞ͘dŚŝƐǁĂƐƉƌŽďĂďůǇĚƵĞƚŽƚŚĞƌŝŐŝĚŶĂƚƵƌĞŽĨƚŚĞŵƵůƚŝůĂŵĞůůĂƌƐǇƐƚĞŵϯϭ͘ϮϬϰ










ĐŚĞůĂƚĞĚďŝůĂǇĞƌƐϯϮ͘ >ŝƚĞƌĂƚƵƌĞ ƐƵŐŐĞƐƚƐ ĂĚĚŝƚŝŽŶŽĨ ĐĂůĐŝƵŵ ŝŽŶƐ ƚŽW^ ǀĞƐŝĐůĞƐ ƚƌŝŐŐĞƌƐ ĨŽƌŵĂƚŝŽŶ ŽĨ ĂƌƌĂǇŽĨϮϭϭ
ŝŶƚĞƌŵĞĚŝĂƚĞƐƚƌƵĐƚƵƌĞƐƐƵĐŚĂƐĚŝƐĐƐ͕ƐŚĞĞƚƐĂŶĚƉĂƌƚŝĂůůǇ ĨŽůĚĞĚďŝůĂǇĞƌƐǁŚŝĐŚĨŝŶĂůůǇŐŝǀĞƌŝƐĞƚŽĐŽĐŚůĞĂƚĞϮϭϮ
ĐǇůŝŶĚĞƌƐϴ͘ĞŝŶŐŶƵĐůĞĂƚŝŽŶͲĚĞƉĞŶĚĞŶƚ͕ ĂŐŐƌĞŐĂƚŝŽŶƉƌŽĐĞƐƐĞƐĂƌĞƵƐƵĂůůǇ ĐŚĂƌĂĐƚĞƌŝǌĞĚďǇĂ ůĂŐƉĞƌŝŽĚ͕ ŝ͘Ğ͘Ϯϭϯ
ƚŝŵĞƌĞƋƵŝƌĞĚĨŽƌƚŚĞĐƌŝƚŝĐĂůŶƵĐůĞŝƚŽĨŽƌŵĐĂŶďĞĚĞĐĞůĞƌĂƚĞĚďǇƌĞĚƵĐŝŶŐƚŚĞƉƌŽĐĞƐƐƚĞŵƉĞƌĂƚƵƌĞϯϯ͘^ŝŶĐĞϮϭϰ
ĨƵƐŝŽŶ ƉƌŽĐĞƐƐĞƐ ĂŶĚ ƌĂƚĞƐ ŽĨ ŵŽƌƉŚŽůŽŐŝĐĂů ƚƌĂŶƐŝƚŝŽŶƐ ĂƌĞ ǀĞƌǇ ĨĂƐƚ ;ŝŶ ŵŝůůŝƐĞĐŽŶĚƐͿ ŝŶ ƐƵďƐƚƌĂƚĞƐ ǁŝƚŚϮϭϱ
ƐŵĂůůĞƌ Žƌ ƵŶƐĂƚƵƌĂƚĞĚ ĐĂƌďŽŶ ĐŚĂŝŶ ůĞŶŐƚŚ͕ ŝƚ ŝƐ ŶŽƚ ĞĂƐǇ ƚŽ ƚƌĂƉ ƚŚĞƐĞ ŝŶŝƚŝĂů ŝŶƚĞƌŵĞĚŝĂƚĞ ƐƚƌƵĐƚƵƌĞƐ͘Ϯϭϲ
ŽŶƐĞƋƵĞŶƚůǇ͕ĨĞǁĞĂƌůǇŝŶƚĞƌŵĞĚŝĂƚĞƐƚƌƵĐƚƵƌĞƐĐŽƵůĚďĞŽďƐĞƌǀĞĚĚƵƌŝŶŐĞǀĂůƵĂƚŝŽŶŽĨĐŽĐŚůĞĂƚĞƐĂŵƉůĞƐŽĨϮϭϳ
ůŽǁ dŵ ůŝƉŝĚƐ͘ ƉĂƌƚ ĨƌŽŵ ƚŚŝƐ ƐŽŵĞ ŚŝŐŚĞƌ ŽƌĚĞƌ ŝŶƚĞƌŵĞĚŝĂƚĞ ƐƚƌƵĐƚƵƌĞƐ ĂůƐŽ ĂƉƉĞĂƌĞĚ ƐŝŵƵůƚĂŶĞŽƵƐůǇ ŝŶϮϭϴ
ƚŚĞƐĞ ƐĂŵƉůĞƐ͘ tĞ ĨŽƵŶĚ ƚŚĂƚ ĂŵŽŶŐ ƐĞůĞĐƚĞĚ W^Ɛ ŚŝŐŚ dŵ ůŝƉŝĚƐ ǁĞƌĞ ŝĚĞĂů ĐĂŶĚŝĚĂƚĞƐ ƚŽ ƚƌĂƉ ĞĂƌůǇϮϭϵ








ĂŶĚ ĚŝĚ ŶŽƚ ƐŚŽǁ ĞĂƌůǇ ŝŶƚĞƌŵĞĚŝĂƚĞƐ Ğ͘Ő ĂŐŐƌĞŐĂƚĞƐ ŽĨ ůŝƉŽƐŽŵĞƐ͕ ĚŝƐĐ ŵŝĐĞůůĞƐ ĞƚĐ͘ ŽĐŚůĞĂƚĞ ƐĂŵƉůĞƐϮϮϴ
ƉƌĞƉĂƌĞĚĂƚůŽǁĞƌƉƌŽĐĞƐƐƚĞŵƉĞƌĂƚƵƌĞƐǁĞƌĞĞǀĂůƵĂƚĞĚŝŵŵĞĚŝĂƚĞůǇ;ϭϬƐĞĐŽŶĚƐͿďǇDďĞĨŽƌĞŝŶĐƵďĂƚŝŽŶƚŽϮϮϵ
ǀŝƐƵĂůŝǌĞ ĞĂƌůǇ ŝŶƚĞƌŵĞĚŝĂƚĞ ƐƚƌƵĐƚƵƌĞƐ͘ ^ĂŵƉůĞƐ ŽĨ ůŽǁ dŵ ůŝƉŝĚƐ ƉƌĞƉĂƌĞĚ Ăƚ ϰ Σ ƐŚŽǁĞĚ ƉƌĞƐĞŶĐĞ ŽĨϮϯϬ
ĂŐŐƌĞŐĂƚŝŽŶƐƚƌƵĐƚƵƌĞƐĂůŽŶŐǁŝƚŚƌŝďďŽŶƐŽƌƐŚĞĞƚƐ͘ŐŐƌĞŐĂƚĞƐŽďƐĞƌǀĞĚŝŶƚŚĞƐĞƐĂŵƉůĞƐǀĂƌŝĞĚŝŶƐŝǌĞĂŶĚϮϯϭ
ƐŚĂƉĞ͘dŚĞƐĞĂŐŐƌĞŐĂƚĞƐĂƉƉĞĂƌĞĚƚŽĐŽŶƚĂŝŶĂůĂƌŐĞŶƵŵďĞƌŽĨĚĞŶƐĞƉĂƌƚŝĐůĞƐ;ĂƐŝŶĚŝĐĂƚĞĚďǇĚĂƌŬĂƌƌŽǁƐŝŶϮϯϮ
&ŝŐ͘ϮĂͲĐͿ͘DƵůƚŝůĂŵĞůůĂƌĂŐŐƌĞŐĂƚĞƐŽďƐĞƌǀĞĚ ŝŶ ƐĂŵƉůĞƐŽĨKW^ĂƉƉĞĂƌĞĚ ůĂƌŐĞůǇĚĞŚǇĚƌĂƚĞĚĂŶĚƌĞǀĞĂůĞĚϮϯϯ
ƌĞƉĞĂƚ ĚŝƐƚĂŶĐĞ ŽĨ ďŝůĂǇĞƌ ƐƵŐŐĞƐƚŝŶŐ ĞĨĨŝĐŝĞŶƚ ďŝŶĚŝŶŐ ŽĨ ĐĂůĐŝƵŵ ŝŽŶ͘ tĞ ƉƌĞƐƵŵĞĚ ƚŚĂƚ ƐƵĐŚ ĚĞŶƐĞϮϯϰ
ĂŐŐƌĞŐĂƚĞƐŵĂǇďĞŚŝŐŚůǇƵŶƐƚĂďůĞĂƐƚŚĞǇĚŝƐƉůĂǇĞĚĂƐǇŵŵĞƚƌŝĐĂůďƵƚĐůŽƐĞůǇƉĂĐŬĞĚůĂŵĞůůĂĞ͘^ƵĐŚŝŶƐƚĂďŝůŝƚǇϮϯϱ






ĨŽůůŽǁŝŶŐ ĂŐŐƌĞŐĂƚŝŽŶ ĂŶĚ ƉŽƐƐŝďŝůŝƚǇ ŽĨ ƌƵƉƚƵƌĞ Žƌ ĨƵƐŝŽŶŽĨ ƚŚĞŵƵůƚŝůĂŵĞůůĂƌ ĂŐŐƌĞŐĂƚĞƐǁŚŝĐŚǁĂƐ ŝŶ ůŝŶĞϮϯϴ
ǁŝƚŚŽƵƌŽďƐĞƌǀĂƚŝŽŶƐϯϰͲϯϲ͘W^ĂŶĚŽĐƚW^ƐĂŵƉůĞƐƌĞǀĞĂůĞĚƐĞǀĞƌĂůƐƵĐŚĂŐŐƌĞŐĂƚĞƐƐŚŽǁŝŶŐĨŽƌŵĂƚŝŽŶŽĨϮϯϵ
ƌŝďďŽŶůŝŬĞƐƚƌƵĐƚƵƌĞƐ;&ŝŐ͘ϮďͿ͘^ŝŵŝůĂƌƉĂƚƚĞƌŶƐǁĞƌĞŽďƐĞƌǀĞĚ ŝŶƐĂŵƉůĞƐŽĨKW^ǁŚŝĐŚƐŚŽǁĞĚĂŐŐƌĞŐĂƚĞƐϮϰϬ
ƌĂĚŝĂƚŝŶŐ ďƌŽĂĚ ƌŝďďŽŶůŝŬĞ ƐƚƌƵĐƚƵƌĞƐ ;&ŝŐ͘ ϮĐͿ͘ dŚŽƵŐŚ ƌĂƌĞ͕ ĨĞǁ ĐŽĐŚůĞĂƚĞ ĐǇůŝŶĚĞƌƐ ǁĞƌĞ ĂůƐŽ ŽďƐĞƌǀĞĚ ŝŶϮϰϭ
ŽĐƚWƐƐĂŵƉůĞƐĂƚƚŚŝƐƐƚĂŐĞ͘ϮϰϮ
/ŶŚŝŐŚdŵůŝƉŝĚƐĂŵƉůĞƐƉƌĞƉĂƌĞĚĂƚϮϬΣ͕ ůĂƌŐĞĨƌĂĐƚŝŽŶŽĨĂŐŐůŽŵĞƌĂƚĞĚďŝůĂǇĞƌƐĂŶĚƌŝďďŽŶƐĂƉƉĞĂƌĞĚƚŽϮϰϯ
ĐŽĞǆŝƐƚ Ăƚ ƚŚĞ ĂŐŐƌĞŐĂƚŝŽŶ ƐƚĂŐĞ͘EŽ ƚƌĂĐĞƐ ŽĨ ĐŽĐŚůĞĂƚĞ ĐǇůŝŶĚĞƌƐǁĞƌĞ ĞǀŝĚĞŶƚ͘ /Ŷ ŚŝŐŚ dŵ ůŝƉŝĚƐ͕ ĞĚŐĞƐ ŽĨϮϰϰ
ďŝůĂǇĞƌ ĚŝƐĐƐ ƉƌŽďĂďůǇ ĨƵƐĞ ǁŝƚŚ Ă ƐƉĞĐŝĨŝĐ ŽƌŝĞŶƚĂƚŝŽŶ ƚŽ ĨŽƌŵ ƌŝďďŽŶůŝŬĞ ƐŝůŚŽƵĞƚƚĞ ŐŝǀŝŶŐ ƌŝƐĞ ƚŽ ƚŚƌĞĞϮϰϱ
ĚŝŵĞŶƐŝŽŶĂů ƌŝŐŝĚ ŶĞƚǁŽƌŬ͘ ŚĂŝŶͲůŝŬĞŵŽƌƉŚŽůŽŐǇ ŽĨ ĂŐŐƌĞŐĂƚĞĚ ĚŝƐĐƐ ŝŶŵŝĐƌŽŶ ůĞŶŐƚŚǁĞƌĞ ĂůƐŽ ŽďƐĞƌǀĞĚϮϰϲ
;&ŝŐ͘ϮĨͿ͘dŚĞƐĞƚŚƌĞĞĚŝŵĞŶƐŝŽŶĂůĂŐŐƌĞŐĂƚĞĚƐƚƌƵĐƚƵƌĞƐĨŝŶĂůůǇĂƉƉĞĂƌƚŽĞǀŽůǀĞŝŶƚŽƌŝďďŽŶƐ;&ŝŐ͘ϮĚͿ͕ǁŚŝĐŚϮϰϳ
ǁĞƌĞĨŽƌŵĞĚŝŶĂďƵŶĚĂŶĐĞĂŶĚǁĂƐŝŶŵŝĐƌŽŶƌĂŶŐĞ͘dŚĞĞĚŐĞƐŽĨďŝůĂǇĞƌĚŝƐĐƐŝŶĂŐŐƌĞŐĂƚĞĚƐƚƌƵĐƚƵƌĞƐŽĨƚĞŶϮϰϴ




D ŝŵĂŐĞƐ ŽĨ Ăůů ƐĂŵƉůĞƐ ƉƌĞƉĂƌĞĚ Ăƚ ůŽǁĞƌ ƉƌŽĐĞƐƐ ƚĞŵƉĞƌĂƚƵƌĞƐ ƌĞǀĞĂůĞĚ ƉƌĞƐĞŶĐĞ ŽĨ ƌŝďďŽŶůŝŬĞ ďŝůĂǇĞƌϮϱϯ
ƐƚƌŝƉƐ͘&ŝŐ͘ϯƐŚŽǁƐ ŝŵĂŐĞƐŽĨƌŝďďŽŶƐĨƌŽŵĚŝĨĨĞƌĞŶƚ ůŝƉŝĚƐ͘dŚĞ ůĞŶŐƚŚŽĨ ƌŝďďŽŶƐŽďƐĞƌǀĞĚ ŝŶ ƐĂŵƉůĞƐǁĞƌĞϮϱϰ
ƋƵŝƚĞĚŝǀĞƌŐĞŶƚ͘ůƚŚŽƵŐŚŚŝŐŚůǇƚƌĂŶƐƉĂƌĞŶƚĂůůƌŝďďŽŶƐŚĂĚǁĞůůͲƐŚĂƉĞĚĞĚŐĞƐǁŝƚŚƚŚŝĐŬŶĞƐƐǀĂƌǇŝŶŐĨƌŽŵϮͲϯϮϱϱ
ďŝůĂǇĞƌƐ ĂƐ ĐĂŶ ďĞ ƐĞĞŶ ŝŶ ĐƌǇŽͲdD ŝŵĂŐĞ ŽĨ^W^ ƌŝďďŽŶƐ ;&ŝŐ͘ ϯĞͿ͘ dŚŽƵŐŚ ĨĞǁ ŝŶ ŶƵŵďĞƌ͕ ƌŝďďŽŶƐǁĞƌĞϮϱϲ
ŶŽƚŝĐĞĚŝŶƐĂŵƉůĞƐŽĨůŽǁdŵůŝƉŝĚƐƉƌĞƉĂƌĞĚĂƚϰΣ͘KĐƚW^;&ŝŐ͘ϯĚͿĂŶĚKW^ƐĂŵƉůĞƐƐŚŽǁĞĚƉƌĞƐĞŶĐĞŽĨϮϱϳ












dŚĞ ƐĂŵƉůĞƐ ŽĨ ŚŝŐŚ dŵ ůŝƉŝĚƐ ƉƌĞƉĂƌĞĚ Ăƚ ϮϬΣ ĂůƐŽ ĐŽŶƐŝƐƚĞĚ ŽĨ Ă ůĂƌŐĞ ĂŵŽƵŶƚ ŽĨ ƌŝďďŽŶƐ ƚŚĂƚ ƉĂƌƚŝĂůůǇϮϲϲ
ŽǀĞƌůĂƉƉĞĚ;&ŝŐ͘ϯĂ͕ďĂŶĚĞͿ͘ŵŽŶŐƐƚƚŚĞƐĞƐĂŵƉůĞƐŽĨ^W^ĂŶĚWW^ĚŝĚŶŽƚƐŚŽǁĂŶǇŽƚŚĞƌŚŝŐŚĞƌŽƌĚĞƌϮϲϳ
ŝŶƚĞƌŵĞĚŝĂƚĞ ƐƚƌƵĐƚƵƌĞƐ͘ dŚĞ ŵĂŝŶ ĨĞĂƚƵƌĞ ŽĨ ƌŝďďŽŶƐ ŽďƐĞƌǀĞĚ ŝŶ ^W^ ĂŶĚ WW^ ƐĂŵƉůĞƐ ;&ŝŐ͘ ϯĂ ĂŶĚ ďͿϮϲϴ
ƉƌĞƉĂƌĞĚ Ăƚ ϮϬ Σ ŝƐ ƚŚĂƚ ƚŚĞǇ ĚŝĚ ŶŽƚ ĞǀŽůǀĞ ŝŶƚŽ ĐůŽƐĞĚ ĂŐŐƌĞŐĂƚĞƐ Žƌ ŐŝǀĞ ƌŝƐĞ ƚŽ ŶĂŶŽƚƵďĞƐ͘ ǀĞŶ ƵƉŽŶϮϲϵ
ƉƌŽůŽŶŐĞĚ ŝŶĐƵďĂƚŝŽŶƵƉƚŽƚǁĞůǀĞŵŽŶƚŚƐďŽƚŚ^W^ĂŶĚWW^ƐĂŵƉůĞƐƉƌĞƉĂƌĞĚĂƚϮϬΣƐŚŽǁĞĚŽŶůǇƚŚĞϮϳϬ
ƉƌĞƐĞŶĐĞŽĨ ĂŐŐƌĞŐĂƚĞĚ ƌŝďďŽŶƐ͘ dŚĞǇ ĨŽƌŵĞĚ ƐƚƌƵĐƚƵƌĞƐ ƚŚĂƚ ůŽŽŬĞĚ ůŝŬĞ ůŽŽƐĞŶĞƚǁŽƌŬƐ ;ƐŚŽǁŶ ŝŶ &ŝŐ͘ ϳďͿϮϳϭ
ŚŽǁĞǀĞƌĨĂŝůĞĚƚŽĨŽƌŵĐŽĐŚůĞĂƚĞƐ͘/ŶĐĂƐĞŽĨDW^ƐĂŵƉůĞƐƉƌĞƉĂƌĞĚĂƚϮϬΣĨĞǁŚĞůŝĐĂůƌŝďďŽŶƐĂŶĚƚƵďƵůĞϮϳϮ
ůŝŬĞƐƚƌƵĐƚƵƌĞƐ ĨŽƌŵĞĚ ĨƌŽŵƐŝŶŐůĞ ƌŝďďŽŶǁĞƌĞĂůƐŽŽďƐĞƌǀĞĚ;ǁŝƚŚŝŶϮϬŵŝŶĂĨƚĞƌĂĚĚŝƚŝŽŶŽĨĐĂůĐŝƵŵ ŝŽŶƐͿ͘Ϯϳϯ
dŚĞƐĞƚƵďƵůĞůŝŬĞƐƚƌƵĐƚƵƌĞƐ;&ŝŐ͘ϮĨŝŶƐĞƚͿƌĞƐĞŵďůĞĚŶĂŶŽƚƵďĞƐĂŶĚƐĞĞŵĞĚƚŽůĂĐŬƚŚĞŵƵůƚŝůĂŵĞůůĂƌƐƚƌƵĐƚƵƌĞϮϳϰ
ŽĨ Ă ƚǇƉŝĐĂů ĐŽĐŚůĞĂƚĞ͘ Ɛ ĐŽŵƉĂƌĞĚ ƚŽ ŽƚŚĞƌ ŚŝŐŚ dŵ ůŝƉŝĚƐ ƚŚĞ DW^ ƐĂŵƉůĞƐ ƉƌĞƉĂƌĞĚ Ăƚ ϮϬ Σ ƐŚŽǁĞĚϮϳϱ
ŚŝŐŚĞƌ ŝŶĐůŝŶĂƚŝŽŶ ƚŽǁĂƌĚƐ ĨŽƌŵĂƚŝŽŶ ŽĨ ŚŝŐŚĞƌ ŽƌĚĞƌ ƐƚƌƵĐƚƵƌĞƐ ŝŶ ƚŚĞ ŚŝĞƌĂƌĐŚǇ ŽĨ ĐŽĐŚůĞĂƚĞ ĨŽƌŵĂƚŝŽŶ͘ /ŶϮϳϲ
ŽƌĚĞƌƚŽĐŽŶĨŝƌŵƚŚĂƚƐƚĂĐŬĨŽƌŵĂƚŝŽŶƚĂŬĞƐƉůĂĐĞĂĨƚĞƌĨŽƌŵĂƚŝŽŶŽĨƌŝďďŽŶƐ͕^W^ƌŝďďŽŶƐǁĞƌĞŚĞĂƚĞĚƵƉƚŽϮϳϳ
ϱϬ Σ͘DĞǀĂůƵĂƚŝŽŶŽĨ ƚŚŝƐ ƐĂŵƉůĞƐŚŽǁĞĚĂ ůĂƌŐĞŶƵŵďĞƌŽĨ ƐƚĂĐŬƐ͘&ƵƌƚŚĞƌŚĞĂƚŝŶŐŽĨ ƚŚŝƐ^W^ƐĂŵƉůĞ͕Ϯϳϴ
ĂďŽǀĞdŵŐĂǀĞƌŝƐĞƚŽĐŽĐŚůĞĂƚĞƐ;ĚĂƚĂŶŽƚƐŚŽǁŶͿ͘Ϯϳϵ
>ŝƚĞƌĂƚƵƌĞĂĚǀŽĐĂƚĞƐƚŚĂƚůĂƌŐĞůŝƉŝĚƐŚĞĞƚƐĐŽŶĚĞŶƐĞĂŶĚĐƵƌůƵƉƚŽĨŽƌŵĂĐǇůŝŶĚƌŝĐĂůƐƚƌƵĐƚƵƌĞϯϳ͘tĞƉƌĞƐƵŵĞϮϴϬ
ĨƌŽŵŽƵƌ ĨŝŶĚŝŶŐƐ ƚŚĂƚ ƌŝďďŽŶůŝŬĞ ĨƌĂŐŵĞŶƚƐ ĂƌĞƉƌŽďĂďůǇ ĨŽƌŵĞĚĂƚ ĞĂƌůǇ ƐƚĂŐĞĚƵƌŝŶŐ ĐŽĐŚůĞĂƚĞ ĨŽƌŵĂƚŝŽŶ͘Ϯϴϭ
/ŶŝƚŝĂƚŝŽŶƉŽŝŶƚ ĨŽƌĂŶǇƐƵƉƌĂŵŽůĞĐƵůĂƌĂƐƐĞŵďůǇǁŽƵůĚďĞƚŚĞĨŽƌŵĂƚŝŽŶŽĨĂƚĞŵƉůĂƚĞďǇŶƵĐůĞĂƚŝŽŶďĞĨŽƌĞϮϴϮ
ƐƵďƐĞƋƵĞŶƚŐƌŽǁƚŚ͘ZŝďďŽŶƐĂƌĞĂůƐŽŵŽƐƚƌĞƉĞĂƚĞĚůǇŽďƐĞƌǀĞĚƉƌĞĐƵƌƐŽƌƐŽĨƚƵďƵůĂƌƐƚƌƵĐƚƵƌĞƐϯϴ͘dŚĞZĞƉĞĂƚϮϴϯ
ĚŝƐƚĂŶĐĞ ŽďƐĞƌǀĞĚ ĨŽƌ ƌŝďďŽŶůŝŬĞ ƐƚƌƵĐƚƵƌĞƐ ŝƐ ƐŵĂůůĞƌ ĂƐ ĐŽŵƉĂƌĞĚ ƚŽ ƚŚĂƚ ŽĨ ďŝůĂǇĞƌƐ ǁŝƚŚŽƵƚ ĐĂůĐŝƵŵϮϴϰ
ŝŶƚĞƌĂĐƚŝŽŶ ;ǁŝƚŚ ƌĞĨĞƌĞŶĐĞ ƚŽ ^y^ ĚĂƚĂͿ͘ dŚŝƐ ƐƵŐŐĞƐƚ ŽƌŝĞŶƚĂƚŝŽŶ ĂŶĚ ŽƌŐĂŶŝǌĂƚŝŽŶ ŽĨ ůŝƉŝĚ ŵŽůĞĐƵůĞƐϮϴϱ





ƐƚƌƵĐƚƵƌĞƐ ŝŶ D ĂŶĂůǇƐŝƐ͘ EŽ ŶĞŐĂƚŝǀĞ ƐƚĂŝŶŝŶŐǁĂƐ ƌĞƋƵŝƌĞĚ ĨŽƌ ĞǀĂůƵĂƚŝŽŶ ŽĨ ƐƚĂĐŬƐ ŝŶ ƚŚĞ ƐĂŵƉůĞƐ ƵŶůŝŬĞϮϵϭ
ƌŝďďŽŶƐ͘&ŝŐ͘ϰƐŚŽǁƐƚŚĞŵŽƌƉŚŽůŽŐǇŽĨƐƚĂĐŬƐǁŚŝĐŚŚĂǀĞĂƐƚƌŽŶŐƚĞŶĚĞŶĐǇƚŽĂƐƐŽĐŝĂƚĞŝŶƚŽŵƵůƚŝůĂŵĞůůĂƌϮϵϮ
ĂŐŐƌĞŐĂƚĞƐ;ĂƐŚŝŐŚůŝŐŚƚĞĚŝŶ&ŝŐ͘ϰĚͿ͘dDŝŵĂŐĞƐĨƌŽŵĞŵďĞĚĚŝŶŐƐƚƵĚǇ;&ŝŐ͘ϰĨͿĂŶĚĐƌǇŽͲ^DĚĂƚĂ;&ŝŐ͘ϱĐͿϮϵϯ
ĂůƐŽ ƌĞǀĞĂů ŵƵůƚŝůĂŵĞůůĂƌŝƚǇ ŽĨ ƚŚĞƐĞ ůŝƉŝĚ ƐƚĂĐŬƐ͘ /ŶƚĞƌĞƐƚŝŶŐůǇ͕ ŵŽƐƚ ŽĨ ƚŚĞ ƐƚĂĐŬƐ ƐŚŽǁĞĚ ĂŶ ĞůŽŶŐĂƚĞĚϮϵϰ
ƚƌĂƉĞǌŽŝĚĂůƐŚĂƉĞ͘^ŽŵĞĞǆŚŝďŝƚĞĚĚŝĨĨĞƌĞŶƚŵŽƌƉŚŽůŽŐǇĚƵĞƚŽĐƵƌůŝŶŐ͕ĂŐŐƌĞŐĂƚŝŽŶ͕ĂŶĚƉŽƐƐŝďůĞĨƵƐŝŽŶǁŝƚŚϮϵϱ
ŽƚŚĞƌ ƐƚĂĐŬƐ͘ ůƚŚŽƵŐŚ ŽƵƌ ƌĞƐƵůƚƐ ŽĨ ĐŚĂƌĂĐƚĞƌŝƐƚŝĐ ƐŚĂƉĞ ĂŶĚ ŵƵůƚŝůĂŵĞůůĂƌŝƚǇ ŽĨ ƐƚĂĐŬƐ ĂƌĞ ŝŶ ůŝŶĞ ǁŝƚŚϮϵϲ
ƉƌĞǀŝŽƵƐ ĨŝŶĚŝŶŐƐ ŽĨ ƚŚĞ ůƵŵĞ ǁŽƌŬŐƌŽƵƉϮϴ ŽƵƌ ĚĂƚĂ ƌĞǀĞĂůĞĚ ƚŚĂƚ ƚŚĞ ĚŝŵĞŶƐŝŽŶƐ ŽĨ ƐƚĂĐŬƐ ǀĂƌŝĞĚϮϵϳ
ĐŽŶƐŝĚĞƌĂďůǇ ŝŶǁŝĚƚŚ͕ ƚŚŝĐŬŶĞƐƐĂŶĚ ůĞŶŐƚŚ;&ŝŐ͘ϱĂΘďͿ͘tĞŽďƐĞƌǀĞĚ ƚŚĂƚ ƐƚĂĐŬƐǁĞƌĞ ŝŶĐůŝŶĞĚƚŽĂƚƚĂĐŚ ƚŽϮϵϴ
ĐŽĐŚůĞĂƚĞƐ Žƌ ĨƵƐĞ ƚŽŐĞƚŚĞƌ ƚŽ ĨŽƌŵ ůĂƌŐĞƌ ƐƚĂĐŬƐ͘ KƵƌ D ĚĂƚĂ ĂůƐŽ ŝŶĚŝĐĂƚĞĚ ĐŽĐŚůĞĂƚĞ ĨŽƌŵĂƚŝŽŶ ĨƌŽŵϮϵϵ
ŚĞůŝĐĂůůǇ ĐŽŝůĞĚƐƚĂĐŬƐ͕ǁŚŝĐŚŵĂǇďĞ ƚŚĞ ƌĞƐƵůƚŽĨ ĐƵƌǀĂƚƵƌĞĂƌŝƐŝŶŐ ĨƌŽŵƉĂĐŬŝŶŐ ĨƌƵƐƚƌĂƚŝŽŶŽĨ ƚŚĞ ƚĞƌŵŝŶĂůϯϬϬ
ůŝƉŝĚŵŽůĞĐƵůĞƐ͘ /ŶŽƵƌƉƌĞǀŝŽƵƐǁŽƌŬǁĞŚĂǀĞŚǇƉŽƚŚĞƐŝǌĞĚƚŚĂƚĞŶĞƌŐǇƌĞƋƵŝƌĞĚĨŽƌƌŽůůŝŶŐŽĨƐƚĂĐŬƐĐŽŵĞƐϯϬϭ
ĨƌŽŵĂ ĐŽŵďŝŶĞĚ ĐŽŶƚƌŝďƵƚŝŽŶ ŽĨ ďĞŶĚŝŶŐ͕ ĂĚŚĞƐŝŽŶ ĂŶĚ Ă ĨƌƵƐƚƌĂƚŝŽŶ ĞŶĞƌŐǇϮ͘ ůƚŚŽƵŐŚ ĨŽƌŵĂƚŝŽŶ ŽĨ ůĂƌŐĞϯϬϮ
ƉůĂŶĂƌ ŵƵůƚŝůĂŵĞůůĂƌ ƐŚĞĞƚƐ ŝƐ ĐŽŶƐŝĚĞƌĞĚ ĂƐ ĐƌŝƚŝĐĂů ƐƚĞƉ ďĞĨŽƌĞ ƚŚĞ ĨŽƌŵĂƚŝŽŶ ŽĨ ĐǇůŝŶĚƌŝĐĂů ĐŽĐŚůĞĂƚĞϯϬϯ
ƐƚƌƵĐƚƵƌĞƐϴ͕ ϰϬ͕ ŽƵƌ ĨŝŶĚŝŶŐƐ ƐƵŐŐĞƐƚĞĚ ƚŚĂƚ ŝƚ ŵĂǇ ŶŽƚ ďĞ ĞƐƐĞŶƚŝĂů͘ W^ ƐĂŵƉůĞƐ ƐƵĐŚ ĂƐ KW^ ĂŶĚ ŽĐƚW^ϯϬϰ
ƉƌĞƉĂƌĞĚĂďŽǀĞdŵĚŝƐƉůĂǇĞĚ ůĂƌŐĞƉůĂŶĂƌ ƐŚĞĞƚƐ ŝŶĂďƵŶĚĂŶĐĞĂƐĐŽŵƉĂƌĞĚƚŽŽƚŚĞƌƐǁŚŝĐŚƐŚŽǁĞĚ ůĂƌŐĞƌϯϬϱ
ŶƵŵďĞƌŽĨƐƚĂĐŬƐĂŶĚŶĞƚǁŽƌŬƐ͘ϯϬϲ
EŽƐƚĂĐŬĨŽƌŵĂƚŝŽŶǁĂƐŽďƐĞƌǀĞĚŝŶƚŚĞƐĂŵƉůĞƐŽĨWW^ĂŶĚ^W^͕ǁŚŝĐŚǁĞƌĞƉƌĞƉĂƌĞĚĂƚϮϬΣďĞůŽǁƚŚĞϯϬϳ
dŵ ŽĨ ƚŚĞ ƌĞƐƉĞĐƚŝǀĞ ůŝƉŝĚƐ͘ dŚĞƐĞ ƐĂŵƉůĞƐ ĚŝĚ ŶŽƚ ĨŽƌŵ ƐƚĂĐŬƐ Žƌ ĂŶǇ ĐǇůŝŶĚƌŝĐĂů ƐƚƌƵĐƚƵƌĞƐ ĞǀĞŶ ƵƉŽŶϯϬϴ
ƉƌŽůŽŶŐĞĚŝŶĐƵďĂƚŝŽŶĨŽƌƵƉƚŽϭϮŵŽŶƚŚƐ͘/ŶĐŽŶƚƌĂƐƚ͕DW^ƐĂŵƉůĞƐƉƌĞƉĂƌĞĚďĞůŽǁdŵƐŚŽǁĞĚƉƌĞƐĞŶĐĞŽĨϯϬϵ
ůŝƉŝĚ ƐƚĂĐŬƐǁŝƚŚŝŶ ϭ ŚŽƵƌ ĂĨƚĞƌ ĂĚĚŝƚŝŽŶ ŽĨ ĐĂůĐŝƵŵ ĂŶĚ ŐĂǀĞ ƌŝƐĞ ƚŽ ĐŽĐŚůĞĂƚĞƐ ĂůŽŶŐǁŝƚŚ ůĂƌŐĞ ĂŵŽƵŶƚ ŽĨϯϭϬ




































ŵƵůƚŝƉůĞ ƐŝƚĞƐ ƐŚŽǁŝŶŐ ƌŝŶŐ ĨŽƌŵĂƚŝŽŶ ŝŶ ^D ŝŵĂŐĞ͘ dD ŝŵĂŐĞƐ ŽĨ ;ĐͿ W^ ĂŶĚ ;ĨͿ DW^͕ ďŝůĂǇĞƌ ƐŚĞĞƚϯϯϵ
ĂƚƚĂĐŚĞĚƚŽĂƌŝŶŐ͘ŽƚƚĞĚĂƌƌŽǁƐ ŝŶĚŝĐĂƚĞƐƚĂĐŬƐͬƐŚĞĞƚĂŶĚƐŽůŝĚĂƌƌŽǁƐ ŝŶĚŝĐĂƚĞƌŝŶŐĨŽƌŵĂƚŝŽŶ͘ůů ƐĂŵƉůĞƐϯϰϬ
ǁĞƌĞƉƌĞƉĂƌĞĚĂďŽǀĞdŵŽĨƌĞƐƉĞĐƚŝǀĞůŝƉŝĚƐ͘ϯϰϭ
EĞƚǁŽƌŬƐϯϰϮ
ůů ƐĂŵƉůĞƐ ƉƌĞƉĂƌĞĚ ĂďŽǀĞ dŵ ĚŝƐƉůĂǇĞĚ ƚŚĞ ƉƌĞƐĞŶĐĞ ŽĨ ŶĞƚǁŽƌŬƐ ŽĨ ƐƚĂĐŬƐ ĂƐ ƐĞĞŶ ŝŶ &ŝŐ͘ϳ͘ dŚĞ ůĂƚĞƌĂůϯϰϯ
ĚŝŵĞŶƐŝŽŶƐŽĨ ůĂŵĞůůĂĞďƵŝůĚŝŶŐŶĞƚǁŽƌŬǀĂƌŝĞĚĨƌŽŵĂĐŽƵƉůĞŽĨďŝůĂǇĞƌƐƚŽůŝƉŝĚƐƚĂĐŬƐǁŝƚŚĐŽŚĞƌĞŶƚƉŝůŝŶŐ͘ϯϰϰ
ƉƉĂƌĞŶƚůǇ͕ ƚŚĞƉƌŽĐĞƐƐŽĨŶĞƚǁŽƌŬĨŽƌŵĂƚŝŽŶŵŝŐŚƚďĞƉƌŽŵŽƚĞĚĚƵĞƚŽƵŶƌĞƐƚƌĂŝŶĞĚŝŶƚĞƌĂĐƚŝŽŶƐďĞƚǁĞĞŶϯϰϱ
ůŝƉŝĚ ƐƚĂĐŬƐ ƌĞƐƵůƚŝŶŐ ŝŶ ƌĂŶĚŽŵ ĂƚƚĂĐŚŵĞŶƚ ƚŽ ŽŶĞ ĂŶŽƚŚĞƌ ;&ŝŐ͘ ϳĂͿ͘ KĐĐĂƐŝŽŶĂůůǇ͕ ƚŚĞƐĞ ĐŽŶǀĞǆʹĐŽŶĐĂǀĞϯϰϲ
ďŝůĂǇĞƌƐ ƐŚŽǁĞĚ Ă ĐŽŶƚŝŶƵŽƵƐ ĨůĂƚƚĞŶĞĚ ƌĞŐŝŽŶƐ͘ dŚĞƐĞ ƌĞŐŝŽŶƐ ŝŶ ŶĞƚǁŽƌŬƐ ĐůĞĂƌůǇ ƐŚŽǁĞĚ ŽƵƚůŝŶĞƐ ŽĨ ůŝƉŝĚϯϰϳ
ƐƚĂĐŬƐ Ăƚ ŚŝŐŚĞƌ ŵĂŐŶŝĨŝĐĂƚŝŽŶ ;&ŝŐ͘ ϳĨͿ͘ dŚŝƐ ƐƵŐŐĞƐƚƐ ƚŚĂƚ ĨŽƌŵĂƚŝŽŶ ŽĨ Ă ŶĞǆƵƐ ŵƵƐƚ ďĞ ǀŝĂ ĐŽŶƚŝŶƵŽƵƐϯϰϴ
ŝŶƚĞƌĐĂůĂƚŝŽŶ ŽĨ ďŝůĂǇĞƌƐ ŽŶ ƚŚĞ ŚŽƐƚ ĂŐŐƌĞŐĂƚĞ͕ ǁŚŝĐŚ ƵůƚŝŵĂƚĞůǇ ƵŶĚĞƌŐŽĞƐ ĨƵƐŝŽŶ ŝŶ ŽƌĚĞƌ ƚŽ ĂĐŚŝĞǀĞϯϰϵ
ƚŚĞƌŵŽĚǇŶĂŵŝĐ ĞƋƵŝůŝďƌŝƵŵ͘ ,ŽǁĞǀĞƌ͕ ĨŽƌ ĐŽĐŚůĞĂƚĞ ĨŽƌŵĂƚŝŽŶ ĐƵƌůŝŶŐ ŽĨ ƐƚĂĐŬƐ Žƌ ƐŚĞĞƚƐ ŝƐ Ă ĐƌŝƚŝĐĂů ƐƚĞƉ͕ϯϱϬ
ǁŚŝĐŚ ŵĂǇ ďĞ ŚŝŶĚĞƌĞĚ ďǇ ƵŶĐŽŶƚƌŽůůĞĚ ĨŽƌŵĂƚŝŽŶ ŽĨ ŶĞƚǁŽƌŬƐ͘ dŚĞ ƐŝǌĞ ĂŶĚ ƐƉĂƚŝĂů ĚŝƐƚƌŝďƵƚŝŽŶ ŽĨ ƚŚĞƐĞϯϱϭ
ŶĞƚǁŽƌŬƐŵƵƐƚŚĂǀĞĂƐƚƌŽŶŐŝŶĨůƵĞŶĐĞŽŶĂĨƌĂĐƚŝŽŶŽĨƐƚĂĐŬƐƚŚĂƚƵŶĚĞƌŐŽƚƌĂŶƐĨŽƌŵĂƚŝŽŶŝŶƚŽĐǇůŝŶĚĞƌƐ͕ĂƐŝƚϯϱϮ
ĚŝƌĞĐƚůǇĐŽƌƌĞůĂƚĞƐǁŝƚŚƚŚĞƉŽƚĞŶƚŝĂůŶƵŵďĞƌŽĨĨĂǀŽƌĂďůĞŝŶƚĞƌĂĐƚŝŽŶƐŝƚĞƐ͘KƵƌŽďƐĞƌǀĂƚŝŽŶƐƵŐŐĞƐƚƐ͕ƐĂŵƉůĞƐϯϱϯ
ŽĨ DW^͕ WW^ ĂŶĚ ^W^ ƉƌĞƉĂƌĞĚ ĂďŽǀĞ dŵ ŚĂĚ ŚŝŐŚĞƌ ĨƌĂĐƚŝŽŶ ŽĨ ŶĞƚǁŽƌŬƐ ƚŚĂŶ ůŽǁ dŵ ůŝƉŝĚƐ͘ dŚĞƐĞϯϱϰ
ƐĂŵƉůĞƐĂůƐŽĞǆŚŝďŝƚĞĚĂůĂƌŐĞŶƵŵďĞƌŽĨĐŽĐŚůĞĂƚĞƐĂƚƚĂĐŚĞĚƚŽŶĞƚǁŽƌŬƐ͘dDŽĨƚŚĞƐĞƐƚƌƵĐƚƵƌĞƐĂƐƐĞĞŶŝŶϯϱϱ










dŵ͘EĞƚǁŽƌŬƐŽďƐĞƌǀĞĚƐĂŵƉůĞƐƉƌĞƉĂƌĞĚďĞůŽǁƚŚĞdŵďͿƌǇŽͲ^D ŝŵĂŐĞŽĨWW^ ;ĐͿƌǇŽ^D ŝŵĂŐĞŽĨϯϲϮ
DW^͘;ŐͿdDŝŵĂŐĞŽĨW^ƐĂŵƉůĞƉƌĞƉĂƌĞĚĂƚϰΣ͘;ĚͿdDŝŵĂŐĞŽĨƐŝŶŐůĞƐƚĂĐŬĨŽƌŵŝŶŐĂĐŽĐŚůĞĂƚĞŝŶϯϲϯ






ĨŽƌŵĂƚŝŽŶŽĨWW^ƐĂŵƉůĞƐ ;ƉƌĞƉĂƌĞĚĂƚϮϬ ΣͿ͘ dŚŝƐ ƚŚƌĞĞͲĚŝŵĞŶƐŝŽŶĂů ƐƉŽŶŐĞ ůŝŬĞĂŐŐƌĞŐĂƚĞƐ ĨŽƌŵĞĚ ĨƌŽŵϯϳϬ
ƚŚĞ ŝŶƚĞƌĂĐƚŝŽŶ ŽĨ ƌŝďďŽŶƐ ŵĂǇ ďĞ ƚŚĞ ƌĞƐƵůƚ ŽĨ ƉŚǇƐŝĐĂů ŐĞůĂƚŝŽŶ͕ Ă ƉŚĞŶŽŵĞŶŽŶ ŽĨƚĞŶ ŽďƐĞƌǀĞĚ ŝŶϯϳϭ
ĐŽŶĐĞŶƚƌĂƚĞĚůŝƉŝĚƐƵƐƉĞŶƐŝŽŶƐŝŶĐƵďĂƚĞĚĨŽƌůŽŶŐĞƌƚŝŵĞϰϭ͘&ƌŽŵ^DŝŵĂŐĞƐ͕ƚŚĞĚŝƐƚƌŝďƵƚŝŽŶŽĨƉŽƌĞƐǁŝƚŚŝŶϯϳϮ
ƚŚĞŶĞƚǁŽƌŬƐ^W^ĂŶĚWW^ƐĂŵƉůĞƐĂƉƉĞĂƌĞĚŵŽƌĞŚŽŵŽŐĞŶĞŽƵƐĂƐĐŽŵƉĂƌĞĚƚŽƚŚĞŶĞƚǁŽƌŬƐŽďƐĞƌǀĞĚŝŶϯϳϯ
ƐĂŵƉůĞƐ ƉƌĞƉĂƌĞĚ ĂďŽǀĞ dŵ͘ dŚĞƐĞ ŶĞƚǁŽƌŬ ůŝŬĞ ƐƚƌƵĐƚƵƌĞƐ ŶĞǀĞƌ ƐŚŽǁĞĚ ĂŶǇ ƉƌĞƐĞŶĐĞ ŽĨ ĞŶƚĂŶŐůĞĚϯϳϰ
ĐŽĐŚůĞĂƚĞƐ͘ DŽƌƉŚŽůŽŐǇ ŽĨ ƚŚĞƐĞ ŶĞƚǁŽƌŬƐ ĚŝĚ ŶŽƚ ĐŚĂŶŐĞ ƐŝŐŶŝĨŝĐĂŶƚůǇ ŽǀĞƌ ƚŚĞ ƉĞƌŝŽĚ ĞǆĐĞƉƚ ĨŽƌ DW^ϯϳϱ
ƐĂŵƉůĞƐƉƌĞƉĂƌĞĚďĞůŽǁdŵ͘/ŶĐĂƐĞŽĨDW^ƐĂŵƉůĞƐƉƌĞƉĂƌĞĚĂƚϮϬΣƉƌĞƐĞŶĐĞŽĨŶĞƚǁŽƌŬƐŵĂĚĞŽĨƐƚĂĐŬƐϯϳϲ
ǁĂƐŽďƐĞƌǀĞĚ;&ŝŐ͘ϳĐͿ͘dŚĞƐĞŶĞƚǁŽƌŬƐǁĞƌĞĚŝĨĨĞƌĞŶƚŝŶĂƉƉĞĂƌĂŶĐĞĂƐĐŽŵƉĂƌĞĚƚŽƚŚĞŽŶĞĨŽƵŶĚŝŶƐĂŵƉůĞƐϯϳϳ





ŽĨ ĂĐǇů ĐŚĂŝŶƐ ŽĨ W^ ƐŝŐŶŝĨŝĐĂŶƚůǇ ĐŚĂŶŐĞĚ ƚŚĞ ĂŐŐƌĞŐĂƚĞĚ ƐƚƌƵĐƚƵƌĞƐ͘ /Ŷ ƐĂŵƉůĞƐ ƉƌĞƉĂƌĞĚ ĂďŽǀĞ dŵ͕ ^W^͕ϯϴϯ
WW^ĂŶĚDW^ƐŚŽǁĞĚƚŚĞƉƌĞƐĞŶĐĞŽĨŝŶƚĞƌŵĞĚŝĂƚĞƐƚƌƵĐƚƵƌĞƐĂůŽŶŐǁŝƚŚƚŚĞĐŽĐŚůĞĂƚĞƐ;&ŝŐ͘ϴͿǇŝĞůĚŝŶŐƚŽϯϴϰ
ƌĞůĂƚŝǀĞůǇ ŚŝŐŚĞƌ ƉŽůǇĚŝƐƉĞƌƐŝƚǇ͘ ŽĐŚůĞĂƚĞƐ ŽĨ ŚŝŐŚ dŵ ůŝƉŝĚƐ ǁĞƌĞ ŽĨƚĞŶ ŽďƐĞƌǀĞĚ ĂƚƚĂĐŚĞĚ ƚŽ ƐƚĂĐŬƐ Žƌϯϴϱ
ŶĞƚǁŽƌŬƐ ;&ŝŐ͘ ϴĐͿ͘ /Ŷ ĐŽŶƚƌĂƐƚ͕ KW^͕ KĐƚW^ ĂŶĚ W^ ƐŚŽǁĞĚ ůĞƐƐ ŝŶƚĞƌŵĞĚŝĂƚĞ ƐƚƌƵĐƚƵƌĞƐ ĂůŽŶŐ ǁŝƚŚϯϴϲ








ůů ƐĂŵƉůĞƐ ŽĨ ůŽǁ dŵ ůŝƉŝĚƐ ƉƌĞƉĂƌĞĚ Ăƚ ϰ Σ ƐŚŽǁĞĚ ĨŽƌŵĂƚŝŽŶ ŽĨ ĐǇůŝŶĚƌŝĐĂů ƐƚƌƵĐƚƵƌĞƐ͘ ŽĐƚW^ ƐĂŵƉůĞƐϯϵϭ
ƉƌĞƉĂƌĞĚĂƚϰΣƐŚŽǁĞĚĐŽĐŚůĞĂƚĞƐǁŝƚŚŝŶ ĨŝƌƐƚϮŵŝŶƵƚĞƐĂĨƚĞƌĂĚĚŝƚŝŽŶŽĨĐĂůĐŝƵŵĂůŽŶŐǁŝƚŚ ŝŶƚĞƌŵĞĚŝĂƚĞϯϵϮ





ŽĨƉƌŽĐĞƐƐ ƚĞŵƉĞƌĂƚƵƌĞ ĨŽƌ ƚŚĞŽƉƚŝŵĂů ĐŽĐŚůĞĂƚĞ ĨŽƌŵĂƚŝŽŶϰϮ͘KŶĞ ĐĂŶ ĂŶƚŝĐŝƉĂƚĞ ƚŚĞ ŝŶĐƌĞĂƐĞĚŵŽďŝůŝƚǇ ŽĨϯϵϴ










dŽ ĨŝŶĚ ŽƵƚĞĨĨĞĐƚŽĨ ĂĐǇů ĐŚĂŝŶƐ ǀĂƌŝĂƚŝŽŶŽŶ ƚŚĞ ƌĞƐƵůƚŝŶŐ ĐŽĐŚůĞĂƚĞƐ͕ǁĞ ƐƚƵĚŝĞĚĚŝŵĞŶƐŝŽŶƐŽĨ ĐŽĐŚůĞĂƚĞƐϰϬϰ
ĨŽƌŵĞĚŝŶƐĂŵƉůĞƐƉƌĞƉĂƌĞĚĂďŽǀĞdŵ͘tĞĞǀĂůƵĂƚĞĚŽǀĞƌϭϱϬϬdDŝŵĂŐĞƐƚŽŵĞĂƐƵƌĞǁŝĚƚŚĂŶĚůĞŶŐƚŚŽĨϰϬϱ
^W^͕WW^͕DW^͕ ĂŶĚKW^ ĐŽĐŚůĞĂƚĞƐ ;dĂďůĞ ϮͿ͘tŚĞŶƉůŽƚƚĞĚ ĂŐĂŝŶƐƚ ŶƵŵďĞƌ ŽĨ ĐĂƌďŽŶ ĂƚŽŵƐ ŝŶ ůŝƉŝĚϰϬϲ
ĐŚĂŝŶ͕ƚŚĞǁŝĚƚŚŽĨĐŽĐŚůĞĂƚĞƐŽĨDW^͕WW^ĂŶĚ^W^ƌĞǀĞĂůƐĂŶĞŐĂƚŝǀĞůŝŶĞĂƌĂƐƐŽĐŝĂƚŝŽŶǁŝƚŚĂĨĂŝƌǀĂůƵĞϰϬϳ
ŽĨ ƚŚĞ ĐŽƌƌĞůĂƚŝŽŶ ĐŽĞĨĨŝĐŝĞŶƚ ;ƌϮсϬ͘ϵϯϲϰͿ͘ dŚŝƐ ƐƵŐŐĞƐƚƐ ƚŚĂƚ ĐŽĐŚůĞĂƚĞƐ ŐĞƚ ƐůĞŶĚĞƌǁŝƚŚ ŝŶĐƌĞĂƐĞ ŝŶ ĐĂƌďŽŶϰϬϴ
ĐŚĂŝŶůĞŶŐƚŚ͘/ƚ ŝƐǁĞůůŬŶŽǁŶƚŚĂƚƚƌĂŶƐŝƚŝŽŶŽĨƚŚĞůŝƉŝĚŵŽůĞĐƵůĞƐĨƌŽŵƚŚĞůŝƋƵŝĚĐƌǇƐƚĂůůŝŶĞƚŽƚŚĞŐĞůƐƚĂƚĞϰϬϵ
ƌĞƐƵůƚƐŝŶĂĚĞĐƌĞĂƐĞŽĨĂƌĞĂƉĞƌŵŽůĞĐƵůĞϰϯ͘/ŶƚŚĞƉĂƐƚǁĞŚĂǀĞƉƌŽƉŽƐĞĚƚŚĂƚƚŚĞĞǆƚĞŶƚŽĨƚŚŝƐĚĞĐƌĞĂƐĞŵĂǇϰϭϬ
ĂĨĨĞĐƚ ƚŚĞ ƐŝǌĞ ŽĨ ƚŚĞ ŝŶŶĞƌ ĐŚĂŶŶĞů ŽĨ ĐŽĐŚůĞĂƚĞƐ ǁŚĞŶ ĂĐǇů ĐŚĂŝŶ ůĞŶŐƚŚ ŝƐ ĐŽŶƐƚĂŶƚϮ͘ dŚŝƐ ĐŽƵůĚ ĞǆƉůĂŝŶϰϭϭ
ĚŝĨĨĞƌĞŶĐĞŝŶǁŝĚƚŚƐďĞƚǁĞĞŶDW^͕WW^ĂŶĚ^W^ĐŽĐŚůĞĂƚĞƐ͘/ƚŝƐŚŽǁĞǀĞƌŽĨŝŶƚĞƌĞƐƚƚŽŶŽƚĞƚŚĂƚƚŚĞŵĞĂŶϰϭϮ
ůĞŶŐƚŚ ŝŶ ĐŽĐŚůĞĂƚĞƐ ŽĨ ŚŝŐŚ dŵ ůŝƉŝĚƐ ĚŝĚ ŶŽƚ ĚŝĨĨĞƌŵƵĐŚǁŝƚŚ ǀĂƌŝĂƚŝŽŶ ŝŶ ĐĂƌďŽŶ ĐŚĂŝŶ ŽĨ ƐĂƚƵƌĂƚĞĚ ĨĂƚƚǇϰϭϯ














;&ŝŐ͘ ϴŚͿ͘ dŚĞƐĞ ƐƚƌƵĐƚƵƌĞƐ ǁĞƌĞ ŽďƐĞƌǀĞĚ ŽŶůǇ ŝŶ KĐƚW^ ĐŽĐŚůĞĂƚĞ ƐĂŵƉůĞƐ͘tĞ ĚŝĚ ŶŽƚ ĐŽŵĞ ĂĐƌŽƐƐ ĂŶǇϰϮϰ
ƌĞĨĞƌĞŶĐĞ ŽĨ ƐƵĐŚ ƐƚƌƵĐƚƵƌĞƐ ŝŶ ƚŚĞ ůŝƚĞƌĂƚƵƌĞ ĨŽƌ ĐŽĐŚůĞĂƚĞƐ͘ dŚĞ ĂŶŐůĞ ŽĨ ƚŚĞ ƐƚƌŝĂƚŝŽŶƐǁĂƐ ĂƉƉƌŽǆŝŵĂƚĞůǇϰϮϱ
ƉĞƌƉĞŶĚŝĐƵůĂƌ ĂƐĐŽŵƉĂƌĞĚ ƚŽ ƚŚĞ ůĞŶŐƚŚŽĨ ĐŽĐŚůĞĂƚĞƐ ŝŶĚŝĐĂƚŝŶŐ ƚŚĞƐƚƌƵĐƚƵƌĞƐ ƚŽďĞƉĞƌŝŽĚŝĐĚĞĐŽƌĂƚŝŽŶƐ͘ϰϮϲ
dŚĞƐĞƐƚƌƵĐƚƵƌĞƐŵĂǇƌĞƐƵůƚĨƌŽŵƐĞůĨͲĂƐƐĞŵďůǇŽĨ ĨƌĞĞĂŵƉŚŝƉŚŝůŝĐŵŽůĞĐƵůĞƐŽŶƚŚĞŚǇĚƌŽƉŚŽďŝĐƐƵƌĨĂĐĞĂƐϰϮϳ








ƐƵƌĨĂĐƚĂŶƚ ůŝŬĞ W^ ŝŶ ƚŚŝƐ ƐƚƵĚǇ͕ ƉŽŝŶƚƐ ƚŽǁĂƌĚ ŚǇĚƌŽƉŚŽďŝĐ ŝŶƚĞƌĂĐƚŝŽŶƐ ďĞƚǁĞĞŶ ĐŽĐŚůĞĂƚĞ ƐƵƌĨĂĐĞ ĂŶĚϰϯϮ









^y^ ĚĂƚĂ ŽĨ ^W^ ĨŽƌ ĨŽƵƌ ƐƚƌƵĐƚƵƌĞƐ ŝ͘Ğ͘ ďŝůĂǇĞƌƐ ďĞĨŽƌĞ ĐĂůĐŝƵŵ ŝŶƚĞƌĂĐƚŝŽŶ ;ĚŝƐĐƐͿ͕ ďŝůĂǇĞƌƐ ĂĨƚĞƌ ĐĂůĐŝƵŵϰϰϮ
ŝŶƚĞƌĂĐƚŝŽŶĂƚϮϬΣ;ƌŝďďŽŶƐͿ͕ƐƚĂĐŬƐƉƌĞƉĂƌĞĚũƵƐƚďĞůŽǁƚŚĞdŵĂƚϱϬΣĂŶĚĐŽĐŚůĞĂƚĞƐĨŽƌŵĞĚĂďŽǀĞƚŚĞdŵϰϰϯ
ĂƌĞƐŚŽǁŶŝŶ&ŝŐ͘ϵ͘ĐĐŽƌĚŝŶŐƚŽ^y^͕ƚŚĞŝŶƚĞƌͲůĂŵĞůůĂƌƌĞƉĞĂƚĚŝƐƚĂŶĐĞĨŽƌĂůůĨŽƵƌƐƚƌƵĐƚƵƌĞƐǁĂƐĐĂůĐƵůĂƚĞĚ͘ϰϰϰ
^W^ ďŝůĂǇĞƌƐ ǁŝƚŚŽƵƚ ĐĂůĐŝƵŵ ƌĞǀĞĂůĞĚ ƚŚĞ ƌĞƉĞĂƚ ĚŝƐƚĂŶĐĞ ŽĨ ϱ͘ϳ Ŷŵ ǁŚĞƌĞĂƐ ƚŚĞ ĐŽƌƌĞƐƉŽŶĚŝŶŐ ƌĞƉĞĂƚϰϰϱ
ĚŝƐƚĂŶĐĞ ĨŽƌ ƌŝďďŽŶƐ͕ ƐƚĂĐŬƐ͕ ĂŶĚ ĐŽĐŚůĞĂƚĞƐ ǁĂƐ ϱ͘ϰ Ŷŵ͕ ϱ͘Ϯ Ŷŵ͕ ĂŶĚ ϱ͘ϭ Ŷŵ͕ ƌĞƐƉĞĐƚŝǀĞůǇ͘ ŝƐƐŝŵŝůĂƌ ^y^ϰϰϲ
ǀĂůƵĞƐ ĨŽƌ ĚŝƐĐƐ ĂŶĚ ƌŝďďŽŶƐ ĂƌĞ ŝŶĚŝĐĂƚŝǀĞ ŽĨ Ă ƐƚƌŽŶŐ ŝŶƚĞƌĂĐƚŝŽŶ ďĞƚǁĞĞŶ ĐĂůĐŝƵŵ ŝŽŶƐ ĂŶĚ ƚŚĞ ƐĞƌŝŶĞϰϰϳ
ŚĞĂĚŐƌŽƵƉƐƚĂŬŝŶŐƉůĂĐĞĞǀĞŶďĞůŽǁdŵŽĨƚŚĞ ůŝƉŝĚ͘'ƌĂĚƵĂůƌĞĚƵĐƚŝŽŶŝŶƚŚĞƌĞƉĞĂƚĚŝƐƚĂŶĐĞƐĨƌŽŵĚŝƐĐƐƚŽϰϰϴ
ĐŽĐŚůĞĂƚĞƐŵĂǇďĞ ŝŶĚŝĐĂƚŝǀĞŽĨ ƚŚĞ ŝŶĐƌĞĂƐĞ ŝŶĚĞŐƌĞĞ ŽĨ ĐŽŶĚĞŶƐĂƚŝŽŶ ŝŶĚŝĨĨĞƌĞŶƚ ŝŶƚĞƌŵĞĚŝĂƚĞ ƐƚƌƵĐƚƵƌĞƐϰϰϵ
ĚƵƌŝŶŐ ĐŽĐŚůĞĂƚĞ ĨŽƌŵĂƚŝŽŶ͘ ĞƐƉŝƚĞ ƚŚĞ ƐĂŵĞ ďĂƐŝĐ ŵŽůĞĐƵůĂƌ ƐƵďƵŶŝƚƐ ƚŚĞ ĚĞŐƌĞĞ ŽĨ ĚŝƐŽƌĚĞƌ ĂŶĚϰϱϬ



















ĨŽƌŵĂƚŝŽŶ ŵĞĐŚĂŶŝƐŵ ŽĨ ĐŽĐŚůĞĂƚĞƐ͘ dŚĞ ŵĞĐŚĂŶŝƐŵ ŽĨ ĐŽĐŚůĞĂƚĞ ĨŽƌŵĂƚŝŽŶ ĨƌŽŵ W^ ŚĂƐ ďĞĞŶ ďƌŝĞĨůǇϰϲϮ
ĚŝƐĐƵƐƐĞĚ ƉƌĞǀŝŽƵƐůǇ ďǇ WĂƉĂŚĂĚũŽƉŽůŽƵƐϴ͘ ^ŽŵĞ ĨƵƌƚŚĞƌ ŝŶǀĞƐƚŝŐĂƚŝŽŶƐ ŽŶ ŝŶƚĞƌŵĞĚŝĂƚĞƐ ĂƌŝƐŝŶŐ ĚƵƌŝŶŐϰϲϯ
ŝŶƚĞƌĂĐƚŝŽŶŽĨW^ǀĞƐŝĐůĞƐǁŝƚŚĐĂůĐŝƵŵŝŽŶƐǁĞƌĞƌĞƉŽƌƚĞĚǁŚŝĐŚŵĞŶƚŝŽŶĨƵƐŝŽŶŽƌǀŝŽůĞŶƚƌƵƉƚƵƌĞŽĨǀĞƐŝĐůĞƐϰϲϰ






ƉƌŽĐĞƐƐ ƚĞŵƉĞƌĂƚƵƌĞĂŶĚĞĨĨĞĐƚŽĨ ŝƚƐǀĂƌŝĂƚŝŽŶŽŶƌĂƚĞŽĨĐŽĐŚůĞĂƚĞĨŽƌŵĂƚŝŽŶ͘ŽĐŚůĞĂƚĞ ĨŽƌŵĂƚŝŽŶďĞŝŶŐĂϰϲϳ
ƉŽůǇŵŽƌƉŚŽƵƐ ƉƌŽĐĞƐƐ ŵĂǇ ŚĂǀĞ ŵŽƌĞ ƚŚĂŶ ŽŶĞ ƐĞĐŽŶĚĂƌǇ ƉĂƚŚǁĂǇƐ ĚƵĞ ƚŽ ƵŶĐŽŶƚƌŽůůĞĚ ŝŶƚĞƌĂĐƚŝŽŶ ŽĨϰϲϴ
ĐĂůĐŝƵŵ ĂŶĚ W^ ŚĞĂĚŐƌŽƵƉƐ͘ /Ŷ ƚŚŝƐ ƐĞĐƚŝŽŶ ǁĞ ŚĂǀĞ ƐƵŵŵĞƌŝǌĞĚ ƚŚĞ ƐĞƋƵĞŶĐĞ ŽĨ ŵŽƌƉŚŽůŽŐŝĐĂů ĐŚĂŶŐĞƐϰϲϵ
ŽďƐĞǀĞĚĚƵƌŝŶŐƚŚŝƐŝŶǀĞƐƚŝŐĂƚŝŽŶƚŽƉƵƚĨŽƌƚŚƚŚĞƉƌŽďĂďůĞĨŽƌŵĂƚŝŽŶŵĞĐŚĂŶŝƐŵ͘ϰϳϬ
tĞŚĂǀĞĐůĂƐƐŝĨŝĞĚƐƚƌƵĐƚƵƌĞƐƵŶĚĞƌƉƌŝŵĂƌǇ͕ƐĞĐŽŶĚĂƌǇĂŶĚƚĞƌƚŝĂƌǇƐƚƌƵĐƚƵƌĞƐ;&ŝŐ͘ϭϬͿ͘ŽĐŚůĞĂƚĞĨŽƌŵĂƚŝŽŶϰϳϭ
ŝŶǀŽůǀĞƐ ƚǁŽ ŵĂŝŶ ƐƚĂŐĞƐ͗ ĨŝƌƐƚ͕ ƌĂƉŝĚ ŶƵĐůĞĂƚŝŽŶ ǁŚŝĐŚ ĂĐƚƐ ůŝŬĞ Ă ƚĞŵƉůĂƚĞ ĨŽůůŽǁĞĚ ďǇ ĂŐŐƌĞŐĂƚŝŽŶ ĂŶĚϰϳϮ
ĂƐƐŽĐŝĂƚŝŽŶŽĨ ƚĞŵƉůĂƚĞƐ ƚŽĂƐƐŝƐƚ ŝŶ ŐƌŽǁƚŚŽĨ ƚŚĞ ĨŝŶĂů ƐƵƉĞƌƐƚƌƵĐƚƵƌĞƐ͘ƵƌŝŶŐŐƌŽǁƚŚĐŽĐŚůĞĂƚĞ ĨŽƌŵĂƚŝŽŶϰϳϯ
ƉĂƚŚǁĂǇŵŽƐƚ ůŝŬĞůǇ ĞǀŽůǀĞƐ ƚŚƌŽƵŐŚ ƌĞĂƌƌĂŶŐĞŵĞŶƚ ĂŶĚ ŽƌŝĞŶƚĞĚ ĂƚƚĂĐŚŵĞŶƚϰϳ͘ WƌŝŵĂƌǇ ƐƚƌƵĐƚƵƌĞƐ ĂƌĞ ƚŚĞϰϳϰ
ƐƚĂƌƚŝŶŐŵĂƚĞƌŝĂůƐ ĂŶĚ ƌĞƉƌĞƐĞŶƚ ůŝƉŽƐŽŵĞƐ͕ ĚŝƐĐƐ ŽƌŵŝĐĞůůĞƐ ŽĨ W^ǁŝƚŚŽƵƚ ĐĂůĐŝƵŵ͘ ĚĚŝƚŝŽŶ ŽĨ ĐĂůĐŝƵŵ ƚŽϰϳϱ





ĐĂƚŝŽŶƐĂƌĞƐĞĐŽŶĚĂƌǇƐƚƌƵĐƚƵƌĞƐ͘dĞŶĚĞŶĐǇŽĨ Ă ƐǇƐƚĞŵƚŽŵŝŶŝŵŝǌĞ ĨƌĞĞĞŶĞƌŐǇƉƌŽďĂďůǇƉƌŽŵŽƚĞƐ ĨƵƌƚŚĞƌϰϴϭ
ĂŐŐƌĞŐĂƚŝŽŶ ĂŶĚ ƉĂƌƚŝĐůĞ ŐƌŽǁƚŚ͘ dŚĞ ƚǁŽ ƉŽƐƐŝďůĞ ƌĞĂƐŽŶƐ ŵĂǇ ŝŶĐůƵĚĞ ƌĞĚƵĐƚŝŽŶ ŝŶ ƐƵƌĨĂĐĞ ĂƌĞĂ ĂŶĚϰϴϮ
ƌĞŐƵůĂƚŝŽŶŽĨŚŝŐŚĞŶĞƌŐǇƐƵƌĨĂĐĞƐ͘ĞĐĂƵƐĞƌŝďďŽŶƐǁŽƵůĚŚĂǀĞůĂƌŐĞƌĞŶĞƌŐĞƚŝĐĂůůǇƵŶĨĂǀŽƌĂďůĞƐƵƌĨĂĐĞƐƚŚĞǇϰϴϯ





KƵƌ ƌĞƐƵůƚƐŚŝŐŚůŝŐŚƚ ƚŚĂƚ ƐƚĂĐŬ ĨŽƌŵĂƚŝŽŶŵĂǇ ďĞ ĂŶ ĞƐƐĞŶƚŝĂů ƐƚĞƉ ŝŶ ŽƌĚĞƌ ƚŽ ĨŽƌŵ ĐŽĐŚůĞĂƚĞƐ͘ ^ƚĂĐŬƐ ĐĂŶϰϴϵ
ĨŽƌŵĐŽĐŚůĞĂƚĞƐǁŝƚŚŽƵƚƵŶĚĞƌŐŽŝŶŐĨƵƌƚŚĞƌĂŐŐƌĞŐĂƚŝŽŶ͘/ƚǁĂƐŽďƐĞƌǀĞĚƚŚĂƚƐƚĂĐŬƐĐĂŶĂůƐŽƵŶĚĞƌŐŽĨƵƐŝŽŶϰϵϬ
ƚŽ ĨŽƌŵ ďƌŽĂĚ ƐŚĞĞƚƐǁŚŝĐŚ ĂƌĞ ŝƌƌĞŐƵůĂƌ ŝŶ ƐŚĂƉĞ ĂŶĚ ƌŽůů ƵƉ ƚŽ ĨŽƌŵ ĐŽĐŚůĞĂƚĞƐ͘ KƵƌ ƐƚƵĚǇ ƉŽŝŶƚƐ ƚŽ ƚŚĞϰϵϭ
ƉŽƐƐŝďŝůŝƚǇƚŚĂƚŐĞŶĞƌĂƚŝŽŶŽĨƌŝŶŐůŝŬĞƐƚƌƵĐƚƵƌĞƐŵĂǇƉůĂǇĂƉĂƌƚŝŶĐŽĐŚůĞĂƚĞĨŽƌŵĂƚŝŽŶďǇŝŶŝƚŝĂƚŝŶŐĐƵƌůŝŶŐŽĨϰϵϮ
ƐƚĂĐŬƐ͕ƐŚĞĞƚƐĞƚĐ͘/ŶƚĞƌŵĞĚŝĂƚĞƐŽďƐĞƌǀĞĚƚŚƌŽƵŐŚŽƵƚƚŚĞĐŽĐŚůĞĂƚĞĨŽƌŵĂƚŝŽŶƉƌŽĐĞƐƐĂƌĞŶŽŶͲƐƚŽŝĐŚŝŽŵĞƚƌŝĐϰϵϯ
ĂŶĚŽĐĐƵƌ ĚƵĞ ƚŽ ƚƌĂŶƐĨŽƌŵĂƚŝŽŶƐ ƉƌĞĐƵƌƐŽƌƐƵŶĚĞƌŐŽďĞĨŽƌĞ ĨŽƌŵŝŶŐ ĐŽĐŚůĞĂƚĞƐ͘ŽĐŚůĞĂƚĞƐ ĂƌĞ ĐĂƌƉĞƚͲƌŽůůϰϵϰ
ůŝŬĞƐƚƌƵĐƚƵƌĞƐǁŝƚŚŚŽůůŽǁĐĞŶƚƌĂůĐŚĂŶŶĞůĂŶĚŽƉĞŶĞŶĚƐ͕ǁŚŝĐŚĐĂŶĨƵƌƚŚĞƌƵŶĚĞƌŐŽĂŐŐƌĞŐĂƚŝŽŶ͘ŽŵƉůĞƚĞϰϵϱ
ĂďƐĞŶĐĞŽĨƚĞƌƚŝĂƌǇƐƚƌƵĐƚƵƌĞƐǁĂƐƐĞůĚŽŵŽďƐĞƌǀĞĚŝŶƐĂŵƉůĞƐŽĨĐŽĐŚůĞĂƚĞƐƉƌĞƉĂƌĞĚĨƌŽŵW^͘ZĞĂƐŽŶďĞŝŶŐϰϵϲ
ǀĂƌŝŽƵƐ ƐƚĞƉƐ ŵĂǇ ƚĂŬĞ ƉůĂĐĞ ƐŝŵƵůƚĂŶĞŽƵƐůǇ ĚƵƌŝŶŐ ĐŽĐŚůĞĂƚĞ ĨŽƌŵĂƚŝŽŶ ƐƵĐŚ ĂƐ ĐƵƌůŝŶŐ͕ ďƌĂŶĐŚŝŶŐ͕ϰϵϳ
ĂŐŐůŽŵĞƌĂƚŝŽŶ͕ƌĞĂƌƌĂŶŐĞŵĞŶƚĞƚĐĂŶĚƚŚĞƐĞĐŽŵƉůĞǆŝŶƚĞƌĂĐƚŝŽŶƐŵĂǇŐŝǀĞƌŝƐĞƚŽĚŝǀĞƌƐĞƚĞƌƚŝĂƌǇƐƚƌƵĐƚƵƌĞƐϰϵϴ
ǁŚŝĐŚĐĂŶĨƵƌƚŚĞƌĨŽƌŵŶĞƚǁŽƌŬƐŽĨƚĞƌƚŝĂƌǇƐƚƌƵĐƚƵƌĞƐĂŶĚͬŽƌĐŽĐŚůĞĂƚĞƐ͘ŽŵƉůĞǆĂƌĐŚŝƚĞĐƚƵƌĞƐĐŽŵƉŽƐĞĚŽĨϰϵϵ















ĚĞĐƌĞĂƐĞĚ ƌĂƚĞŽĨ ĐŽĐŚůĞĂƚĞ ĨŽƌŵĂƚŝŽŶĂƚ ůŽǁĞƌ ƚĞŵƉĞƌĂƚƵƌĞƐ͕ŚŽǁĞǀĞƌŵŽƌĞƐƚƵĚŝĞƐǁŝƚŚ ĨŽĐƵƐŽŶŬŝŶĞƚŝĐƐϱϭϭ
ĂŶĚ ĐĂůŽƌŝŵĞƚƌǇ ĂƌĞ ƌĞƋƵŝƌĞĚ ĨŽƌ ĨƵƌƚŚĞƌ ƵŶĚĞƌƐƚĂŶĚŝŶŐ ŽĨ ƚŚŝƐ ĂƐƉĞĐƚ͘ /ƚ ŝƐ ŶŽƚĞǁŽƌƚŚǇ ƚŚĂƚ ƚŚĞ ŝŶĂďŝůŝƚǇ ƚŽϱϭϮ
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ABSTRACT: Cochleates are self-assembled cylindrical condensates that consist of large rolled-up lipid bilayer sheets and
represent a novel platform for oral and systemic delivery of therapeutically active medicinal agents. With few preceding
investigations, the physical basis of cochleate formation has remained largely unexplored. We address the structure and stability of
cochleates in a combined experimental/theoretical approach. Employing diﬀerent electron microscopy methods, we provide
evidence for cochleates consisting of phosphatidylserine and calcium to be hollow tubelike structures with a well-deﬁned constant
lamellar repeat distance and statistically varying inner and outer radii. To rationalize the relation between inner and outer radii,
we propose a theoretical model. Based on the minimization of a phenomenological free energy expression containing a bending,
adhesion, and frustration contribution, we predict the optimal tube dimensions of a cochleate and estimate ratios of material
constants for cochleates consisting of phosphatidylserines with varied hydrocarbon chain structures. Knowing and understanding
these ratios will ultimately beneﬁt the successful formulation of cochleates for drug delivery applications.
■ INTRODUCTION
Since their discovery in 1975 by Papahadjopoulos and co-
workers,1 cochleates have attracted considerable interest, both
because of their remarkable structural properties2 and because
of their potential use as drug delivery vehicles. Cochleates are
elongated spiral rolls that consist of phospholipid and divalent
(or higher-valent) cation complexes. Their highly condensed
solidlike structure imparts protection to incorporated mole-
cules3 and potential for slow release. This together with
stability, ease of production, and biocompatibility renders
cochleates promising candidates for the delivery of a wide range
of drugs and fragile molecules such as proteins and peptides.4,5
Until now, cochleates have been successfully utilized for the
delivery of multiple active ingredients such as antifungal
agents,6 DNA, and vaccines.7
The building blocks of cochleates are negatively charged
phospholipids with either saturated or unsaturated hydrocarbon
chains. Several natural phospholipids such as phosphatidylser-
ine,8 phosphatidylglycerol,9 and phosphatidic acid10 have been
used as precursors for cochleates. Their interactions with
divalent or higher-valent cationic condensing agents result in
the formation and precipitation of stacks of bilayer sheets.
Interbilayer attraction and expulsion of water molecules are
believed to originate from bridging of the condensing agent
between opposed lipid layers, thus forming a compact aggregate
with a concomitant increase in the value of the endothermic
transition temperature.11 Bending of the condensate into a
cylindrical structure appears to be thermodynamically more
favorable than the formation of other supramolecular
structures, including a planar bilayer stack.
The past few decades have witnessed substantial improve-
ments of protocols to form cochleates.12,13 In addition, the
usage of drug molecules as condensing agents instead of metal
cations has been explored. One of the reported strategies
employing multivalent cationic drugs utilizes tobramycine as
the bridging agent.14 We would like to point out that most
previous studies have focused on the feasibility of using
cochleates as drug delivery vehicles rather than on investigating
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their structure and stability. As a result, structural features,
thermodynamic stability, and formation pathways of cochleates
have remained largely unexplored. Our study addresses some of
these aspects in a combined experimental and theoretical
approach. By employing electron microscopy we demonstrate
that both DOPS (dioleoylphosphatidylserine) and DSPS
(distearoylphosphatidylserine) cochleates prepared with Ca2+
as bridging agent contain an aqueous inner channel. We
quantify both the inner and outer radii of cochleate tubes
consisting of calcium and phosphatidylserine with varying
degree of chain saturation. In an attempt to rationalize the
measured distribution of tube radii, we propose a theoretical
model. Based on a phenomenological free energy expression,
the model enables us to estimate the optimal dimensions of a
cochleate. The model accounts for the degree to which
cochleates are rolled up in thermal equilibrium and establishes a
relation between the inner and outer radii. The model suggests
that the sum of bilayer bending energy and calcium-mediated
bilayer−bilayer adhesion energy alone is insuﬃcient to explain
the experimentally observed size distribution of cochleates.
However, our data can be rationalized if we further add a
mismatch contribution to the free energy that originates from
an incomplete lipid relaxation during bending of an initially
planar membrane stack into a tubular structure.
■ EXPERIMENTAL SECTION
Materials. Dioleoylphosphatidylserine and distearoylphosphatidyl-
serine were obtained from Avanti Polar Lipids Inc. (USA). For
embedding studies, Araldite LY 564 was obtained from Huntman
Advanced Materials GmbH (Switzerland). All buﬀers and other
chemical reagents were of analytical grade and were obtained from
Sigma-Aldrich GmbH (Germany).
Preparation of Cochleates. Cochleates were prepared by a
trapping method.6 Brieﬂy, lipid was dissolved in a mixture of
chloroform:methanol (3:1) in a round-bottom ﬂask followed by
removal of the organic solvents using a rotary evaporator (R-144
BUCHI Labortechnik GmbH, Germany) to form a thin lipid ﬁlm. The
lipid ﬁlm was further hydrated with 10 mM TRIZMA [2-amino-2-
(hydroxymethyl)-1,3-propanediol] buﬀer above the transition temper-
ature. The suspension was vortexed and extruded through a
polycarbonate membrane of 100 nm pore size (Avestin, Canada) to
produce a homogeneous lipid dispersion. Cochleates were formed by
addition of calcium chloride (100 mM) to the lipid dispersion in buﬀer
(NaCl, 100 mM; TRIZMA, 10 mM) under constant stirring above the
lipid transition temperature. The molar ratio of lipid to calcium was
1:1. The precipitated dispersions were then stored at 4 °C.
Scanning Electron Microscopy. An aliquot of 5 μL of the
cochleate dispersion was adhered for 5 min onto a perforated
Formvar-coated copper grid (300 mesh, Quantifoil, Germany). Excess
of liquid was removed with a lint-free ﬁlter paper. Further, the grid was
quickly plunged in liquid propane−ethane (−180 °C), freeze-dried in
a BAL-TEC BAF 060 (Baltec, Liechtenstein) and examined in a LEO
1350 Gemini (Carl Zeiss, Germany) scanning electron microscope
(SEM) at 3 kV acceleration voltage and working distance of 6 mm
using a secondary electron detector.
Transmission Electron Microscopy. Cochleate dispersion was
air-dried on a Formvar-carbon coated copper grid (300 mesh, Plano,
Germany). Grids were investigated using a Zeiss EM 902A (Carl Zeiss,
Germany) transmission electron microscope (TEM) operated at 80
kV. Images were acquired with a 1k × 1k FastScan-F114 CCD Camera
(TVIPS GmbH, Germany).
Cryoelectron Tomography. Sample Preparation. Cochleate
dispersion was added to a carbon-coated copper grid (R1.2/1.3 + 2
nm, Quantifoil Micro Tools GmbH, Germany). After excess liquid was
blotted from the sample, it was subjected to plunge freezing in liquid
ethane at −180 °C as described by Dubochet et al.15 The grid was
freeze-dried at −90 °C for 1 h in a Philips CM 120 cryo-TEM (Philips,
Netherlands). Further, the grid was gold labeled by placing 3 μL of 5
nm colloidal gold clusters (Sigma, USA) for subsequent alignment
purposes. The grids were then transferred into a liquid nitrogen cooled
(T = −196 °C) ±70° tilt cryo-holder (Gatan Inc., USA) and inserted
into the cryoelectron microscope.
Preparation of Tomographic Tilt Series. Tomographic tilt series
were collected under low-dose conditions with an increment of 3°
within a tilt range from −65 to +65° using a TEM operating at 120 kV
and a 1k × 1k FastScan-F114 CCD Camera (TVIPS GmbH,
Germany). The defocus level was typically around −3 μm. Data
acquisition was fully automated as described previously.16 The pixel
size at the specimen level was between 1.08 and 1.7 nm.
Image Processing and Visualization. The projection images were
aligned and back-projected, resulting in a three-dimensional (3D)
Figure 1. Transmission electron micrographs of (a) DOPS-Ca cochleates and (b) DSPS-Ca cochleates. Positions marked by arrows indicate the
tubelike hollow cochleate structure.
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reconstruction with a resolution of about 10 nm.17 The IMOD
software package (University of Colorado, USA) was used for 3D
processing and visualization.
Investigation of Cross Section of Resin-Embedded Cochle-
ates. Cochleates were centrifuged and the pellet was redispersed in
100 mM cacodylate buﬀer (pH 7.2) containing 1% OsO4 for 2 h.
Cochleates were centrifuged again and the pellet was rinsed in buﬀer
and dehydrated in ethanol (50% v/v) for 15 min. It was further
subjected for 1 h to 1% uranyl acetate solution to improve contrast.
The pellet was then dispersed in an epoxy resin Araldite LY 564, used
as the embedding medium. The mixture was polymerized in a closed
mold for 2 days at 60 °C. The polymer blocks were microtomed into
thin (70−100 nm) slices, using a diamond knife mounted on an
Ultracut E device (Reichert Labtec, Germany) at room temperature.
The slices were then transferred to copper grids (Quantifoil,
Germany) and examined by TEM.
Small Angle X-ray Scattering (SAXS). Cochleate samples were
dialyzed using Spectra/Por CE dialysis tubing, 10 000 molecular
weight cutoﬀ (Spectrum Medical Industries, USA) and freeze-dried
(Christ Epsilon 2-4 LSCPlus, Martin Christ Gefriertrocknungsanlagen
GmbH, Germany) before evaluation. SAXS measurements of
cochleate samples were performed on a Bruker Nanostar (Bruker,
Germany), equipped with a microfocus X-ray source (Incoatec IμS Cu
E025, Incoatec, Germany), operating at λ = 1.54 Å. A pinhole setup
with 750, 400, and 1000 μm (in the order from source to sample) was
used, and the sample-to-detector distance was 107 cm. Samples were
mounted on a metal rack and ﬁxed using tape. All measurements were
carried out at room temperature for 120 min, with a two-dimensional
position-sensitive detector, Vantec 2000 (Bruker GmbH, Germany).
The scattering patterns were corrected for the beam stop and the
background prior to evaluations and radially integrated to obtain the
scattering intensity as a function of the scattering vector q = (4π/λ) sin
θ, with 2θ being the scattering angle and λ the X-ray wavelength.
■ RESULTS AND DISCUSSION
Assessment of Cochleate Formation. Following the
procedure outlined in the Experimental Section, DOPS and
DSPS cochleates were prepared with Ca2+ as bridging agent by
the trapping method.6 Samples were ﬁrst observed by TEM and
SEM. The presence of cylindrical structures indicated successful
cochleate formation for both lipids. Figure 1 shows TEM
micrographs of cochleate particles. In TEM analysis, cochleates
appeared like elongated cylinders with the occasional
appearance of bilayer patterns at higher magniﬁcation. Most
importantly, at higher accelerating potentials, a hollow tube
within the cochleates (highlighted in Figure 1 by arrows) was
evident despite poor contrast due to the electron-dense nature
of the system. SEM micrographs in Figure 2 also indicate
channels inside the cylindrical particles, corroborating our TEM
ﬁndings. All the samples were prepared in triplicate. The freeze-
dried samples were also analyzed by electron microscopy to
evaluate changes in their structure. The morphology of
lyophilized cochleates was not altered, which can be attributed
to the negligible water content associated with the bilayers.4 All
the samples were conﬁrmed to have formed cochleates before
they were subjected to any further characterization.
Cochleate Structure Studied by Cryoelectron Tomog-
raphy. The self-assembly of cochleates is characterized by a
compact packing of lipid bilayers. Consequently, electrons
cannot pass through the cochleate easily thus resulting in an
image with poor contrast. Hence, TEM is not the method of
choice for obtaining speciﬁc information about the internal
cochleate structure, as most of the particles appear dark against
Figure 2. Scanning electron micrographs of (a) DOPS-Ca cochleates and (b) DSPS-Ca cochleates.
Figure 3. Three-dimensional reconstruction of (a) DOPS-Ca cochleates and (b) DSPS-Ca cochleates showing the inner channel from diﬀerent
perspectives.
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a bright background. Electron tomographic techniques can be
more useful in providing detailed information about the inner
structure of cochleates. We performed a 3D reconstruction of a
cochleate particle from acquisition and postacquisition
processing of several TEM projection series for both DOPS-
Ca and DSPS-Ca cochleates. Figure 3 shows the corresponding
reconstructions viewed at two diﬀerent angles for cochleate
microstructures corresponding to each of the two lipids. The
3D reconstruction revealed a dense and uniformly packed
bilayer stack adopting a cylindrical geometry with a channel
spanning the entire structure. No sample damage was observed
during measurements.
In the past, cochleates have been described employing
predominantly freeze−fracture microscopy as cigar-shaped
structures.18−20 Some studies also suggested the possible
presence of a luminal opening.9,21 In our microscopic
investigations we observed virtually all cochleate particles to
exhibit a continuous central channel that spans the entire
Figure 4. TEM of transverse sections of (a and b) DOPS-Ca and (c) DSPS-Ca cochleates obtained from resin-embedded samples showing inner
cavities, (d) DOPS-Ca cochleate with concentric bilayers and inner cavity, and (e) DSPS-Ca cochleate with lack of inner cavity and bilayer
representing a rolled-up structure.
Figure 5. TEM images of (a) DOPS-Ca and (b) DSPS-Ca cochleates at medium magniﬁcation with clearly visible inner tubules.
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structure, with an opening at each terminus of a cochleate. In
aqueous dispersions the central channel would be ﬁlled with
water. On the basis of the prevalence of a central channel in
cochleates, we suggest referring to its morphology as “carpet
roll” rather than “cigarlike”, as cigars usually have a dense core.
The central channel in a cochleate may be of relevance in
pharmacokinetics due to its possible inﬂuence on the release
kinetics of active ingredients trapped inside the particle.
Investigation of Cross Section of Resin-Embedded
Cochleates. TEM micrographs of cross sections of resin-
embedded DOPS-Ca and DSPS-Ca cochleates (Figure 4)
display the presence of hollow tubules inside the particles. The
majority of investigated particles exhibit cross sections of
multilamellar scrolls folding into a compact, rolled-up structure.
However, this is not discernible from all images as some
micrographs displayed lipid bilayers arranged in a concentric
manner. The tubules inside the particles were ﬁlled with epoxy
resin, which most likely entered via the open ends of the central
channel in the particle. Particles without any voids were also
found, although their occurrence was very rare. During
microscopy some ﬁelds also revealed bilayer stacks attached
to the cochleate cylinders. The orientation of cochleate
cylinders within the resin matrix could not be controlled in
this technique, and as a result not all cross sections were
perpendicular to the long axis of the cochleates.
Evaluation of Dimensions of the Cochleates. Unlike
liposomes or microemulsions, cochleates cannot be adequately
characterized with the help of dynamic light scattering due to
their complex cylindrical shape. Hence we decided to analyze
479 TEM micrographs with the help of ImageJ version 1.45s22
for determining dimensions of cochleates. Speciﬁcally, we
measured the outer and inner diameters for an ensemble of
cochleate tubes at randomly selected positions. In the TEM
micrographs (for an example, see Figure 5) the boundaries of
the inner channel can clearly be discerned at high accelerating
potentials. For a given single tube, both outer and inner
diameters were measured at the same point. The results for the
average outer and inner diameters (and their ratio) are listed in
Table 1. The diﬀerence between the ratios for DOPS-Ca and
DSPS-Ca cochleates is apparent and statistically signiﬁcant.
Below, in Figure 7, we also show the individual diameters in a
scatter plot. Data obtained from these measurements are used
in the section Theoretical Modeling to motivate a theoretical
model.
According to the summary of our data in Table 1,
unsaturation in the lipid chain resulted in the formation of
cochleates with wider inner tubules as compared to the
saturated lipid.
SAXS. The SAXS patterns of DOPS-Ca and DSPS-Ca
cochleate samples (Figure 6) exhibit an intense reﬂection along
with further weak reﬂections of higher order, characteristic of a
lamellar structure.23 The ﬁrst reﬂection peak in the diﬀraction
pattern corresponds to the characteristic domain spacing in the
sample, i.e., the bilayer thickness together with an interbilayer
space containing the bridging agent.24 Both diﬀractograms of
DOPS-Ca and DSPS-Ca cochleates yielded an identical
interlamellar repeat distance of 5.1 nm. The magnitude of the
repeat distance obtained from SAXS studies agrees well with
that measured geometrically using TEM micrographs (data not
shown).
Theoretical Modeling. Our electron microscopy results
demonstrate cochleates to be tubelike structures with an inner
aqueous channel running through the particle. Visual inspection
of our TEM images suggests a statistical distribution of tube
sizes with signiﬁcant diﬀerences between DOPS and DSPS. To
quantify these diﬀerences, we have plotted the inner diameter
2R1 and outer diameter 2R2 of more than 200 randomly
selected cochleate tubes (Figure 7), where R1 and R2 denote the
corresponding radii.
Despite the large scatter in the measured tube sizes, there
appears to be a systematic lipid-dependent relation between the
inner and outer diameters, 2R1 and 2R2. In the following we
discuss possible mechanisms that may give rise to this relation.
To this end, we propose a theoretical model in which we
assume the cochleate to be a cylindrically symmetric multi-
lamellar vesicleof suﬃciently large extension L so that end
eﬀects can be neglectedwith inner and outer radii R1 and R2,
respectively, and a bilayer repeat distance h. Because it is
invariant along its axis of symmetry, we need to consider only
the cochleate’s free energy per unit length of the cylinder, F/L.
We ﬁrst account for two contributions to the total free energy F
= Fb + Fa, a bending energy Fb of the lipid multilayer structure
and a calcium-mediated bilayer−bilayer adhesion energy Fa
between each pair of neighboring lipid bilayers in the cochleate.
The bending energy of a single cylindrically curved bilayer in
a cochleate tube that is at distance r from the axis of cylindrical
symmetry is f b = Ablκc
2/2, where Abl = 2πrL is the lateral area of
this bilayer and c = 1/r is its curvature. The constant κ denotes
the bending energy of a single bilayer. Integrating the result, f b
= πLκ/r, over all bilayers of the cochleate yields the total
bending energy per unit length of the cochleate:





















We point out that the integration in eq 1 treats the individual
bilayers as a continuum. Yet this is an excellent approximation
as becomes evident by comparing the continuum expression
Fb/(Lπκ) = ln(R2/R1)/h with the discrete version Fb/(Lπκ) =
∑i=1n 1/[R1 + h(i − 1/2)], where n = (R2 − R1)/h is the number
of bilayers crossed along the radial direction of the cochleate.
For example, choosing the representative case h = 5 nm, R1 =
20 nm, and R2 = 70 nm yields Fb/(Lπκ) = 0.2505/nm for the
continuum approximation and Fb/(Lπκ) = 0.2501/nm for the
discrete version.
The adhesion energy can be expressed by assigning an energy
penalty to the water-exposed innermost and outermost bilayers.
Denoting this free energy penalty per unit area by σ, we can
write for the adhesion energy of the innermost bilayer 2πR1σL,
and analogously 2πR2σL for the outermost bilayer. Hence, the
total adhesion energy penalty per unit length of the cochleate is
Fa/L = 2πσ(R1 + R2). Combining the expressions for Fb and Fa
leads to the total free energy:






(nm) ± SE ratio ± SE
DOPS
(n = 224)
314.7 ± 6.4 108.1 ± 3.6 3.3 ± 0.07
DSPS
(n = 255)
203.6 ± 4.3 35.5 ± 1.6 7.4 ± 0.2
aSE = standard error of the mean; n = number of samples.
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Note that, for the model in eq 2 to apply, it is irrelevant if we
assume the cylindrical cochleate to be multilamellar (that is,
with (R2 − R1)/h individual bilayers) or a rolled-up structure,
which consists only of one single bilayer that is wound upon
itself. The latter can be modeled, mathematically, as the
involute of a circle x(s) = (h/2s)[cos(s) + s sin(s)] and y(s) =
(h/2s)[sin(s) + s cos(s)], which maintains a ﬁxed bilayer−
bilayer distance everywhere. The rolled-up cochleate has a local
curvature c = 2π/(hs), which (as a simple calculation shows)
leads to the same free energy as for the multilamellar structure
as long as the inner diameter is signiﬁcantly larger than the
repeat distance h. We assume the cochleate consists of a ﬁxed
number of lipids, each with constant cross-sectional area. The
cochleate then has a ﬁxed total bilayer area A = Ll, written here
as the product of the cochleate tube length L and the total
contour length












of all bilayers that appear in the cochleate’s cross section. For
any ﬁxed l, the two radii R1 and R2 are no longer independent.
Hence, the total free energy F(R1,R2) adopts its minimum in
thermodynamic equilibrium with respect to R1 and R2, subject
to l being kept constant. The minimization can be carried out
conveniently using the Langrangian multiplier method, which








A least-squares ﬁt of the relation in eq 4 to the data in Figure
7 yields hσ/κ = 0.0054/nm for DOPS and hσ/κ = 0.022/nm for
DSPS. The corresponding relation between R1 and R2
according to eq 4 is shown in Figure 7 as a dashed line in
each diagram. Note that eq 4 predicts a saturation of the inner
cochleate radius R1 with growing outer radius R2. The predicted
saturation is a result of the membrane’s bending energy penalty
which makes the decrease of the inner tube radius R1 below a
value of about κ/(2hσ) very costly. Since no such penalty
aﬀects the outer radius R2, eq 4 predicts the cochleate to
increase radius R2 with only minor concomitant changes of R1.
However, our experimental data in Figure 7 do not support the
prediction of an essentially constant radius R1. What they
suggest, instead, is that R1 continues to grow with R2.
Membrane bending and calcium-mediated membrane−
membrane adhesion alone cannot rationalize the data in Figure
7. The question arises, what other physical mechanism is able
to keep R1 and R2 growing together? In the following, we
discuss an additional free energy contribution that is able to
account for the joint growth of R1 and R2. Consider the
bending of a planar membrane stack into a multilamellar
cylindrical vesicle. Note that this hypothetical bending scenario
merely compares the two states prior and after bending; it does
not imply that the actual formation of a cochleate proceeds this
way. If all individual bilayers of the initially planar stack are of
the same lateral area, then an elastic stretching/compression
deformation of the bilayers is required for a multilamellar tube
Figure 6. SAXS patterns of (a) DOPS-Ca and (b) DSPS-Ca cochleates exhibiting a primary peak (001) followed by higher order peaks (002) and
(003).
Figure 7. Scatter plots of inner and outer diameters, 2R1 and 2R2, of randomly selected cochleate tubes of DOPS (n = 255, left) and DSPS (n = 224,
right). Dashed and solid lines are best ﬁts of eqs 4 and 7, respectively.
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to form. Speciﬁcally, the outer bilayers must stretch and the
inner ones must compress in order to compensate for the
changes in circumference of the bilayer’s cross section after
bending. The energy cost Fm per unit length L of the cochleate
of this area mismatch-compensating deformation depends on
the area compressibility modulus K of a bilayer (which typically
is on the order25 of K = 50 kBT/nm
2, where kB is the Boltzmann
constant and T is the absolute temperature) and can be
expressed as































where r ̅ = (R1 + R2)/2 is the mean radius of the cochleate tube.
Note that eq 5 assumes there is no lipid exchange between the
bilayers during the bending deformation. Indeed without lipid
exchange bending deformations would imply large stretching
and compression deformations, especially of the outer and
inner bilayers, of the cochleate. For example, a cochleate with
an outer radius twice the inner one (which is not an unusual
case; see Figure 7) the relative stretching of the outer bilayer
would be 33%, which would lead to membrane rupture.
However, a large degree of lipid exchange will substantially
reduce the degree of stretching. A reduction to about 0.3% of
the stretching/compression values without any lipid relaxation
is, in fact, what we ﬁnd below from the analysis of our
experimental data.
The presence of lipid exchange can approximately be
accounted for by replacing r ̅ with r ̅ + η(r − r)̅ in the integral
of eq 5, where η is a relaxation parameter. The relaxation
parameter adopts the value η = 0 if no lipid exchange takes
place and η = 1 for complete lipid exchange. In the latter case
lipids rearrange during the bending deformation such that all
area mismatch is removed, implying Fm = 0. If η is only slightly
smaller than 1, we can still use eq 5, yet with K replaced by the
eﬀective area compressibility modulus K̅ = K(1 − η). We will
use K̅ instead of K in the following and justify this choice a
posteriori. Adding Fm/L to the total free energy in eq 2 and
performing the minimization, again subject to ﬁxing l, yields
σ
κ κ
















Equation 6 has two unknown parameters: hσ/κ and K̅/κ. For
K̅ = 0 (or, equivalently, η = 1, where the bilayer stretching/
compression deformation is absent and thus does not incur an
energy penalty) the model reduces to that in eq 4. Note that eq
6 cannot conveniently be expressed explicitly as R1 = R1(R2).
Still, we can calculate R1 numerically and then ﬁnd the best ﬁt
of eq 6 to the data in Figure 7. The result is shown as the solid
line in each of the two diagrams of Figure 7. The ﬁt yields hσ/κ
= 0.0318/nm and K̅/κ = 0.00295/nm2 for DOPS, as well as hσ/
κ = 0.0691/nm and K̅/κ = 0.00299/nm2 for DSPS. We ﬁrst
point out that the model in eq 6 is able to reproduce the joint
growth of R1 and R2. The reason is that the energy penalty of
the stretching/compression deformation energy in eq 5 grows
quadratically with the ratio R2/R1 of the two radii. Hence, this
free energy contribution tends to keep the diﬀerence R2 − R1
small. For a cochleate with a large number of lipids (and thus a
large contour length l), it is favorable to form a larger tube
(with a larger inner diameter), despite the less favorable
membrane−membrane adhesion energy. More speciﬁcally, for a
suﬃciently large cochleate, the radii R2 and R1 become
independent of the bending stiﬀness κ, and the relative















Recall that the repeat distance h = 5.1 nm is known from our
SAXS experiments and is the same for both lipids. Hence, we
obtain an estimate for the ratio between the calcium-mediated
adhesion energy σ and the bending stiﬀness, κ, namely σ/κ =
0.0062/nm2 for DOPS and σ/κ = 0.0135/nm2 for DSPS.
Neither one of the individual material constants is known from
experiment. Generally, the order of magnitude for the bending
stiﬀness of lipid bilayers26,27 in their ﬂuid state is 10 kBT. We
only know of one single experimental determination of κ
involving phosphatidylserine. It was reported for a DOPS/
DOPE mixture residing in the inverse-hexagonal phase using X-
ray diﬀraction and applying osmotic stress,28 yielding κ = 11
kBT, largely independent of composition. However, cochleates
involve millimolar calcium concentrations at which the lipids
are condensed, with highly ordered alkyl tails and a loss of lipid-
associated water,29 and likely a signiﬁcantly larger bending
stiﬀness. Indeed κ can increase by an order of magnitude when
transitioning from the liquid to the gel state.30 Comparing
DOPS with DSPS, it is likely that for DSPS κ is equally large or
larger because its saturated lipid chains tend to be more
condensed. It is thus remarkable that DSPSa lipid with likely
not a smaller bending stiﬀness than DOPSforms cochleates
with a smaller tube diameter. Let us assume, as an order-of-
magnitude estimate, κ = 50 kBT for the membranes in both
cochleate types. This would give rise to σ = 0.31 kBT/nm
2 for
DOPS and σ = 0.67 kBT/nm
2 for DSPS, amounting to an
energy gain on the order of a few tenths of a kBT per lipid
associated with the calcium-mediated bilayer−bilayer adhesion.
The fact that calcium mediates a bridging interaction between
phosphatidylserine in apposed lipid bilayers was already
proposed long ago29 and is supported by recent molecular
dynamics simulations31 (using, however, phosphatidylcholine
instead of phosphatidylserine). The 2 times larger value of σ/κ
for DSPS as compared to DOPS likely reﬂects a stronger
calcium-mediated bilayer−bilayer interaction. What is the
reason for the diﬀerence, given that the headgroups of DOPS
and DSPS are of identical chemical structure? Recent work that
combines experimental investigations with atomistic computer
simulations provides insights into the interactions of calcium
with phosphatidylserine or mixed phosphatidylserine/phospha-
tidylcholine bilayers.32,33 Speciﬁcally, Boettcher et al.32 ﬁnd
calcium to order and rigidify the phosphatidylserine headgroup,
thereby favoring two major headgroup conformations and
exerting only a minor inﬂuence on the mobility of the acyl
chains. A dehydrating eﬀect of calcium as well as preferential
binding to the phosphate and carboxyl moieties of the
phosphatidylserine headgroup were identiﬁed by Martin-
Molina et al.33 Endothermic membrane binding of calcium is
also an indication for the liberation of water molecules34 and a
concomitant membrane dehydration. All this evidence supports
a calcium-induced ordering and dehydration of the phospha-
tidylserine headgroups in each bilayer. Spatially more ordered
headgroups in apposed bilayers facilitate calcium to mediate a
bridging interaction. Hence, we expect the calcium-mediated
bilayer−bilayer interaction to depend sensitively on how
hydrocarbon chain packing aﬀects the degree of headgroup
ordering. The more ordered DSPS chains can be expected to
Langmuir Article
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allow for a larger degree of headgroup order as compared to
DOPS, thus facilitating the bridging interaction and increasing
σ.
The estimate for the parameter K̅/κ = (1 − η)K/κ = 0.003/
nm2 from the ﬁt of eq 6 to the data in Figure 7 is the same for
both DOPS and DSPS. Although neither K nor κ is known,
their orders of magnitude are very roughly K = 50 kBT/nm
2 and
κ = 50 kBT, implying η = 1 − (κ/K)(0.003)/nm2 = 0.997. As
we had assumed (see the discussion after eq 5), η is very close
to 1. That is, our model prediction is consistent with a very
minor degree of area mismatch for the lamellae in the
cochleate. Yet, this small mismatch is still suﬃcient to cause
the inner cochleate radius R1 not to saturate as the model in eq
4 would predict. Varying degrees of η may also contribute to
the large size variations of cochleates, namely the occurrence of
a variety of outer radii R2 at ﬁxed R1.
We ﬁnally discuss a possible structural implication of having a
relaxation parameter η close to 1. Recall that η = 1 corresponds
to complete lipid relaxation, thus removing any stretching/
compression deformations upon bending a multilamellar sheet
from an initially planar state to a cylinder-like cochleate. In fact,
there is a simple structural mechanism that allows for complete
lipid relaxation: the multilamellar sheet may close after bending
such that sheet n connects with sheet n + 1, thus forming a
cochleate that consists of a single rolled-up bilayer. Because a
rolled-up cochleate consists of only one single bilayer, it can
more easily relax internal stress as compared to a multilamellar
cochleate, where the relaxation would require ﬁssion and fusion
or lipid transfer from one bilayer to another. Hence, our
estimate of η being very close to 1 suggests that the cochleates
consist predominantly of rolled-up bilayers and not of a
multilamellar sheet.
■ CONCLUSION
We have used electron microscopy to study the structure of
cochleates that consist of calcium as binding agent and
phosphatidylserines with either saturated or unsaturated
hydrocarbon chains. For both lipid types we demonstrate
cochleates to be tubules where a stack of cylindrically curved
bilayers encloses an inner aqueous channel. The inner and
outer radii of a cochleate vary statistically, yet with characteristic
diﬀerences for the two lipids. Speciﬁcally, the unsaturated lipid
tends to form cochleates with larger dimensions, and the
diameter of the inner tube does not saturate as the outer
diameter of the cochleate grows. To rationalize these ﬁndings,
we have proposed a theoretical model that is based on
minimizing a phenomenological free energy expression. Our
calculations suggest that membrane bending and calcium-
induced bilayer−bilayer adhesion alone are insuﬃcient to
reproduce the observed relation between inner and outer
cochleate tube radii. Yet, we can reproduce it by considering an
additional free energy contribution that accounts for an area
compression/expansion of the lipid bilayers within the
cochleate. Our modeling approach yields predictions for ratios
of material constants, namely the ratio between the area
compressibility and the bending modulus as well as the ratio
between the bilayer adhesion energy and the bending modulus.
Although our model contains approximations (such as the
neglect of the end-cap energy of the cochleate), it is likely that
it captures some of the underlying principles of cochleate
stability and thus may prove valuable for the design and
understanding of cochleates as drug delivery vehicles.
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ABSTRACT 27 
Cochleates have been of increasing interest in pharmaceutical research due to their extraordinary 28 
stability. However the existent techniques used in the synthesis of cochleates still need significant 29 
improvements to achieve monodispersed formulations. In this study, we report a simple method for 30 
the synthesis of spherical composites (3о5 ʅŵ ŝŶ ĚŝĂŵĞƚĞƌͿ made up of nanocochleates from 31 
phosphatidylserine and calcium. Products obtained from the proposed method were evaluated with 32 
electron microscopy and small angle X-ray scattering and compared with those obtained by the 33 
established cochleate preparation techniques. In this method, a lipid solution in an organic solvent, 34 
ethanol and aqueous solution of a binding agent is subjected to rapid and uniform mixing with a 35 
microfluidic device. The presence of high concentration of organic solvent promotes the formation of 36 
composites made of nanocochleates. This simple methodology eliminates elaborate preparation 37 
methods, while providing a monodisperse cochleate system with analogous quality. 38 
39 
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INTRODUCTION 40 
Cochleates are cylindrical particles featuring a rolled up carpet-like morphology made up of multiple 41 
stacked layers of negatively charged phospholipids bound by a positively charged binding agent such 42 
as calcium (Nagarsekar et al., 2014). Cochleates represent a potential delivery system with remarkable 43 
advantages being non-immunogenic, highly stable and with the ability to impart safety to 44 
incorporated active ingredients (Zarif, 2002). Cochleates have a hollow central channel and little or no 45 
internal aqueous space in the lipid sheets (Zarif, 2005, Nagarsekar et al., 2014). In past few decades 46 
cochleates are being explored for a number of possible applications thanks to their exceptional 47 
properties. The know-how of cochleates has been employed to improve delivery of drugs (Zarif et al., 48 
2000, Syed et al., 2008), genes (Zarif and Mannino, 2000), flavoring agents (Mannino and Gould-49 
Fogerite, 2002), and antigens (Gould-Fogerite and Mannino, 2000). Cochleates of various lipids such 50 
as phosphatidylserines, sphingolipids, and phosphatidylglycerols have been synthesized by groups 51 
around the world. Cochleates are also found to be structurally more divergent if compared to lipid 52 
tubules or nanotubes (Zarif, 2005, Kulkarni et al., 1999, Sarig et al., 2011, Kulkarni et al., 1996, Garidel 53 
et al., 2001). Cochleates are accepted to be well suited for intramuscular (Gould-Fogerite et al., 2000) 54 
and oral delivery (Delmas et al., 2002) however, being prone to aggregation they are not ideally 55 
suitable for intravenous or ocular administration (Wang et al., 2014). 56 
Different strategies have been developed for the preparation of cochleates. The conventional 57 
preparation strategies such as trapping method or dialysis method are known to form aggregated 58 
cochleates with variable and large particle sizes (Sankar and Reddy, 2010). This is mainly due to the 59 
uncontrolled and continuous aggregation between the bilayer sheets. During the last decade research 60 
was focused on synthesis strategies to form nanocochleates mainly by isolating or limiting the number 61 
of building blocks that come in close contact. The development of methods such as hydrogel isolation 62 
(Zarif et al., 2003) and emulsion-lyophilization (Wang et al., 2014) have opened up a new field of 63 
application based research for various biomolecules using cochleates with sizes in the sub-micrometer 64 
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range. However, these are multistep methods which commonly involve formation of colloidal 65 
structures such as liposomes or micelles as the first step, and subsequently form the cochleates 66 
(Huergo et al., 1997, Jin et al., 2001). These processes often involve complex and time consuming steps 67 
such as multiple emulsions, washing off polymers etc., which tend to be difficult to scale up and might 68 
also cause regulatory issues. Although these methods were successful in preparing sub-micron 69 
cochleates, they often form cochleates with a broad particle size distribution, a problem that has 70 
seldom received attention. These limitations can critically limit suitability of cochleates as drug 71 
delivery systems in the pharmaceutical market (Zayas et al., 2013). Hence, an economical method 72 
which could easily be translated into mass production needs to be developed for the formation of 73 
monodisperse cochleate systems. 74 
Cochleate formation follows a continuous self-assembly process which includes unrestrained 75 
nucleation and growth of particles (Kulkarni et al., 1999, Zarif, 2002), this makes it difficult to control 76 
either morphology or the dimensions of individual particles. In conventional cochleate formation, 77 
bilayers or micelles of an acidic phospholipid in presence of a cationic binding agent undergo an 78 
aggregation step to form planar bilayer stacks. These stacks further aggregate to form larger sheets 79 
which eventually undergo curling to form cochleates with a carpet roll like morphology (Poste et al., 80 
1976). Also the intermediate structures that could coexist with the cochleates make the purification 81 
of cochleate system a challenging task (reference: manuscript under review). Hence, the development 82 
of a formation strategy should mainly focus on limiting uncontrolled interactions after nucleation. 83 
Moreover, such a novel methodology for attaining monodispersity in case of natural lipids might also 84 
render a cost effective system. 85 
Recently we came across a very interesting solvent effect where phosphatidylserines (PS) formed 86 
much smaller stacks during precipitation from ethanol compared to precipitation in water. In this 87 
study we have utilized this solvent effect towards formulation development. We tried to exploit this 88 
finding with the aim of reducing random particle aggregation and thereby decreasing size dispersity 89 
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in cochleate systems. We have developed one-step, simple, reproducible and economic procedure 90 
where emulsification or polymers are not required prior to the formation of cochleates. In this case, 91 
we exploit precipitation by solvent displacement. Nanoprecipitation is an attractive choice as the 92 
process parameters such as rate of mixing or the concentration of reactants allow the control of size, 93 
shape, and encapsulation efficiency of the final product. In order to precisely control the mixing rate 94 
and mixing ratios we decided to employ a microfluidic reactor. A reactor with fast and reproducible 95 
mixing has proven to be an excellent tool for creating a monodisperse system of multiple particles 96 
with varied morphologies (Nie et al., 2006). Recently, the area of microfluidics has been explored for 97 
synthesis and scale-up of various nanoparticles, where a final product with small and uniform 98 
dimensions can be easily achieved by precision controlled fast mixing, dominated by diffusion or 99 
convection (Whitesides, 2006, Kastner et al., 2014, Belliveau et al., 2012). 100 
In this study, we report the formation of novel microparticles with spherical morphology made up of 101 
nano-sized cochleate subunits using a microfluidic device. Throughout this manuscript we have 102 
referred to these novel particles as ‘cochleate composites’. We have demonstrated that controlled 103 
mixing provided by the microfluidic device enabled us to fine-tune the cochleate composites. Products 104 
obtained from the proposed method have been characterized and compared with those obtained 105 
from conventional methodologies. Our method eliminates elaborate preparation procedures, while 106 
providing a unique monodispersed cochleate system with analogous qualities. 107 
108 
MATERIALS AND METHODS 109 
Materials 110 
1, 2-dioleoyl-sn-glycero-3-phsphatidylserine (DOPS) was purchased from Avanti Polar Lipids, Inc 111 
(Alabama, USA). Araldite® LY 564 used for embedding studies was obtained from HunTcan Advanced 112 
Materials GmbH (Switzerland). Absolute ethanol used to prepare lipid solutions was purchased from 113 
VWR International GmbH (Germany). All other chemical reagents were of analytic grade and were 114 
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used as received. Buffers used in the study were prepared using ultrapure water (Milli-Q® Direct-Q™ 115 
System, Merck-Millipore, Germany). 116 
117 
Preparation of cochleates 118 
To achieve spherical morphology with desired particle size and to obtain a stable dispersion of 119 
cochleate composites, the effect of different process variables was investigated during preparation. 120 
To optimize the organic phase, various organic solvents which could dissolve DOPS i.e. ethanol, 121 
methanol, chloroform, dichloromethane and DMSO were studied for preparation of cochleates. 122 
Ethanol was selected as organic phase based on preliminary screening for all further experiments. 123 
124 
Using microfluidics: 125 
Modified nanoprecipitation method was employed for preparation of cochleate composites. Ethanolic 126 
solution of DOPS was prepared with the aid of bath sonication. 60 mM CaCl2 solution in 10 mM Tris 127 
buffer was used as source of binding cations. Formulations were prepared using a benchtop 128 
NanoAssemblr™ instrument (Precision NanoSystems Inc., Canada) employing Poly (dimethyl siloxane) 129 
micromixer chips (Precision NanoSystems Inc., Canada). The micromixer chips had molded channels 130 
which were 200 ʅŵŝŶǁŝĚƚŚĂŶĚϳϵ ʅŵŝŶŚĞŝŐŚƚĂŶĚa series of herringbone features of 50 × 31 ʅŵ 131 
(Kastner et al., 2014). Disposable 1 mL syringes (B-D Disposable Syringes, Luer-Lock Tips) attached at 132 
the two inlet streams to the chip served as the reservoir of reactor solutions viz. organic lipid solution 133 
and aqueous CaCl2 solution. The syringe pumps allowed for a precise contro  of the flow rates and the 134 
solvent phase ratios between the two inlet streams. The resulting suspensions were collected from 135 
the outlet stream. To understand the effect of mixing rate on morphology of the particles, the ratio of 136 
the aqueous phase : organic phase was varied from 1:1 to 1:9 (with constant flow rate of 12 ml/min). 137 
In a different set of experiments the flow rate was varied from 1 ml/min to 18 ml/min (with constant 138 
flow rate ratio of 1:9). Concentration of lipid was kept constant at 1 mg/ml for both experiments. 139 
Further, to understand the effect of lipid concentration, the amount of DOPS was varied from 0.1 140 
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mg/mL to 1mg/mL keeping the ratio of aqueous phase : organic phase (1:9) and flow rate (12 mL/min) 141 
constant. All samples were prepared in triplicate and the effect of changing parameters on the 142 
morphology of formulation was assessed using electron microscopy (EM). 143 
144 
Modified trapping method: 145 
To understand the influence of microfluidic device on the morphology, cochleate composites were 146 
also prepared using T-25 Ultra-Turrax® homogenizer maintaining the 1:9 CaCl2(aqueous) : DOPS(ethanolic) 147 
ratio. Cochleate composites ǁĞƌĞ ĨŽƌŵĞĚ ďǇ ƐůŽǁ ;ϭϬ ʅů Ăƚ Ă ƚŝŵĞͿ ĂĚĚŝƚŝŽŶ ŽĨ aqueous calcium 148 
chloride (60 mM in 10 mM Tris) to an ethanolic DOPS solution under constant stirring. Addition of 149 
calcium chloride solution was carried out at a constant 13500 rpm with T-25 Ultra-Turrax® 150 
homogenizer (IKA, Germany) stirring was continued for another five minutes after complete addition 151 
of calcium chloride. Mixture was then stirred continuously up to 1 hour using a magnetic stirrer (RCT 152 
Basic-Ika, Staufen, Germany). The molar ratio of lipid to calcium was 1:1. At the end of 1 hours 153 
precipitated mixtures were collected and stored at 4 °C. All samples were prepared in triplicate and 154 
evaluated by EM. 155 
156 
Preparation of cochleates by conventional methods: 157 
Conventional cochleates were prepared in order to evaluate the difference in SAXS patterns and size 158 
distribution with respect to cochleate composites. For the preparation of conventional cochleates, 159 
DOPS liposomes were prepared by thin-lipid film hydration method. In brief, DOPS was dissolved in a 160 
mixture of chloroform : methanol (3:1) in a round bottom flask and was subjected to a rotary 161 
evaporator (R-144 BÜCHI Labortechnik GmbH, Germany) to form a thin lipid film. The lipid film was 162 
hydrated with 10 mM Tris buffer and the resultant dispersion was subjected to extrusion through a 163 
polycarbonate membrane of 100 nm pore size to produce uniform dispersion of liposomes. Cochleates 164 
ǁĞƌĞĨŽƌŵĞĚďǇƐůŽǁ;ϭϬʅůĂƚĂƚŝŵĞͿĂĚĚŝƚŝŽŶŽĨĐĂůĐŝƵŵĐŚůŽƌŝĚĞ;60 mM) to the liposomes under 165 
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constant stirring using a magnetic stirrer at room temperature. The molar ratio of lipid to calcium was 166 
1:1. Precipitated mixtures were then stored at 4°C. All samples were prepared in triplicate. 167 
168 
Preparation of nano cochleates by hydrogel isolation method: 169 
Nano cochleates were prepared by hydrogel isolation method as described previously by Jin et al. 170 
(2001). DOPS liposomes were formed as described above in section 2.2.3. The liposome suspension 171 
was further dispersed in 40 %w/w dextran 500,000 solution in ratio of 1:2 v/v. This mixture was then 172 
slowly added to 15 %w/w PEG 8,000 solution with a syringe under magnetic stirring (1100 rpm). To 173 
this dispersion an aqueous CaCl2 solution (60 mM) was added to reach the equimolar ratio of lipid and 174 
calcium. After 2 hours of stirring, the resultant mixture was washed thrice by mixing with equal volume 175 
of buffer (1 mM CaCl2 and 150 mM NaCl) and centrifuged at 3000 rpm for 30 min. The resultant pellet 176 
was resuspended ǁŝƚŚďƵĨĨĞƌĂŶĚƐƚŽƌĞĚĂƚϰȗ͘ All samples were prepared in triplicate. 177 
178 
Characterization of formulations 179 
Scanning electron microscopy: 180 
A droplet of the sample was adhered on a perforated Formvar -coated copper grid (300 mesh, 181 
Quantifoil Micro Tools GmbH, Germany). Excess liquid was removed with a lint-free filter paper and 182 
examined in a LEO 1530 Gemini (Carl Zeiss, Germany) scanning electron microscope (SEM) at 4 kV 183 
acceleration voltage. Images of randomly selected 110 particles of optimized formulation prepared 184 
using NanoAssemblr™ were measured using Image J to estimate the average size (Rasband, 1997-185 
2014). The coefficient of variance or CV (%) corresponding to the particle size distribution was 186 
calculated as described by Perez et al. (2015) using formula CV (%)= (ʍ/ D)×100 where ʍis the standard 187 
deviation (SD) of the particle size and D is their mean diameter. 188 
189 
190 
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Cryo-transmission electron microscopy: 191 
A drop of formulation (2 μl) was placed on a carbon-coated copper grid (Quantifoil Micro Tools GmbH, 192 
'ĞƌŵĂŶǇͿ͘dŚĞƐĂŵƉůĞǁĂƐƐƵďũĞĐƚĞĚƚŽƉůƵŶŐĞĨƌĞĞǌŝŶŐŝŶůŝƋƵŝĚĞƚŚĂŶĞĂƚоϭϴϬΣC. The grids were 193 
ƚŚĞŶƚƌĂŶƐĨĞƌƌĞĚŝŶƚŽĂůŝƋƵŝĚŶŝƚƌŽŐĞŶĐŽŽůĞĚ;dсоϭϵϲΣͿцϳϬΣƚŝůƚĐƌǇŽ-holder (Gatan Inc., USA) and 194 
inserted into the cryoelectron microscope Philips CM 120 cryo-TEM (Philips, Netherlands). Images 195 
were captured using a TEM operating at 120 kV. 196 
197 
Investigation of cross section of resin-embedded cochleate composites: 198 
Embedding was carried out using the procedure described previously by Nagarsekar et al.(2014). 199 
Briefly, sample was redispersed in 100 mM cacodylate buffer (pH 7.2) containing 1% OsO4 for 2 h. 200 
Sample was centrifuged again and rinsed in buffer before dehydration in ethanol (50% v/v) for 15 min. 201 
It was further subjected to 1% uranyl acetate solution for 1 h to improve contrast. The pellet was then 202 
redispersed in an epoxy resin Araldite® used as an embedding medium. The mixture was polymerized 203 
and ultramicrotomed in ƚŽƚŚŝŶ;ϳϬоϭϬϬŶŵͿƐůŝĐĞƐƵsing a diamond knife mounted on an Ultracut E 204 
device (Reichert Labtec, Germany) at room temperature. The slices were transferred to copper grids 205 
(Quantifoil, Germany) and examined by cryo-TEM. 206 
207 
Small angle X-ray scattering: 208 
Small angle X-ray scattering (SAXS) measurements were performed Ăƚ ʄсϭ͘ϱϰ Å using a Bruker 209 
Nanostar (Bruker, Germany) equipped with a μ-focus X-ray source (IμS, Incoatec, Germany), equipped 210 
with a 2D position sensitive detector Vantec 2000 (Bruker GmbH, Germany). Sample-to-detector 211 
distance was maintained at 107 cm. Samples were mounted on a metal rack and fixed using tape. All 212 
measurements were carried out at room temperature and duration of measurement was 2 hours. 213 
Prior to evaluations the scattering patterns were corrected for the background (Scotch tape) and 214 
radially integrated to obtain the scattering intensity (using q= (ϰʋͬʄͿƐŝŶ ɽ͕ǁhere Ϯɽ=scattering angle 215 
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ĂŶĚʄ= X-ray wavelength). All samples were centrifuged, washed and freeze dried before evaluation 216 
and measurements were undertaken in triplicates. 217 
218 
RESULTS AND DISCUSSION: 219 
The cochleate formation is a result of an instantaneous self-assembly induced by aggregation of 220 
negatively charged lipid molecules interacting with a cationic binding agent such as calcium. So far 221 
water and aqueous buffers have been widely reported for the preparation of cochleates. In our 222 
preliminary studies, different solvent systems were compared for precipitation of cochleates to 223 
investigate lipid-calcium interactions. We could show that spherical cochleate-composites were only 224 
formed in aqueous-ethanolic mixtures (aqueous calcium chloride, ethanolic DOPS solutions). When 225 
ethanolic DOPS was precipitated with ethanolic calcium in water-free environment, SEM analysis 226 
revealed that the lipid precipitates formed did not exhibit any cochleates but showed aggregates of 227 
lipid sheets or stacks (Fig. 1f). When ethanol was replaced with non-polar solvents such as chloroform, 228 
dichloromethane and DMSO for dissolving DOPS, no cochleates or precipitates were formed. This 229 
might be due to the high solubility of the lipid in these solvents and, therefore, ethanol was selected 230 
as organic phase in our current study. 231 
232 
Preparation of cochleate composites using microfluidic device: 233 
Microfluidic techniques provide a precise control over mixing of reactants and can be employed for 234 
reproducible mixing. The following studies were carried out with the aim to optimize parameters with 235 
respect to their effect on morphology and size of cochleate composites. Influence of solvent ratio, 236 
flow rate and lipid concentration on final product was assessed with electron microscopy. The 237 
conditions which allow most uniform formulation were identified based on the data obtained from 238 
these experiments. 239 
240 
241 
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Influence of ratio of aqueous phase to organic phase: 242 
In nanoprecipitation, solvent concentration is an important parameter. This experiment was carried 243 
out in order to understand the influence of ratio of ethanol and water on the resulting morphologies 244 
of the cochleate composites. For the precipitation experiment, calcium chloride was dissolved in 10 245 
mM Tris buffer and DOPS was dissolved in ethanol. Care was taken to maintain a constant molar ratio 246 
of calcium chloride : DOPS (1:1) for all experiments despite the changing flow ratios. Mixing was 247 
carried out at flow rate of 12 ml/min. We prepared cochleate composites to achieve aqueous: 248 
ethanolic phase ratios from 1:1, 1:2, 1:3, 1:5 and 1:9. In complete absence of ethanol, conventional 249 
long cylindrical cochleates were obtained in preliminary studies. This observation did not change 250 
significantly when high ratio of CaCl2(aqueous) : DOPS(ethanolic) (3:1) was used (data not shown). However, 251 
when the ethanol fraction was increased beyond 75%, the morphology of the resulting particles 252 
changed from large cochleate aggregates to spherical nanocochleate composites, as shown in Fig. 1. 253 
At the ratio of 1:1 (Fig. 1a) large aggregated cylindrical cochleates were formed and their aggregation 254 
lacked structure. These samples also showed presence of unrolled sheets. Increasing the amount of 255 
ethanol (flow ratio 1:2) led to a big change in the morphology of aggregates. Agglomerates 256 
approximately 6-12 μm in diameter consisting of large cochleates were formed as seen in Fig. 1b. At 257 
both ratios cochleates formed were in micron range. Flow ratio of 1:3 produced particles containing 258 
nanocochleates (Fig. 1c) which were roughly spherical and showed high tendency of aggregation. 259 
Aggregates were usually made of at least 2-5 loosely packed cochleate-composites. It’s important to 260 
note that at this ratio microspheres clearly showed presence of nanocochleates which seemed to 261 
indicate that increased ethanol content was important for the formation of cochleates with smaller 262 
dimensions. Further increase in amount of ethanol (ratio 1:5) resulted in particles (Fig. 1d) which were 263 
more spherical and uniform than before (approx. 3-6 μm diameter). These cochleate composites also 264 
showed the tendency to aggregate and individual cochleate composites were made up of aggregated 265 
nanocochleates. The ratio with minimum amount of water i.e. 1:9 produced cochleate composites 266 
(Fig. 1e) which were spherical and were made up of densely packed nanocochleates. When the 267 
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precipitation was carried out in pure ethanol, ethanolic DOPS and ethanolic CaCl2, the formation of 268 
stacks was observed (Fig. 1f). However, these stacks did not form any cochleates even when the 269 
samples were observed after 8 months of storage. From these results we suspect that the presence 270 
of small amount of water is crucial for curling of bilayers into nanocochleate cylinders, however 271 
further investigation is necessary to understand the exact underlying mechanism. 272 
273 
Influence of flow rate: 274 
It is well known that size and morphology can be varied easily by changing the rate of mixing in a 275 
microfluidic reactor. To evaluate this effect, we varied the flow rate from 1 ml/min to 18 ml/min 276 
keeping a constant flow ratio for CaCl2(aqueous phase) : DOPS(ethanolic phase) at 1:9. Resulting lipid aggregates 277 
were analyzed using electron microscopy. Fig. 2 shows the influence of flow rate on the morphology 278 
of resulting cochleate composites. In general, we found that lower flow rates formed particles arrested 279 
and aggregated at intermediate stages of formation of cochleate composites. High flow rates due to 280 
faster mixing formed spherical cochleate composites. At the slowest flow rate of 1 ml/min long 281 
cylindrical cochleates were formed along with dense lipid precipitates as shown by arrows in Fig. 2a. 282 
These precipitates may be non-bilayer structures formed as a result of interfacial deposition of lipid 283 
due to displacement of ethanol. This result was an indication that not only high ethanol contents but 284 
also high mixing rates are a prerequisite for the formation of nano-sized cochleates. When the flow 285 
rate was increased to 3 ml/min, aggregates of 3-10 roughly spherical particles were observed (Fig. 2b). 286 
Particles seemed to exhibit a higher aggregation tendency and large conventional cochleates were 287 
also rarely observed. For samples prepared at 6 ml/min, dense isolated spherical particles with large 288 
diameter were observed (Fig. 2c). The surface of these particles appeared much denser compared to 289 
the cochleate composites. The dense nature of the particles was not completely clear and further 290 
evaluation is required, but it was observed repeatedly for this flow rate. It appeared as if the growth 291 
of particles was initiated before nucleation was completed. Which may result in competition between 292 
growth of new nuclei and grown particles and causes high polydispersity. Flow rate of 12 and 18 293 
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ml/min gave rise to much more spherical and regular particles (Fig. 2d and 2e respectively) as 294 
compared to those prepared at lower flow rates. Cochleate composites prepared at high flow rates 295 
were made up of aggregated nanocochleates and stacks. At 18 ml/min particles seemed to vary in size 296 
much more than that at 12 ml/min. Fig. 2e shows two particles, a completely formed particle (dark 297 
arrow) and an incompletely formed particle (white arrow) which was often observed at flow rate of 298 
18 ml/min. This morphological evolution was probably due to the high flow rate which does not give 299 
enough time for aggregates to form spherical structures. Hence the flowrate of 12mL/min was chosen 300 
as most appropriate for further experiments. 301 
302 3 
304 
Influence of Lipid Concentration: 305 
Fig. 3 shows SEM images of cochleate composites at different lipid concentrations. We tested lipid 306 
concentrations ranging from 1 mg/ml to 0.1 mg/ml while maintaining a flow rate of 12 ml/min and 307 
flow ratio of CaCl2(aqueous phase) : DOPS(ethanolic phase) at 1:9. All lipid concentrations produced spherical 308 
cochleate composites made of nanocochleates. The morphology of the composites became more 309 
regular and uniform in size with decreasing lipid concentration. For high lipid concentrations of 1 and 310 
0.75 mg/ml, spherical cochleate composites were observed aggregated along with many small 311 
inconsistent non-spherical cochleate composites (shown by arrows in Fig. 3a). Such morphology was 312 
probably a result of very high nucleation and incomplete growth. Reducing the lipid concentration 313 
further resulted in much more uniform and spheroid particles and had almost no signs of attached 314 
aggregates (Fig. 3b). For smallest lipid concentration of 0.1 mg/mL the cochleate composites were 315 
extremely regular (Fig. 3c). Hence it was chosen as ‘optimized formulation’ for further experiments. 316 
In samples with high lipid concentrations, cochleate composites were made of a large number of 317 
number of lipid stacks along with few nanocochleates. In our opinion, lipid stacks may be the primary 318 
structures formed from nucleates when lipid solution encounters the binding agent. High lipid 319 
concentrations probably gives rise to a large number of nucleates with small inter-particulate 320 
distances. This high density of nucleates might cause aggregation before ‘stacks to cochleate’ 321 
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transformation is complete. Therefore the cochleate formation or curling of the stacks in these 322 
particles seemed to be arrested at intermediate stages. For low lipid concentrations, cochleate 323 
composites showed nanocochleates and highly curled stacks. This was probably because aggregation 324 
was relatively gentle and allowed time for the stacks to evolve in to nanocochleates. 325 
326 
327 
Morphological evaluation and size distribution of cochleate composites:328 
Optimized formulation of cochleate composites was further evaluated using SEM, cryo TEM and resin 329 
embedding technique to understand the morphology of the aggregated subunits. Fig. 4a shows a high 330 
magnification SEM micrograph of a cochleate composite showing many nanocochleates (white 331 
arrows) along with few curled stacks (dark arrows). Cochleates have a tube like appearance and can 332 
easily be identified by the hollow central channel. All of the aggregated nanocochleates and curled 333 
stacks had sub-micron dimensions. Fig. 4b shows a cryo-TEM image of cochleate composite at higher 334 
magnification where nanocochleates and curled stacks (dark arrow) can be clearly seen. 335 
Nanocochleates had approximate diameter of 100 - 200 nm and were made up of 8-20 lipid bilayers. 336 
Cross sections of cochleate composites obtained from the embedding study are as shown in Fig. 4c. 337 
The cross sections confirmed that cochleate composites were mainly made up of hollow 338 
nanocochleates which were aggregated to yield a spherical composite. Based on our EM studies, 339 
cochleate composites were mainly made up of (1) nanocochleates with hollow central channel 340 
(approx. length 400-600 nm) (2) curled bilayer stacks and (3) voids inside the cochleate composites 341 
(few hundred nanometers). To investigate whether the microfluidic device had any influence on the 342 
intrinsic structure of the nanocochleates, we also prepared cochleate composites using the ‘modified 343 
trapping method’ as explained in the method section 2.2.2. EM studies of these samples reveled 344 
formation of cochleate composites having irregular non-spherical shape (data not shown) which 345 
confirmed our anticipation that efficient mixing achieved in the NanoAssemblr™ was responsible for 346 
the spherical shape and uniformity of the cochleate composites. 347 
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The size distributions of cochleates obtained from trapping method and hydrogel isolation method 348 
were compared with cochleate composites. The representative SEM images corresponding to 349 
nanocochleates prepared by hydrogel isolation method and conventional trapping method are shown 350 
in Fig. 5. The particle size distribution histograms of cochleates prepared by all three techniques are 351 
shown in Fig. 6. The average diameter of optimized cochleate composites was about 4.4 ± 0.3 ʅŵwith 352 
CV (%) of 7.1. Compared to cochleates prepared by other methods, cochleate composites displayed a 353 
very narrow size distribution. The mean particle size obtained from both trapping method and 354 
hydrogel isolation method was 5.7 цϯ͘ϬϲʅŵĂŶĚϭ͘ϭцϬ͘ϳϵʅŵ respectively. Their size distribution 355 
histograms indicated a skewed size distribution profile (Fig. 6a and 6b). The total range of particle size 356 
found for cochleates prepared by the trapping method ranged from 1.2 to 16.5 ʅŵ ĂŶĚ for 357 
nanocochleates, from 0.1 to 6.6 ʅŵ. The CV (%) for cochleates prepared by trapping method was 53.3 358 
and for nanocochleates it was ͸ͻǤͻ, representing highly polydispersed samples. Considering CV (%) 359 
values, the samples of cochleate composites were quite monodispersed when compared to the 360 
conventional cochleates and nanocochleates. Hence the rate and homogeneity of mixing achieved 361 
using microfluidic technique has a marked effect on the particle size of final cochleate formulation. 362 
Similarly presence and amount of ethanol has a profound effect on the particle size distributions 363 
obtained by reducing the probability of aggregation. 364 
365 
Small angle X-ray scattering: 366 
To understand differences in the lamellar order between conventional cochleates prepared by 367 
trapping method, hydrogel isolation method and cochleate composites presented in this study, SAXS 368 
experiments were carried out. The SAXS patterns of both cochleate composites, prepared using 369 
NanoAssemblr™ and ‘modified trapping method’ showed exactly the same pattern as conventional 370 
DOPS cochleates and nanocochleates (Fig. 7). Diffractograms of cochleate composites, 371 
nanocochleates and conventional cochleates yielded interlamellar repeat distance of 5.1 nm with 372 
sharp reflexes at Ϯצ values ŽĨϭ͘ϳȗĂŶĚϯ͘ϰȗ. The SAXS data obtained for cochleate composites agrees 373 
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well with electron microscopy results and confirm that cochleate composites are in fact aggregates of 374 
nanocochleates with high regularity. 375 
376 
Formation mechanism of cochleate composites: 377 
Probable formation mechanism for the cochleate composites consists two steps, 1) nucleation, where 378 
phosphatidylserine molecules bind calcium and grow longitudinally to form small lipid stacks which 379 
can eventually roll into nanocochleates and 2) aggregation, where high mixing rates within the 380 
microfluidic device gives rise to spherical cochleate composite formed by aggregation of 381 
nanocochleates. From our observation, the nucleation process was heavily influenced by ethanol 382 
concentration. Literature suggests that phospholipid bilayers can coexist in ethanol concentrations up 383 
to 45 – 50 % (Touitou et al., 2000) and from our experiments it could be seen that when reaction 384 
mixture had 50 % ethanol (solvent ratio 1:1) with 50 % aqueous calcium chloride, conventional long-385 
cylindrical cochleates were formed. Only when ethanol concentration was raised above 75 % 386 
nanocochleates were formed. Ethanol forms hydrogen bonds with phosphate in the phospholipid 387 
head groups and when present in high concentrations can increase alkyl chain disorder and can lead 388 
to decrease in the bending energy in phospholipid bilayers (Patra et al., 2006, Feller et al., 2002, 389 
Chanturiya et al., 1999). When cochleates are prepared in aqueous environment, stack formation is 390 
caused by interaction between calcium and phosphatidylserine bilayers. This has a dehydrating effect 391 
on the bilayers which results in highly condensed alkyl chains with high degree of order and interior 392 
which is characterized by almost complete lack of water (Nagarsekar et al., 2014, Martin-Molina et al., 393 
2012). The resulting stacks would aggregate rapidly due to their hydrophobic surfaces leading to larger 394 
planner sheets. These sheets further undergo curling to reduce their surface area to form cochleate 395 
cylinders. However in ethanol rich environment, hydrophobic surfaces of stacks would be stabilized 396 
by ethanol, resulting in smaller stacks. Stabilization coupled with lower bending energy could explain 397 
the nanoscale dimensions of the cochleates found within the spherical cochleate composites. 398 
Resulting nanocochleates and stacks further undergo aggregation to form cochleate composites. 399 
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Morphology of the composites was dictated by the mixing stage. This is a vital step and should be as 400 
uniform and as fast as possible since any fluctuations in mixing can result in asymmetrical particles 401 
with varying sizes. Poor mixing can also result in overlapping of nucleation and growth steps causing 402 
formation of heterogeneous system. Ideal mixing conditions were difficult to reach by using 403 
conventional mixing devices as we found out when we tried to replicate the composites using a 404 
homogenizer. Where as in case of micro mixer of microfluidic device the mixing time is very small (in 405 
milliseconds) which results in better control over process parameters and reproducibility (Kastner et 406 
al., 2014). 407 
408 
CONCLUSION: 409 
Polydispersity has always been the ‘Achilles heel’ of a cochleate system. In this study we report on 410 
new monodisperse microparticulate system of nanocochleates. This method was developed to 411 
fabricate cochleate composites with a simple microfluidic setup, which could easily be programmed 412 
to transform for large scale production. We also propose strong influence of solvent conditions over 413 
formation of the cochleate structures. The morphology of the microspheres prepared using 414 
microfluidic device was strongly affected by flow rate and lipid concentration. Microfluidics could be 415 
used further to tailor particle diameter of the formulation. Cochleate composites being made of 416 
nanocochleates retain the basic advantages of cochleates. Hence the formulation of cochleate 417 
composites may emerge with potential uses for pharmaceutical applications. We believe that our 418 
study represents an important step forward to perceive processes governing the formation of 419 
monodispersed cochleate drug delivery systems. Future outlook for our work would involve drug 420 
loading and release experiments and to study the morphology when these composites are 421 
manufactured from different cochleate forming lipids. 422 
423 
424 
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4 Discussion  
4.1 General discussion: 
It is apparent that recent developments in preparation methods, characterization and evaluation 
have allowed considerable improvements of cochleate formulations for drug delivery. However, in 
order to reach the market there is still need to carry out further research. We believe that the detailed 
knowledge of cochleates may contribute to tailor them for optimal use in vivo and reflect on the 
challenges that lie in this way. Therefore, in this dissertation cochleates were evaluated for their 
structure and formation using different microscopy techniques. Apart from this, the challenge of 
polydispersity of cochleate formulations has also been addressed by successfully combining the 
knowledge of solvent effect with the concept of controlled mixing using microfluidics to prepare a 
monodispersed system. In this section, we intend to discuss the details regarding the pathway of 
cochleate formation, effect of the building block on structural features of cochleates, feasibility of 
our new method for formulation of cochleates and potential applications of these new developments. 
4.1.1 Investigation on formation of cochleates: 
The mechanism of cochleate formation from PS has been speculated in brief by Papahadjopoulos et 
al. (1975). Their theory was based on results from freeze fracture-TEM and explains that on the 
addition of high affinity cations to negatively charged lipids, a formation of array of structures takes 
place. Presumably, bilayer fusion is believed to advance though several semi-stable intermediate 
structures such as discs, sheets which finally are converted into cochleates. Some investigations on 
intermediates arising during cochleate formation have been reported previously. Kachar et al. 
reported that pure PS vesicles may undergo fusion or violent rupture on interaction with calcium ions 
(Kachar et al., 1986). In 1981 Miller et al. showed the presence of flattened structures in microscopy 
within 10 ms after addition of cations to PS. Most of these studies involved bovine brain extract PS 
rather than pure PS which have not been studied in detail. Our major objective in (Manuscript 1) was 
to provide a sequence of the morphological changes that bilayers of PS with different saturation and 
carbon chain length undergo after interaction with calcium using experimental evidence. A number 
of variations on this interaction scheme have been exercised such as video-enhanced microscopy 
(Kachar et al., 1986), rapid mixing (Rand et al., 1985) and using a freezing device (Miller and Dahl, 
1982) etc. However in this study we have focused on the influence of the process temperature. When 
the process temperature is above the transition temperature of the phospholipid the intermediate 
steps occur at tremendous speed i.e. within milliseconds and an appearance of intermediate 
structures seems to be synchronous. To deal with this issue we hypothesized that decreasing the 
process temperature below or around transition temperature (Tm) of lipid might decrease the speed 
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of reaction allowing us a measurable window of time to have a look at different intermediate stages 
taking place. As noted in (Manuscript 1) we evaluated cochleate samples of different 
phosphatidylserines using various electron microscopy techniques. Our interpretation for the 
sequence of events during cochleate formation is based on the comparison between observed 
morphology in these samples. The experimental data from (Manuscript 1) shows that different 
chosen phosphatidylserines exhibited similar morphologies during cochleate formation. Our results 
agree with previously reported early morphological changes where immediately after addition of 
calcium, primary structures like liposomes, micelles undergo mutual adhesion and fusion (Kachar et 
al., 1986). The intermediate multilamellar structures with dense packing were often observed after 
aggregation. The flat areas of contact resulting due to aggregation indicated that interaction may be 
sufficiently strong to deform primary structures indicating high values of adhesion energy. Such 
deformation may further result in bilayer rupture due to increased tension (Evans and Kwok, 1982; 
Evans and Parsegian, 1983). Our observations of cryo TEM showed that these aggregated structures 
further give rise to secondary bilayer fragments (which we named ribbons). We interpret that these 
structures result due to bilayer destabilization in intermediate multilamellar aggregates. This loss of 
stability might evolve from fusion particularly between the outer monolayers of aggregated bilayer 
structures. It was demonstrated that the repeat distance of such ribbon like structures by SAXS 
appeared to be much different as compared to both cochleates and primary structures like liposomes 
or micelles. This may result due to presence of calcium in these bilayers and was considered as an 
indication for intermediate structure.  
 
Figure 4.1: Diagrammatic representation of cochleate formation depicting sequence of intermediate 
structures during the process. 
Our studies suggested that formation of cochleates directly from ribbons seems to be a demanding 
affair. This interpretation is based on the observation that no cochleate formation was observed in 
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DPPS and DSPS ribbon samples over long incubation times. This renders to possibility that formation 
of tertiary structures from ribbons requires energy. Our results show that ribbons further undergo 
aggregation to form an array of tertiary structures most characteristic of which are stacks. These 
structures had been previously also identified by Garidel et al. (2001) as bands in samples of DMPG 
cochleates. Stacks are multilamellar and generally have elongated trapezoidal shape (as depicted in 
Figure 4 of manuscript 1). Our results highlighted that stack formation may be essential in order to 
form cochleates. It was observed that stacks can also undergo fusion to form broad sheets or 
networks. Our SAXS experiments indicated that the tertiary structures do not reveal the same results 
for repeat distance as cochleates. Complete absence of tertiary structures was seldom observed in 
samples of cochleates prepared from PS. We interpret that these complex architectures composed 
of fused lipid networks, sheets and cochleates may be the final result of thermodynamic equilibrium 
during formation process. Such tertiary structures appear to be stable and may coexist with 
cochleates. The tertiary structures i.e. stacks or sheets further roll upon to form cochleates. Figure 
4.1 displays diagrammatic representation of cochleate formation based on results from (Manuscript 
1). We presume that the rate of conversion of tertiary structures to cochleates is an important 
parameter which would influence polydispersity of the final cochleate formulation. This could be of 
interest from a pharmaceutical point of view considering the fact that for optimization of 
formulations, presence of intermediates can be an important issue as it can significantly influence 
physicochemical properties, drug loading, release properties etc.  
Taken together (Manuscript 1) ascertained that cochleate formation is through evolution of well-
defined hierarchical morphologies like ribbons, stacks, networks, sheets that leads to a stable 
cochleate structure. The most important conclusions from these studies are qualitative. Although 
cochleate formation may have more than one secondary pathway due to uncontrolled interactions, 
summary of our study in (Manuscript 1) provides enough support to speculate a fundamental order 
of probable intermediates arising during cochleate formation.  
4.1.2 Structural features of cochleates: 
Based on our microscopy results in (Manuscript 1 and 2), the first point worth discussing about 
structure of cochleates is its central channel. As per Papahadjopoulos et al. cochleates are cigar like 
structures with folded morphology (1975) whereas Garidel et al. (2001) and Kodama et al. (1999) 
have mentioned the possibility of luminal opening in DMPG cochleates. All these arguments are 
based on freeze fracture TEM or TEM techniques, and need further research to support this 
observation completely. Hence to evaluate this issue the systematic observation of the internal 
structure of cochleates was carried out using 3D reconstruction from cryo electron tomography. 
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Figure 3 in (Manuscript 2) clearly depicts the presence of a continuous central channel that opens at 
both terminus of the cylindrical cochleate structure confirming the hypothesis of Garidel et al. (2001). 
Our observations suggested that unlike real cigars, cochleates do not possess a dense core. This 
observation was supported by other microscopy techniques such as SEM, TEM and evaluation of cross 
sections of resin embedded cochleates. Amongst all the evaluated cochleate particles, we very rarely 
came across some with absence of central channel as mentioned in (Manuscript 2 Figure 4e). 
Investigation of cross section of resin-embedded Cochleates in (Manuscript 2 Figure 4) indicated that 
the majority of particles exhibited multilamellar scrolls folding into a compact, rolled-up structure as 
previously described by Papahadjopoulos et al. (1975). This study also confirmed the presence of 
central channel in cochleates. Based on these observations we deduced that cochleates have carpet 
roll like morphology and not cigar like structure. This structural feature might have a strong influence 
on physicochemical aspects of the drug delivery system. The parameters like mechanical stability, 
drug release pattern, area for surface chemistry modification or drug loading may change 
considerably depending upon presence or absence of the central cavity in the cochleate particle. 
Hence, one can anticipate that this knowledge can be casted to render an efficient drug carrier. 
Evaluation of the effect of variation in acyl chains of phosphatidylserines on the structural features 
of cochleates was not carried out previously. We have used different phosphatidylserines to form 
cochleates in order to evaluate the effect of acyl chain length and saturation on structural features. 
In (Manuscript 1 and 2) we have analyzed electron micrographs with the help of the software Image 
J for determining dimensions of cochleates. We have specifically measured the width and length for 
a large ensemble of cochleate tubes. These measurements show apparent and statistically significant 
difference in dimensions with respect to the lipids used for preparation. Our microscopy studies 
showed that the width of inner channel of cochleates increased with presence of unsaturation. 
Changes in carbon chain length of lipids also resulted in change in dimensions of cochleates. Based 
on these results we suggest that the dimensions of cochleates are highly dependent upon their 
building blocks.  
Considering the findings of electron microscopy studies, a theoretical model that was based on 
minimizing a phenomenological free energy expression was proposed. The calculations suggested 
that membrane bending and calcium induced bilayer−bilayer adhesion alone were insufficient to 
reproduce the observed relation between inner and outer cochleate tube radii. Yet, it could be 
reproduced by considering an additional free energy contribution that accounts for an area 
compression/expansion of the lipid bilayers within the cochleate. This modeling approach offers 
predictions for ratios of material constants, namely the ratio between the area compressibility and 
the bending modulus as well as the ratio between the bilayer adhesion energy and the bending 
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modulus. We believe that despite all approximations the theoretical model may succeed to capture 
some of the underlying principles of cochleate stability and may prove valuable for understanding of 
cochleates.  
4.1.3 Effect of ethanol on formation of cochleates: 
Since the preparation of cochleates by hydrogel-isolation method (Zarif et al., 2003), interest in their 
use for biomedical applications has been growing exponentially. In previously used preparation 
methods conventional techniques were used, for obtaining reaction conditions aimed at interaction 
of minimum number of bilayers with cations (Wang et al., 2014; Zarif et al., 2003). However cochleate 
formation is through process of continuous self-assembly which caters for coexistence of 
intermediates along with final product. Apart from this, the nature of cochleates to undergo 
continuous aggregation due to their hydrophobicity also makes control over final product a 
challenging task. Therefore, the approaches such as increasing viscosity of reaction medium or 
formulation of multiple emulsion did not help with issue of polydispersity even though they provided 
limited control over the size of final cochleate particles. Hence, we believe that although controlled 
mixing of reactants is a pivotal parameter for preparation of monodisperse cochleate system it is not 
the sole aspect that governs the final product.  
 
Figure 4.2: Diagrammatic representation of formation of monodisperse cochleate composites using 
microfluidic device after interaction of lipid solution with of calcium ions. 
In (Manuscript 3) we have employed non-aqueous medium in combination with controlled mixing to 
formulate cochleates. The formation of lipid structures by nanoprecipitation in water-miscible 
organic solvents is not new. In this strategy using organic solvents along with aqueous phase aids in 
formation of nano-sized particles. Also as compared to aqueous environment it might aid in reducing 
surface tension at the interface of lipid particle and aggregation during preparation (Ramteke et al., 
2012). Our dedication for this approach was supported by preliminary investigations which indicated 
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that the presence of water miscible organic solvent (>50% v/v) during precipitation gave rise to 
spheres made of nano-sized cochleates. To produce cochleates consistently, using microfluidic device 
was also a preferred choice. Microfluidics is a platform that has been known for its versatility 
regarding formulation of wide range of drug delivery systems (Zhang et al., 2013) and could exercise 
far greater control on the particle size than is possible by conventional methods.  
In (Manuscript 3), we have presented a microfluidics-based high through-put method for formation 
of microspheres (3-5 μm in diameter) made up of nano-cochleates. The formation of cochleates in a 
micromixer chip of microfluidic device is probably mediated by the diffusion of organic solvent into 
the miscible aqueous phase which causes nucleation, forming the lipid stacks. The high ethanol 
concentration during formulation of cochleates might stabilize the hydrophobic surfaces of stacks 
and assists in decreasing their bending energy (Feller et al., 2002; Patra et al., 2006). This may explain 
the formation of nano-scaled cochleates which further undergo aggregation to form microspheres. 
The process parameters such as flow rate and ratio of organic phase were optimized to produce 
monodispersed particles. Our results revealed that the particle size could be varied by changing the 
flow rate during preparation. The intermediates arising from overlapping of nucleation and growth 
phase could be minimized using optimized parameters. Particles obtained by this method were 
considerably uniform in size as compared to those obtained from conventional methods. This could 
be attributed to the fact that microfluidic device allowed for precise and reproducible mixing over 
micrometer length scales with controlled mechanical conditions. In comparison with conventional 
techniques, our approach offered easy handling and short formulation time. Microscopy studies and 
SAXS data confirmed the reproducibility of this technique and homogeneity of the products. Hence, 
development of this process could improve the quality attributes of cochleate formulations. 
4.2 Conclusions and potential applications of this study  
During current investigations of cochleates, findings regarding morphology and sequence of 
evolution of hierarchical structures have been made. The conclusions of this study may aid in finding 
missing links in previous literature on the formation mechanism of cochleates. Improved 
understanding of the formation mechanism could also allow for rectification of currently available 
formulation methods and the development new methods with higher reproducibility. The knowledge 
of different hierarchical structures and their possibility of coexistence might be of great interest 
considering their direct influence on physicochemical characteristics, stability, release kinetics etc. 
The high resolutions techniques used during this investigation availed gathering of additional 
information regarding peculiar structural features such as the hollow central channel. The detailed 
elucidation of structure of cochleates could help to establish a better perception regarding their 
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possible applications. This, in turn, would contribute to the design of cochleates for specific tasks. 
Developing a simple protocol to prepare monodisperse formulation of cochleates is a step ahead 
towards pharmaceutical industry and has several practical advantages. The described methodology 
availed reproducibility to the cochleate formulations. This would enable reproducibility of 
physicochemical characteristics of drug delivery system. Further a microfluidics device may allow for 
improved assistance in retaining the properties of sensitive drugs by providing controlled 
environment during preparation of cochleates as compared to conventional methods. The 
conventional approaches generate polydisperse aggregates of cochleates along with the 
intermediate morphologies. Given that stages like milling, homogenization, purification, washing of 
the final product cause an additional expense, using our strategy could prove cost effective. Cochleate 
microparticles synthesized using the microfluidic device can be easily modulated to produce higher 
yields. This can be of major advantage for expensive drugs considering the minimization of losses 
during production. So we postulate that our methodology described formation of monodisperse 
system that could widen the range of applications of cochleates. However, further studies are needed 
in order to reach the goal of incorporation of drug in formulation and further evaluation for efficiency. 
Nevertheless we hope that our study would contribute to advance the knowledge of cochleates and 
facilitate future research. 
 
4.3 Future prospects of cochleates: 
Cochleates are promising vehicles and are under investigation by companies like Matinas BioPharma 
in order to improve efficacy of some orally ineffective therapeutic agents. Considering medical 
applications, we can expect several drugs such as amphotericin B, ibuprofen etc. formulated into 
cochleate formulations in coming decades. Immunotherapy is another area in which researchers may 
expect progress. However to exercise potential of cochleates as drug delivery system in vivo, clear 
understanding of their mechanism of action at tissue and cellular level is required. More attention 
needs to be paid in understanding the effect of different building materials on systems efficiency in 
vivo. To design cochleates for successful drug delivery it is essential to carry out fundamental research 
to understand complex interactions such as drug release rates in different pathologies, effect of 
biological interactions like opsonization, and the barriers subjected while approaching target site etc. 
Given that the efficiency of cochleates is so far mainly gauged based on cell culture assays and murine 
models, the priority for future research should be to conduct bioavailability studies in humans. Apart 
from pharmaceutical industry cochleates may also prove to be useful in other areas such as food and 
nutrition industry, agricultural industry etc. Although during pharmaceutical investigations 
cochleates are made from pure and expensive raw materials using high technology, the low-purity 
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lipid extracts may also be used for preparation. The growth of lipid based novel technologies in 
cosmetic products like skin creams, sunscreen lotions etc. have always helped in capturing the 




5 Summary  
Cochleates represent a unique and attractive platform for biomedical applications. Interest of 
pharmaceutical industries towards phospholipid based biodegradable drug delivery systems have 
propelled investigations on cochleates in recent years. While, evaluating versatility and efficiency 
of cochleates as a drug delivery vehicle remains the main focus of current research, cochleates still 
need to overcome some hurdles which stand in the way to reach the other side of a product 
pipeline. Better understanding of fundamental details such as structure and formation 
mechanisms will assist in improving performance of cochleates as a drug delivery vehicle. In this 
thesis we have carried out investigations on structural features and formation pathways of 
cochleates. Furthermore, we have employed our knowledge in developing novel methodology to 
produce improved cochleate formulation.  
In the past most of the investigations related to structural features or formation of cochleates have 
relied heavily on freeze fracture techniques. In this study, we have investigated cochleates of 
phosphatidylserines using different microscopy techniques for searching metastable 
intermediates and their coexistence with cochleates. Based on our morphological exploration, we 
speculate a probable order of well-defined hierarchical structures in the pathway for cochleate 
formation. This mechanism may be through evolution of unstable intermediate aggregates that 
form ribbonlike structures containing calcium. Ribbons further aggregate to form stacks or sheets, 
which leads to the formation of stable cochleates. It was found that the structures such as stacks, 
sheets and their networks can coexist with cochleates up to 12 months. The highlight of our study 
was the observation that, stack formation was an essential stage in the formation mechanism, as 
in its absence cochleate formation was hindered. Data from tomographic evaluation 
demonstrated cochleates to be cylindrically curved bilayers enclosing an inner channel. The 
dimensions of a cochleate vary statistically with changes in building lipids. Specifically, the 
unsaturated lipid tends to form cochleates with larger dimensions as compared to the saturated 
lipid. We proposed a theoretical model based on these findings in order to predict dimensions 
of cochleates.  
All the observations of microscopy studies pointed towards the fact that for achievement of 
desired cochleate formulation, controlled environment allowing a single morphology to prevail is 
very important. Hence, in the current investigation we have developed a simple method for 
preparation of monodisperse cochleate formulations. We used a combined approach employing 
solvent effect along with controlled mixing by a microfluidic device. For this purpose, the lipid 
solution in an organic solvent was subjected to fast mixing with very small amount of aqueous 
solution of binding agent. The novel formulation obtained by this method consisted of 
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microspheres (~4 μm in diameter) made up of nanocochleates and was suitable for large scale 
production. Our studies suggest that during controlled mixing, lipid stacks are generated within 
milliseconds. These stacks probably entangle and fuse into a micro spherical composite. We 
presumed that excess of ethanol reduced the bending energy and might have stabilized the 
interface of lipid stacks reducing the aggregation. This might aid in both, formation of 
nanocochleates and regular microspheres. The microspheres obtained were characterized using 
SAXS and electron microscopy and compared with cochleates obtained from preexisting 
methodologies. EM data confirmed that the cochleate composites were clustered matrices of 
nanoscale cochleates. Findings from characterization studies confirmed that our methodology 
eliminated elaborate preparation methods, while providing a monodispersed cochleate system 
with analogous qualities to nanocochleates.  
In conclusion our project has managed to capture new information regarding the structural details 
and formation mechanisms of cochleates. Furthermore a simple, fast, efficient and highly 
reproducible method with strong control over process parameters was successfully developed for 
formation of monodispersed cochleate system. We believe our effort will provide a better 
understanding of formation of cochleates, which may help scientists to tailor their formulations by 




Cochleate stellen ein einzigartiges und attraktives Konzept für biomedizinische Anwendungen dar. 
Das steigende Interesse der pharmazeutischen Industrie an bioabbaubaren 
Arzneistoffträgersystemen auf Basis von Phospholipiden hat in den letzten Jahren die Forschung 
über Cochleate vorangetrieben. Aktuell ist das Hauptanliegen der Forschung die Ermittlung der 
Leistungsfähigkeit und Vielseitigkeit der Cochleate als Arzneistoffträgersysteme. Allerdings 
müssen noch einige Hürden überwunden werden, bevor Cochleate den Sprung aus der 
Produktpipeline auf den Markt schaffen können. Ein tieferes Verständnis grundlegender 
Eigenschaften wie die Struktur und der Entstehungsmechanismus sollen helfen, die Leistung von 
Cochleaten als Arzneistoffträgersystemen zu verbessern. In dieser Arbeit haben wir 
Untersuchungen zu strukturellen Merkmalen und Entstehungsmechanismen von Cochleaten 
durchgeführt. Zusätzlich haben wir unsere Erfahrung in der Methodenentwicklung genutzt, um 
verbesserte Cochleatformulierungen herzustellen. In der Vergangenheit basierte die Mehrheit der 
Untersuchungen zu strukturellen Eigenschaften oder der Entstehung von Cochleaten auf 
Gefrierbruchtechniken. In dieser Arbeit haben wir Cochleate aus Phosphatidylserinen mit Hilfe 
verschiedener Mikroskopietechniken in Hinblick auf metastabile Zwischenzustände und deren Co-
Existenz mit Cochleaten untersucht. Basierend auf unseren morphologischen Untersuchungen 
beschreiben wir die Entstehung der Cochleate als eine mögliche Abfolge klar abgegrenzter, 
hierarchischer Strukturen. Der beschriebene Mechanismus verläuft über die Entstehung instabiler 
Zwischenprodukte, die bandartige Strukturen mit Calcium darstellen. Diese bandartigen 
Strukturen verbinden sich weiter zu Folien oder Stapeln, was schließlich zur Bildung stabiler 
Cochleate führt. Es konnte gezeigt werden, dass die Strukturen wie Stapel und Folien bis zu 12 
Monate mit Cochleaten co-existieren können. Der Höhepunkt dieser Studie war die Beobachtung, 
dass die Stapelbildung ein essentieller Schritt in der Entstehung der Cochleate ist, da in ihrer 
Abwesenheit die Cochleatbildung verhindert wurde. Tomographische Untersuchungen zeigten, 
dass Cochleate aus zylindrisch gekrümmten Bilayern bestehen, die einen inneren Kanal 
umschließen. Die Größe von Cochleaten variiert statistisch und hängt vom verwendeten Lipid ab. 
Besonders ungesättigte Phosphatidylserine tendieren im Vergleich zu ihren gesättigten Analoga 
dazu, größere Cochleate zu bilden. Auf Grundlage dieser Beobachtungen stellen wir ein 
theoretisches Modell vor, mit dessen Hilfe sich die Größe der Cochleate vorhersagen lässt. Unsere 
Beobachtungen belegen die Tatsache, dass für die Produktion einer speziellen 
Cochleatformulierung kontrollierte Bedingungen, die das Auftreten einer einzigen Morphologie 
begünstigen, sehr wichtig sind. Somit haben wir mit der vorliegenden Arbeit eine einfache 
Methode zur Herstellung monodisperser Cochleate entwickelt. Wir haben hierfür 
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Lösungsmitteleffekte, die durch Ethanol auf Cochleate1 verursacht werden, mit einem 
kontrollierten Mischen durch einen Microfluidizer2 kombiniert. Zu diesem Zweck wurden die 
Phosphatidylserine in einem organischen Lösungsmittel gelöst und schnell mit einer kleinen 
Menge einer wässrigen Lösung des Bindemittels gemischt. Die durch diese Methode erhaltene 
neue Formulierung besteht aus Mikrokugeln3 (~4 μm Durchmesser), die aus Nanocochleaten 
zusammengesetzt sind, und eignet sich für die Großproduktion. Unsere Studie legt nahe, dass 
während des kontrollierten Mischens Lipidstapel innerhalb von Millisekunden entstehen. Diese 
Stapel verfangen sich und fusionieren zu einem kugelförmigen Konstrukt im µm Bereich. Wir 
nehmen an, dass ein Überschuss an Ethanol die Biegeenergie reduziert und so möglicherweise die 
Grenzflächen der Lipidstapel stabilisiert und die Aggregation behindert. Dies kann sowohl bei der 
Entstehung der Nanocochleate als auch der regelmäßigen Mikrokugeln helfen. Die entstandenen 
Mikrokugeln wurden mit Hilfe von SAXS und Elektronenmikroskopie charakterisiert und mit 
Ergebnissen vorhandener Methoden verglichen, um die Bildung der Cochleate zu bestätigen. 
Durch Elektronenmikroskopie konnte belegt werden, dass die Cochleatverbände ein gebündeltes 
Netzwerk nanoskaliger Cochleate sind. Die Erkenntnisse aus den Charakterisierungsstudien 
bestätigen, dass unsere Methode etablierte Herstellmethoden verdrängt, indem eine 
monodisperse Cochleatformulierung mit vergleichbarer Qualität zu Nanocochleaten entsteht. 
Zusammenfassend konnte unser Projekt einige neue Informationen in Bezug auf die strukturellen 
Eigenschaften und den Entstehungsmechanismus der Cochleate aufdecken. Weiterhin wurde eine 
einfache, schnelle, effiziente und reproduzierbare Methode mit streng kontrollierten 
Prozessparametern zur Herstellung monodisperser Cochleate etabliert. Diese Arbeit trägt zu 
einem besseren Verständnis der Entstehung von Cochleaten bei und gibt Wissenschaftlern die 
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AFM → Atomic force microscopy 
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DMPS → 1,2-dimyristoyl-sn-glycero-3-phospho-L-serine 
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